data_2i1t_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2i1t _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.676 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.314 0.578 . . . . 99.99 109.879 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.409 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -92.13 -118.32 2.41 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.711 -1.356 . . . . 99.99 109.711 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.493 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -147.55 -143.1 3.78 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.238 -1.545 . . . . 99.99 109.238 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.404 ' HA ' ' HE2' ' A' ' 22' ' ' TYR . 27.3 t80 -90.68 -37.78 13.51 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.296 -1.12 . . . . 99.99 110.59 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.82 70.49 1.35 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.513 -0.742 . . . . 99.99 109.808 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.493 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 16.7 m0 -96.85 166.19 11.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.36 -0.838 . . . . 99.99 109.734 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -92.12 134.74 34.57 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.166 -0.958 . . . . 99.99 110.919 -179.55 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 31.2 p -151.07 159.03 44.76 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 120.036 -0.666 . . . . 99.99 110.579 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.82 -115.89 1.0 Allowed Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.427 -1.469 . . . . 99.99 109.427 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.517 ' HG3' ' HB3' ' A' ' 26' ' ' LYS . 1.0 OUTLIER -90.66 29.58 1.29 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.435 -1.038 . . . . 99.99 110.044 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.92 38.68 3.31 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.147 -1.581 . . . . 99.99 109.147 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.575 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -74.16 -57.34 2.31 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.406 -1.055 . . . . 99.99 110.572 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 46.9 Cg_endo -74.58 134.99 19.3 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 O-C-N 123.719 1.378 . . . . 99.99 109.975 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -71.84 105.77 1.87 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.92 1.484 . . . . 99.99 110.693 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.0 m -74.79 176.57 6.92 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.397 -0.814 . . . . 99.99 109.761 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.676 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.1 m -81.2 161.9 23.81 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.28 -0.887 . . . . 99.99 110.301 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -56.24 125.66 22.77 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.562 -0.711 . . . . 99.99 110.543 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.6 -18.73 54.71 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.122 -1.191 . . . . 99.99 110.122 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.51 ' CD1' ' HB2' ' A' ' 19' ' ' CYS . 52.8 m-85 -94.58 142.47 27.4 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.253 -1.145 . . . . 99.99 110.153 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -124.82 140.81 52.59 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.426 -0.796 . . . . 99.99 110.349 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 14.1 t -89.44 159.56 17.22 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.51 -0.744 . . . . 99.99 110.158 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -138.14 123.27 19.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.62 -0.675 . . . . 99.99 111.031 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.517 ' HB3' ' HG3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -76.63 -35.12 58.24 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.658 -0.651 . . . . 99.99 110.003 179.157 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.4 m -69.99 -38.75 76.1 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.46 -0.775 . . . . 99.99 109.389 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.526 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 40.3 m0 -80.02 -40.85 26.94 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.4 -0.592 . . . . 99.99 109.4 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.48 16.37 43.3 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.412 -1.075 . . . . 99.99 110.412 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.526 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.0 p90 -151.0 177.84 9.77 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.999 -1.295 . . . . 99.99 111.021 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 25.2 t -127.27 128.37 45.88 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.698 -0.626 . . . . 99.99 110.235 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.48 172.83 14.34 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.605 -0.684 . . . . 99.99 110.096 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.459 HG22 ' CE2' ' A' ' 22' ' ' TYR . 99.1 t . . . . . 0 N--CA 1.501 2.108 0 O-C-N 121.389 -0.82 . . . . 99.99 110.018 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.478 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.081 0.467 . . . . 99.99 109.958 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.548 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -78.84 -142.87 2.31 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.149 -1.18 . . . . 99.99 110.149 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.502 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -142.7 -151.48 5.5 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.7 -1.36 . . . . 99.99 109.7 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -76.92 -29.33 55.63 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.34 -1.094 . . . . 99.99 111.059 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -153.83 69.97 0.81 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.315 -0.866 . . . . 99.99 110.233 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.548 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 20.8 m0 -98.62 176.07 5.77 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.494 -0.754 . . . . 99.99 109.704 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.77 138.93 31.06 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.143 -0.973 . . . . 99.99 110.393 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 33.6 t -150.99 161.01 43.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.541 -0.724 . . . . 99.99 110.442 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -103.49 -121.43 4.93 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.471 -1.452 . . . . 99.99 109.471 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.575 ' HA ' ' HB3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.71 37.37 0.92 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.364 -1.08 . . . . 99.99 110.347 179.638 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.17 34.55 7.09 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.74 -1.344 . . . . 99.99 109.74 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.568 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 1.4 tptp -77.58 -58.97 0.87 Allowed Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.319 -1.107 . . . . 99.99 110.19 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 47.2 Cg_endo -75.07 133.4 16.43 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.694 1.365 . . . . 99.99 110.018 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.63 104.93 1.68 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 O-C-N 123.899 1.473 . . . . 99.99 110.589 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.2 m -72.38 166.36 22.7 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.414 -0.804 . . . . 99.99 109.728 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -67.77 155.97 38.09 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.255 -0.903 . . . . 99.99 110.407 -179.689 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.02 128.67 28.18 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.667 -0.646 . . . . 99.99 111.138 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.65 -20.42 50.73 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.479 -1.048 . . . . 99.99 110.479 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.458 ' N ' ' CD1' ' A' ' 22' ' ' TYR . 12.3 m-30 -89.7 150.89 22.13 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.168 -1.195 . . . . 99.99 110.31 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.39 142.42 51.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.671 -0.643 . . . . 99.99 109.852 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 18.3 t -89.3 159.69 17.26 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.447 -0.783 . . . . 99.99 110.622 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.0 m -138.64 106.92 5.78 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.635 -0.666 . . . . 99.99 110.424 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.575 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -72.99 -33.4 65.79 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.371 -0.83 . . . . 99.99 110.285 179.363 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.6 m -68.87 -36.74 78.46 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.471 -0.768 . . . . 99.99 109.83 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.573 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 47.0 m0 -84.04 -40.16 18.71 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.747 -0.595 . . . . 99.99 109.565 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.96 14.91 25.46 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 111.032 -0.827 . . . . 99.99 111.032 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.573 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 2.6 p90 -151.46 177.77 9.96 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.843 -1.387 . . . . 99.99 111.458 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 15.8 t -126.89 126.53 43.44 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.45 -0.574 . . . . 99.99 109.45 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.9 177.91 7.63 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.555 -0.715 . . . . 99.99 110.498 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 17.6 t . . . . . 0 N--CA 1.496 1.87 0 O-C-N 121.452 -0.78 . . . . 99.99 110.208 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 121.281 0.563 . . . . 99.99 109.92 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.537 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -77.22 -149.61 3.49 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.331 -1.108 . . . . 99.99 110.331 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.443 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -139.49 -139.56 3.8 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.66 -1.376 . . . . 99.99 109.66 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -90.25 -19.22 24.39 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.447 -1.031 . . . . 99.99 111.242 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -161.85 65.01 0.25 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.27 -0.894 . . . . 99.99 109.679 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.537 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 20.7 m0 -97.15 162.19 13.47 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.472 -0.767 . . . . 99.99 109.697 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -90.79 134.41 34.46 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.994 -1.066 . . . . 99.99 110.873 -179.555 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.1 p -150.79 169.85 20.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.516 -0.74 . . . . 99.99 110.471 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.6 -131.02 2.53 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.687 -1.365 . . . . 99.99 109.687 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.588 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.45 55.02 2.89 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.478 -1.013 . . . . 99.99 110.026 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 78.68 35.4 32.22 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.061 -1.216 . . . . 99.99 110.061 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.5 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 2.3 mttt -76.36 -60.32 0.94 Allowed Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.327 -1.102 . . . . 99.99 110.356 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.5 ' CD ' ' CB ' ' A' ' 15' ' ' LYS . 47.3 Cg_endo -73.2 141.36 32.27 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.651 1.343 . . . . 99.99 110.168 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.442 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 42.9 Cg_endo -71.78 103.23 1.43 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.856 1.45 . . . . 99.99 110.867 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.493 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 24.7 m -71.27 162.16 29.88 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.366 -0.834 . . . . 99.99 109.659 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.423 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -63.93 148.99 48.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.125 -0.985 . . . . 99.99 109.681 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.54 126.0 18.16 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.618 -0.676 . . . . 99.99 111.101 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.34 -29.21 9.82 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.096 -1.202 . . . . 99.99 110.096 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 5.5 m-85 -95.26 152.87 18.0 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.299 -1.118 . . . . 99.99 110.497 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -128.78 146.97 50.76 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.648 -0.658 . . . . 99.99 110.143 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.563 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 0.8 OUTLIER -91.82 160.87 15.1 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.435 -0.79 . . . . 99.99 110.566 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.539 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 0.5 OUTLIER -135.88 122.33 20.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.647 -0.658 . . . . 99.99 110.392 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.588 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -73.68 -42.02 61.88 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.456 -0.777 . . . . 99.99 109.38 179.189 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.8 m -63.27 -40.0 96.17 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.686 -0.634 . . . . 99.99 109.782 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.539 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 42.4 m0 -80.18 -46.07 17.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.773 -0.579 . . . . 99.99 109.5 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.7 18.45 23.01 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.785 -0.926 . . . . 99.99 110.785 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.508 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.8 p90 -151.38 -176.54 5.62 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.924 -1.339 . . . . 99.99 111.394 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.563 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 6.6 t -126.46 125.56 42.33 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.414 -0.588 . . . . 99.99 109.414 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.58 174.33 10.67 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.442 -0.786 . . . . 99.99 110.668 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.0 t . . . . . 0 N--CA 1.497 1.887 0 O-C-N 121.485 -0.759 . . . . 99.99 110.07 -179.767 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 121.268 0.556 . . . . 99.99 109.976 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.473 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -81.07 -149.45 6.57 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.224 -1.151 . . . . 99.99 110.224 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.441 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -131.44 -140.9 4.67 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.44 -1.464 . . . . 99.99 109.44 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.556 ' HA ' ' CE1' ' A' ' 22' ' ' TYR . 20.6 p90 -90.51 -22.03 21.54 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.402 -1.058 . . . . 99.99 110.901 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 32.4 t90 -156.59 69.44 0.61 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.247 -0.908 . . . . 99.99 109.701 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.473 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 17.8 m0 -99.69 174.37 6.26 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.441 -0.787 . . . . 99.99 109.662 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.9 mtmm -90.15 138.52 31.45 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.955 -1.091 . . . . 99.99 110.261 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.422 ' SG ' ' HD2' ' A' ' 16' ' ' PRO . 13.9 t -150.67 162.44 40.69 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.972 -0.691 . . . . 99.99 110.256 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -102.27 -117.65 4.31 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.375 -1.49 . . . . 99.99 109.375 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.595 ' HA ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -91.25 28.99 1.51 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.42 -1.047 . . . . 99.99 110.305 179.362 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.15 32.54 5.52 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.596 -1.402 . . . . 99.99 109.596 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.572 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 4.8 tptt -72.22 -58.7 3.03 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.373 -1.075 . . . . 99.99 110.2 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 49.1 Cg_endo -75.85 131.89 13.78 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.701 1.369 . . . . 99.99 109.974 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.41 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 42.8 Cg_endo -71.82 100.95 1.12 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.767 1.404 . . . . 99.99 110.167 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.8 m -67.92 161.32 26.71 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.33 -0.856 . . . . 99.99 109.994 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -64.7 156.47 30.22 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.462 -0.774 . . . . 99.99 110.087 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.53 128.38 35.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.445 -0.784 . . . . 99.99 110.616 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.28 -28.0 16.19 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.893 -1.283 . . . . 99.99 109.893 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.556 ' CE1' ' HA ' ' A' ' 7' ' ' PHE . 88.9 m-85 -94.36 142.98 26.79 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.503 -0.998 . . . . 99.99 110.112 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.41 148.81 43.29 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.549 -0.719 . . . . 99.99 110.056 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.5 t -88.73 160.96 17.07 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.495 -0.753 . . . . 99.99 110.266 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.7 m -140.05 102.24 4.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.651 -0.656 . . . . 99.99 110.701 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.595 ' HB2' ' HA ' ' A' ' 13' ' ' ARG . 2.1 tptp -69.12 -36.31 77.35 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.311 -0.868 . . . . 99.99 109.76 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.4 m -62.26 -37.79 86.8 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.619 -0.676 . . . . 99.99 110.185 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.56 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 45.7 m0 -88.44 -50.23 6.44 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.622 -0.674 . . . . 99.99 109.952 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.54 16.08 6.66 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.524 -0.846 . . . . 99.99 111.209 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.56 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.4 p90 -150.51 -177.85 6.2 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.831 -1.394 . . . . 99.99 111.281 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 22.5 t -129.92 126.23 37.39 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.671 -0.643 . . . . 99.99 110.233 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.19 173.22 14.17 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.672 -0.642 . . . . 99.99 110.191 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.5 t . . . . . 0 N--CA 1.501 2.106 0 O-C-N 121.272 -0.892 . . . . 99.99 109.904 179.816 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.494 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.576 0.703 . . . . 99.99 110.239 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.454 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -92.56 -126.09 3.9 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.183 -1.567 . . . . 99.99 109.183 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.51 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -147.66 -142.41 3.67 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.219 -1.552 . . . . 99.99 109.219 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.404 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 44.5 m-85 -90.57 -32.66 16.2 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.443 -1.033 . . . . 99.99 110.528 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -145.02 70.52 1.27 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.497 -0.752 . . . . 99.99 109.93 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.51 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 15.6 m0 -100.52 175.51 5.65 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.425 -0.797 . . . . 99.99 109.983 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt -89.8 138.76 31.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.133 -0.979 . . . . 99.99 110.55 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.461 ' SG ' ' HD2' ' A' ' 16' ' ' PRO . 29.1 t -151.61 161.85 41.98 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.546 -0.721 . . . . 99.99 110.38 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.56 -117.1 3.92 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.171 -1.572 . . . . 99.99 109.171 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.428 ' HA ' ' HB2' ' A' ' 26' ' ' LYS . 13.6 tpt180 -90.7 21.69 3.92 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.393 -1.063 . . . . 99.99 109.898 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.51 34.18 3.41 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.473 -1.451 . . . . 99.99 109.473 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.534 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -77.28 -54.7 1.45 Allowed Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.361 -1.082 . . . . 99.99 110.824 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 47.5 Cg_endo -74.28 132.38 16.37 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.678 1.357 . . . . 99.99 110.115 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -71.45 104.57 1.59 Allowed 'Trans proline' 0 C--N 1.314 -1.271 0 O-C-N 123.771 1.406 . . . . 99.99 110.667 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.2 m -75.26 167.2 22.37 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.404 -0.81 . . . . 99.99 109.386 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -64.37 165.1 10.2 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.25 -0.906 . . . . 99.99 110.303 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.0 126.17 27.19 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.322 -0.861 . . . . 99.99 110.195 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.44 4.97 54.7 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.547 -1.021 . . . . 99.99 110.547 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 87.9 m-85 -118.28 150.71 39.01 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.082 -1.246 . . . . 99.99 109.507 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -127.84 147.21 50.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.325 -0.86 . . . . 99.99 110.589 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.4 t -88.97 162.08 16.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.585 -0.697 . . . . 99.99 110.539 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.461 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 7.7 t -139.26 113.6 8.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.652 -0.655 . . . . 99.99 110.63 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 13' ' ' ARG . 14.2 tptm -74.01 -39.83 63.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.496 -0.753 . . . . 99.99 110.213 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.3 m -65.5 -36.93 85.31 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.487 -0.758 . . . . 99.99 110.306 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.515 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 49.0 m0 -83.86 -46.9 11.64 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.613 -0.679 . . . . 99.99 110.027 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.02 19.98 10.26 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 120.373 -0.918 . . . . 99.99 111.174 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.515 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.7 p90 -150.79 -175.28 5.06 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.864 -1.374 . . . . 99.99 110.991 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 18.5 t -133.39 125.22 28.64 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.507 -0.746 . . . . 99.99 110.214 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.29 168.16 24.87 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.779 -0.575 . . . . 99.99 109.727 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 81.5 t . . . . . 0 N--CA 1.502 2.125 0 O-C-N 121.315 -0.866 . . . . 99.99 109.753 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.495 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 121.3 0.572 . . . . 99.99 110.646 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.434 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -106.44 -112.16 3.66 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.299 -1.52 . . . . 99.99 109.299 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.533 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -152.77 -148.98 5.01 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.482 -1.447 . . . . 99.99 109.482 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.444 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 3.1 t80 -89.62 -35.87 15.61 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.3 -1.118 . . . . 99.99 110.585 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -137.28 78.37 1.69 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.326 -0.859 . . . . 99.99 108.954 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.533 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 11.7 m0 -109.33 166.97 10.46 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.401 -0.812 . . . . 99.99 110.069 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.08 137.64 32.24 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.016 -1.053 . . . . 99.99 110.814 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.8 p -150.87 166.72 29.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.581 -0.7 . . . . 99.99 110.419 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.12 -118.6 3.69 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.358 -1.497 . . . . 99.99 109.358 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.572 ' HA ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.93 38.36 0.95 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.508 -0.995 . . . . 99.99 110.097 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.95 37.08 5.81 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.725 -1.35 . . . . 99.99 109.725 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.552 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 2.0 tttt -80.11 -56.55 0.72 Allowed Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.366 -1.079 . . . . 99.99 110.771 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.552 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 48.7 Cg_endo -75.94 126.39 9.33 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.647 1.341 . . . . 99.99 110.266 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.03 114.61 4.09 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.901 1.474 . . . . 99.99 110.55 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 81.1 m -83.4 -179.16 7.29 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.581 -0.699 . . . . 99.99 110.128 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.495 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.4 OUTLIER -72.42 158.64 35.38 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.261 -0.899 . . . . 99.99 110.243 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -54.99 122.47 10.98 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.454 -0.779 . . . . 99.99 110.07 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.2 -26.3 22.36 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.635 -1.386 . . . . 99.99 109.635 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.48 ' CE2' ' CG2' ' A' ' 33' ' ' VAL . 88.3 m-85 -89.72 135.97 33.31 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.408 -1.054 . . . . 99.99 109.492 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -123.2 148.56 45.67 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.272 -0.892 . . . . 99.99 110.34 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 7.1 t -89.04 159.49 17.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.517 -0.74 . . . . 99.99 110.251 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.403 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 2.4 m -137.41 113.41 9.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.679 -0.638 . . . . 99.99 110.465 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.572 ' HB2' ' HA ' ' A' ' 13' ' ' ARG . 3.3 ttpt -70.79 -39.76 72.96 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.531 -0.731 . . . . 99.99 109.57 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.0 m -62.05 -39.09 91.17 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.658 -0.651 . . . . 99.99 109.666 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.489 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 42.5 m0 -82.22 -41.6 20.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.727 -0.608 . . . . 99.99 109.626 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.5 14.92 33.68 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.423 -1.071 . . . . 99.99 110.423 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.489 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.7 p90 -151.62 -179.95 7.86 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.013 -1.287 . . . . 99.99 110.941 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 49.2 t -126.43 127.2 45.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.62 -0.675 . . . . 99.99 110.209 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -148.04 174.74 11.62 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.511 -0.743 . . . . 99.99 109.915 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.48 ' CG2' ' CE2' ' A' ' 22' ' ' TYR . 87.2 t . . . . . 0 N--CA 1.499 2.008 0 O-C-N 121.238 -0.914 . . . . 99.99 110.424 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.544 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 121.455 0.645 . . . . 99.99 110.245 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.529 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -83.93 -134.9 2.71 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.737 -1.345 . . . . 99.99 109.737 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.464 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -146.47 -147.11 4.5 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.517 -1.433 . . . . 99.99 109.517 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -77.07 -30.14 55.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.326 -1.102 . . . . 99.99 111.26 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -153.65 72.8 0.93 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.242 -0.911 . . . . 99.99 110.186 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.529 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 18.1 m0 -102.49 174.86 5.71 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.46 -0.775 . . . . 99.99 109.444 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.16 145.47 25.41 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.028 -1.045 . . . . 99.99 110.199 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.557 ' SG ' ' HG2' ' A' ' 16' ' ' PRO . 44.4 t -151.04 160.38 43.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.55 -0.719 . . . . 99.99 110.714 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.02 -123.84 4.64 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.029 -1.628 . . . . 99.99 109.029 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.65 ' HA ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -88.71 -37.96 15.11 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.377 -1.073 . . . . 99.99 109.789 179.391 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.02 36.2 0.13 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.389 -1.484 . . . . 99.99 109.389 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.629 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 5.0 mttp -89.72 -69.15 0.1 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.371 -1.076 . . . . 99.99 110.534 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.629 ' HD3' ' CB ' ' A' ' 15' ' ' LYS . 49.6 Cg_endo -77.25 113.07 3.51 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 O-C-N 123.525 1.276 . . . . 99.99 109.913 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.408 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 49.5 Cg_endo -77.24 116.47 4.16 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.834 1.439 . . . . 99.99 110.7 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 22' ' ' TYR . 0.5 OUTLIER -68.4 157.39 35.88 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.978 -0.749 . . . . 99.99 108.978 179.117 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.544 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -60.7 153.1 24.93 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.083 -1.011 . . . . 99.99 110.461 -179.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -45.07 127.85 6.91 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.795 -0.566 . . . . 99.99 111.076 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.66 -29.04 10.35 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.902 -1.279 . . . . 99.99 109.902 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.44 ' CD1' HG22 ' A' ' 33' ' ' VAL . 4.1 m-85 -104.1 129.84 51.8 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.41 -1.053 . . . . 99.99 110.245 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -101.31 148.54 25.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.47 -0.769 . . . . 99.99 109.538 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 2.8 t -89.15 159.41 17.51 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.17 -0.956 . . . . 99.99 110.27 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.522 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 0.3 OUTLIER -143.96 121.2 11.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.585 -0.697 . . . . 99.99 111.289 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.65 ' HB2' ' HA ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -75.92 -41.43 51.85 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.536 -0.727 . . . . 99.99 109.402 178.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.6 m -58.92 -37.29 76.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.74 -0.6 . . . . 99.99 109.702 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.522 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 42.5 m0 -86.15 -37.29 18.9 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.275 -0.639 . . . . 99.99 109.275 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.38 16.1 47.99 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.375 -1.09 . . . . 99.99 110.375 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.492 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 2.6 p90 -152.01 178.15 9.74 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.001 -1.294 . . . . 99.99 110.779 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 9.8 p -130.66 127.27 38.56 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.433 -0.792 . . . . 99.99 110.117 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.8 -178.22 6.33 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.682 -0.636 . . . . 99.99 110.124 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.44 HG22 ' CD1' ' A' ' 22' ' ' TYR . 24.8 t . . . . . 0 N--CA 1.503 2.184 0 O-C-N 121.222 -0.924 . . . . 99.99 110.302 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.425 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 121.28 0.562 . . . . 99.99 110.494 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.421 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -105.78 -112.27 3.68 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.053 -1.619 . . . . 99.99 109.053 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.55 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -151.06 -153.62 6.23 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.483 -1.447 . . . . 99.99 109.483 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -85.13 -33.42 22.36 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.221 -1.164 . . . . 99.99 110.706 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 16.8 t90 -142.76 75.01 1.47 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.332 -0.855 . . . . 99.99 109.593 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.55 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 14.5 m0 -104.51 166.16 10.58 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.651 -0.656 . . . . 99.99 109.447 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -90.61 136.83 32.81 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.999 -1.063 . . . . 99.99 110.568 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.1 p -150.84 171.81 16.63 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.976 -0.69 . . . . 99.99 110.723 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.33 -123.23 3.17 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.835 -1.306 . . . . 99.99 109.835 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.428 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -91.11 24.86 2.67 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.416 -1.05 . . . . 99.99 110.441 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.76 37.3 2.06 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.595 -1.402 . . . . 99.99 109.595 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.434 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 0.5 OUTLIER -82.43 -56.86 0.5 Allowed Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.4 -1.059 . . . . 99.99 111.062 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' A' ' 15' ' ' LYS . 46.9 Cg_endo -73.93 130.89 14.95 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 O-C-N 123.568 1.299 . . . . 99.99 110.517 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -73.14 113.06 3.68 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.785 1.413 . . . . 99.99 110.951 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.8 m -85.27 -178.99 6.89 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.638 -0.664 . . . . 99.99 110.221 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.425 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -74.93 151.78 38.86 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.235 -0.916 . . . . 99.99 110.211 179.709 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.33 115.6 2.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.703 -0.623 . . . . 99.99 110.638 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.83 -33.77 3.8 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.557 -1.417 . . . . 99.99 109.557 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -94.7 149.99 20.67 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.507 -0.996 . . . . 99.99 110.304 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -126.19 150.05 48.59 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.569 -0.707 . . . . 99.99 109.789 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 15.9 t -89.06 158.22 18.05 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.226 -0.921 . . . . 99.99 110.395 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.1 m -141.51 131.59 24.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.651 -0.655 . . . . 99.99 110.77 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.428 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 11.6 tptp -84.73 -44.48 13.32 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.669 -0.644 . . . . 99.99 109.34 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.2 m -59.12 -38.94 80.82 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 109.251 -0.648 . . . . 99.99 109.251 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.48 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 44.3 m0 -81.88 -41.57 20.77 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.342 -0.614 . . . . 99.99 109.342 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.61 16.81 41.13 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.892 -0.883 . . . . 99.99 110.892 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.48 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 2.9 p90 -151.18 178.33 9.33 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.94 -1.329 . . . . 99.99 111.302 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 17.5 t -123.26 119.02 28.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.764 -0.585 . . . . 99.99 110.148 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.16 178.49 8.93 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.828 -0.545 . . . . 99.99 110.012 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.9 t . . . . . 0 N--CA 1.5 2.071 0 O-C-N 121.31 -0.869 . . . . 99.99 110.27 -179.866 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.483 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 121.206 0.527 . . . . 99.99 110.229 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.525 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -98.02 -133.89 8.12 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.012 -1.235 . . . . 99.99 110.012 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.557 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -144.7 -150.76 5.29 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.681 -1.368 . . . . 99.99 109.681 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -85.35 -24.38 27.63 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.37 -1.077 . . . . 99.99 111.438 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.419 ' CD1' ' N ' ' A' ' 8' ' ' TRP . 17.5 p-90 -149.45 61.03 1.02 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.062 -1.024 . . . . 99.99 110.046 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.557 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 17.2 m0 -94.23 154.7 17.41 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.24 -0.912 . . . . 99.99 109.43 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -88.89 132.76 34.54 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.885 -1.135 . . . . 99.99 111.379 -178.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.406 ' HB2' ' CG ' ' A' ' 16' ' ' PRO . 31.4 p -150.87 173.66 13.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.819 -0.551 . . . . 99.99 110.28 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.38 -132.16 3.11 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.551 -1.419 . . . . 99.99 109.551 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.51 54.16 2.65 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.474 -1.015 . . . . 99.99 109.819 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.8 41.12 7.82 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.765 -1.334 . . . . 99.99 109.765 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.525 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -81.76 -61.01 0.38 Allowed Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.444 -1.033 . . . . 99.99 110.585 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.525 ' HD3' ' CB ' ' A' ' 15' ' ' LYS . 51.2 Cg_endo -76.38 140.44 21.81 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.668 1.352 . . . . 99.99 110.267 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.45 113.8 3.82 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.799 1.42 . . . . 99.99 110.779 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.56 176.6 8.91 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.43 -0.794 . . . . 99.99 109.818 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.483 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -71.32 151.96 43.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.274 -0.892 . . . . 99.99 109.31 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.08 124.05 11.98 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.194 -0.941 . . . . 99.99 110.331 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.7 -24.84 27.41 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.119 -1.192 . . . . 99.99 110.119 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.461 ' CE2' ' CG2' ' A' ' 33' ' ' VAL . 85.3 m-85 -91.11 136.76 32.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.199 -1.177 . . . . 99.99 110.057 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -121.34 150.0 42.11 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.586 -0.697 . . . . 99.99 110.145 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.604 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 1.0 OUTLIER -89.46 162.39 15.76 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.322 -0.861 . . . . 99.99 110.228 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.572 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 0.4 OUTLIER -137.12 120.33 16.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.451 -0.78 . . . . 99.99 110.648 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -36.36 63.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.433 -0.792 . . . . 99.99 109.542 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.8 m -64.49 -43.29 94.61 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.672 -0.643 . . . . 99.99 109.735 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.572 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 42.2 m0 -81.83 -46.92 13.49 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.796 -0.565 . . . . 99.99 109.645 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.71 18.14 15.0 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.629 -0.989 . . . . 99.99 110.629 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.51 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.7 p90 -150.85 -175.65 5.21 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.011 -1.287 . . . . 99.99 111.194 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.604 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 46.1 t -122.58 130.88 53.49 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.536 -0.728 . . . . 99.99 110.576 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.53 174.42 10.78 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.962 -0.462 . . . . 99.99 109.98 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.461 ' CG2' ' CE2' ' A' ' 22' ' ' TYR . 97.5 t . . . . . 0 N--CA 1.5 2.059 0 O-C-N 121.224 -0.922 . . . . 99.99 110.044 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 121.208 0.528 . . . . 99.99 109.949 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.489 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -86.64 -122.63 1.48 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.053 -1.219 . . . . 99.99 110.053 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.491 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -151.54 -145.34 4.11 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.29 -1.524 . . . . 99.99 109.29 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.41 -27.28 19.4 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.221 -1.164 . . . . 99.99 110.817 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 33.0 t90 -149.13 73.84 1.22 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.411 -0.806 . . . . 99.99 109.623 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.491 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 15.4 m0 -104.56 159.05 16.07 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.456 -0.778 . . . . 99.99 109.428 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 1.9 mptt -90.7 132.99 35.48 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.852 -1.155 . . . . 99.99 111.311 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 23.7 p -150.82 170.35 19.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.61 -0.681 . . . . 99.99 110.604 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -117.58 1.87 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.633 -1.387 . . . . 99.99 109.633 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.568 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.73 41.48 1.06 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.533 -0.98 . . . . 99.99 110.176 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.17 33.4 17.7 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.808 -1.317 . . . . 99.99 109.808 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.573 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 0.2 OUTLIER -69.57 -55.27 9.56 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.247 -1.149 . . . . 99.99 110.489 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 47.9 Cg_endo -74.38 135.87 20.98 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 O-C-N 123.586 1.308 . . . . 99.99 109.729 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.42 107.39 2.27 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.704 1.371 . . . . 99.99 110.986 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.88 174.99 8.49 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.346 -0.846 . . . . 99.99 109.327 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.557 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 2.2 m -80.22 147.11 31.38 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.931 -1.106 . . . . 99.99 108.799 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -44.78 127.51 6.32 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.466 -0.771 . . . . 99.99 111.278 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.6 -25.81 21.75 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.317 -1.113 . . . . 99.99 110.317 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.561 ' CD1' HG22 ' A' ' 33' ' ' VAL . 7.9 m-30 -99.33 136.64 38.98 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.079 -1.248 . . . . 99.99 110.19 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -118.29 149.79 40.56 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.413 -0.804 . . . . 99.99 109.778 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.701 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 0.8 OUTLIER -89.28 160.07 17.08 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.353 -0.842 . . . . 99.99 110.694 -179.742 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.4 m -132.56 110.84 10.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.582 -0.699 . . . . 99.99 110.517 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.568 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 39.7 tptt -68.86 -36.8 78.55 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.478 -0.764 . . . . 99.99 110.061 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.9 m -66.27 -37.69 86.05 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.637 -0.665 . . . . 99.99 109.921 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.517 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 42.7 m0 -86.07 -48.17 8.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.717 -0.614 . . . . 99.99 109.949 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.24 16.35 12.44 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.661 -0.781 . . . . 99.99 111.186 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.517 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.0 p90 -150.87 179.46 8.21 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.717 -1.461 . . . . 99.99 111.426 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.701 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 49.1 t -121.39 128.99 52.77 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.633 -0.667 . . . . 99.99 110.028 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -146.9 174.86 11.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.711 -0.618 . . . . 99.99 110.087 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.561 HG22 ' CD1' ' A' ' 22' ' ' TYR . 12.5 t . . . . . 0 N--CA 1.498 1.954 0 O-C-N 121.371 -0.831 . . . . 99.99 109.875 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 121.312 0.577 . . . . 99.99 110.025 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.524 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -81.48 -128.84 0.99 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.93 -1.268 . . . . 99.99 109.93 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.461 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -146.77 -140.13 3.39 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.461 -1.456 . . . . 99.99 109.461 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.56 -33.5 15.87 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.288 -1.125 . . . . 99.99 110.769 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -146.75 68.31 1.17 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.405 -0.81 . . . . 99.99 109.788 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.524 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 18.1 m0 -94.92 161.83 13.99 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.453 -0.78 . . . . 99.99 109.844 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 1.2 mttp -89.68 136.54 32.97 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.108 -0.995 . . . . 99.99 111.062 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.1 p -151.06 156.52 41.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.702 -0.624 . . . . 99.99 110.172 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.92 -118.45 0.84 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.297 -1.521 . . . . 99.99 109.297 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.457 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.86 34.04 0.92 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.414 -1.05 . . . . 99.99 110.001 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.51 39.72 3.37 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.61 -1.396 . . . . 99.99 109.61 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.48 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 3.8 mtpt -77.81 -58.74 0.86 Allowed Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.368 -1.078 . . . . 99.99 110.814 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.48 ' HD3' ' CB ' ' A' ' 15' ' ' LYS . 46.5 Cg_endo -74.56 136.9 22.03 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 O-C-N 123.652 1.343 . . . . 99.99 110.369 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.94 115.8 4.48 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.934 1.492 . . . . 99.99 110.701 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 96.1 m -84.91 -179.42 7.07 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.395 -0.816 . . . . 99.99 110.168 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.547 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 2.1 m -88.28 165.81 14.75 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.357 -0.839 . . . . 99.99 110.238 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp -58.18 124.77 20.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.388 -0.82 . . . . 99.99 110.223 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.8 -25.79 27.03 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.708 -1.357 . . . . 99.99 109.708 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.481 ' CD1' ' HB2' ' A' ' 19' ' ' CYS . 80.0 m-85 -92.13 133.44 35.77 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.552 -0.969 . . . . 99.99 110.066 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.92 145.27 47.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.543 -0.723 . . . . 99.99 109.89 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 9.1 t -88.82 160.34 17.29 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.581 -0.699 . . . . 99.99 110.089 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.413 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 2.5 m -142.6 122.9 13.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.587 -0.696 . . . . 99.99 111.208 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.457 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -73.77 -41.35 62.56 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.059 -0.719 . . . . 99.99 109.059 178.824 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.1 m -61.98 -40.28 95.07 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.692 -0.63 . . . . 99.99 109.599 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.493 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 34.9 m0 -80.28 -38.43 30.82 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.277 -0.638 . . . . 99.99 109.277 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.61 14.84 56.29 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.272 -1.131 . . . . 99.99 110.272 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.493 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 2.5 p90 -151.94 176.72 11.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.987 -1.302 . . . . 99.99 111.021 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 37.3 t -124.28 125.89 45.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.516 -0.74 . . . . 99.99 110.118 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.53 -178.25 5.99 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.671 -0.643 . . . . 99.99 109.785 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.6 t . . . . . 0 N--CA 1.501 2.087 0 O-C-N 121.138 -0.976 . . . . 99.99 110.155 179.877 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 121.303 0.573 . . . . 99.99 110.47 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.95 -122.45 3.79 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.498 -1.441 . . . . 99.99 109.498 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.554 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -151.31 -150.08 5.23 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.741 -1.344 . . . . 99.99 109.741 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 30.0 t80 -81.32 -42.68 20.21 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.316 -1.108 . . . . 99.99 110.824 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 8.8 t90 -136.98 74.85 1.5 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.397 -0.814 . . . . 99.99 109.944 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.554 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 13.5 m0 -102.44 173.92 6.14 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.619 -0.676 . . . . 99.99 109.744 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.05 139.17 30.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.019 -1.051 . . . . 99.99 110.242 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.2 t -151.08 160.75 43.7 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.474 -0.766 . . . . 99.99 110.209 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.43 -116.43 3.73 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.954 -1.658 . . . . 99.99 108.954 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.628 ' HA ' ' HB3' ' A' ' 26' ' ' LYS . 7.6 mmt180 -90.5 29.19 1.33 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.312 -1.11 . . . . 99.99 110.122 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.77 34.69 4.28 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.782 -1.327 . . . . 99.99 109.782 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.501 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -76.73 -59.99 0.9 Allowed Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.308 -1.113 . . . . 99.99 110.105 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.501 ' HD3' ' CB ' ' A' ' 15' ' ' LYS . 47.5 Cg_endo -75.13 128.67 11.57 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.654 1.344 . . . . 99.99 110.081 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.52 111.61 3.01 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.852 1.449 . . . . 99.99 110.588 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 79.3 m -83.72 161.64 20.96 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.606 -0.684 . . . . 99.99 110.018 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.461 ' HB2' ' CD2' ' A' ' 22' ' ' TYR . 0.1 OUTLIER -62.25 150.15 39.9 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.522 -0.736 . . . . 99.99 110.653 -179.74 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.39 123.11 12.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.602 -0.686 . . . . 99.99 110.269 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.11 -26.66 11.07 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.65 -1.38 . . . . 99.99 109.65 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.467 ' N ' ' CD1' ' A' ' 22' ' ' TYR . 11.4 m-30 -89.21 160.52 16.91 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.378 -1.072 . . . . 99.99 109.809 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.19 144.68 50.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.457 -0.777 . . . . 99.99 110.308 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.4 ' SG ' ' N ' ' A' ' 25' ' ' SER . 25.7 t -89.57 162.62 15.57 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.624 -0.673 . . . . 99.99 110.271 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.4 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 15.6 m -138.9 94.68 2.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.409 -0.807 . . . . 99.99 110.81 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.628 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -61.58 -32.02 72.1 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.221 -0.925 . . . . 99.99 110.323 179.278 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.5 m -72.1 -38.58 69.3 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.583 -0.698 . . . . 99.99 110.186 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.549 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 46.2 m0 -82.96 -48.19 10.94 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.631 -0.668 . . . . 99.99 109.638 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.36 15.53 9.62 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.584 -0.817 . . . . 99.99 111.206 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.549 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.0 p90 -150.95 178.7 8.91 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.758 -1.437 . . . . 99.99 110.995 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 9.2 t -127.62 130.43 48.97 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.657 -0.652 . . . . 99.99 109.758 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -149.89 179.75 7.79 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.497 -0.752 . . . . 99.99 110.781 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 39.0 t . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.452 -0.78 . . . . 99.99 110.021 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 121.497 0.665 . . . . 99.99 110.572 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.452 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -113.24 -106.53 2.77 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 108.794 -1.722 . . . . 99.99 108.794 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.554 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -152.7 -161.22 10.12 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.637 -1.385 . . . . 99.99 109.637 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 36.5 p90 -82.56 -19.81 37.79 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.347 -1.09 . . . . 99.99 111.219 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 22.8 t90 -154.44 72.59 0.87 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.28 -0.888 . . . . 99.99 109.637 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.554 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 17.6 m0 -104.41 169.2 8.61 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.471 -0.768 . . . . 99.99 110.151 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -91.32 136.67 32.94 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.193 -0.942 . . . . 99.99 110.607 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.4 p -150.77 156.71 41.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.489 -0.757 . . . . 99.99 110.426 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.32 -117.72 1.63 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.245 -1.542 . . . . 99.99 109.245 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.564 ' HA ' ' HB3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.4 50.82 1.9 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.419 -1.048 . . . . 99.99 109.906 179.425 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.61 38.19 21.35 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.678 -1.369 . . . . 99.99 109.678 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.488 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -77.46 -60.03 0.78 Allowed Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.383 -1.069 . . . . 99.99 110.707 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 15' ' ' LYS . 47.3 Cg_endo -75.07 131.95 14.79 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 123.615 1.324 . . . . 99.99 110.273 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.21 119.69 5.93 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.833 1.438 . . . . 99.99 110.653 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -89.47 171.18 9.9 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.597 -0.689 . . . . 99.99 110.095 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -68.23 149.36 49.61 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.371 -0.831 . . . . 99.99 110.243 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.99 109.13 0.38 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.687 -0.633 . . . . 99.99 110.401 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.84 -39.24 1.82 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.588 -1.405 . . . . 99.99 109.588 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.493 ' CD1' HG22 ' A' ' 33' ' ' VAL . 4.6 m-85 -90.99 141.83 28.42 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.42 -1.047 . . . . 99.99 110.001 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -118.54 150.87 38.9 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.547 -0.721 . . . . 99.99 110.234 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 10.8 t -89.61 160.61 16.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.42 -0.8 . . . . 99.99 110.224 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.407 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 56.7 m -135.03 105.22 6.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.572 -0.705 . . . . 99.99 110.966 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.564 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -66.12 -31.61 72.56 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.458 -0.776 . . . . 99.99 110.064 179.211 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.541 ' N ' ' HG2' ' A' ' 26' ' ' LYS . 54.6 m -67.05 -39.9 87.03 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.696 -0.627 . . . . 99.99 110.168 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.614 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 43.4 m0 -86.76 -48.6 8.1 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.601 -0.687 . . . . 99.99 109.842 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.44 14.89 8.58 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.851 -0.9 . . . . 99.99 110.851 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.614 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.1 p90 -151.5 177.37 10.38 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.925 -1.338 . . . . 99.99 111.057 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 8.2 t -126.0 130.57 51.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.456 -0.777 . . . . 99.99 110.204 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -147.71 -172.22 3.99 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.597 -0.689 . . . . 99.99 110.184 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.493 HG22 ' CD1' ' A' ' 22' ' ' TYR . 10.6 t . . . . . 0 N--CA 1.5 2.027 0 O-C-N 121.35 -0.843 . . . . 99.99 110.022 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.545 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.909 0 CA-C-O 121.163 0.506 . . . . 99.99 109.906 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.456 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -101.25 -124.28 5.35 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.59 -1.404 . . . . 99.99 109.59 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.542 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -150.29 -154.77 6.57 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.29 -1.524 . . . . 99.99 109.29 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 1.5 t80 -77.8 -36.14 50.63 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.212 -1.169 . . . . 99.99 110.962 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 38.7 t90 -142.8 77.58 1.58 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.408 -0.808 . . . . 99.99 109.856 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.542 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 15.3 m0 -105.66 156.68 18.04 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.545 -0.722 . . . . 99.99 109.169 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.46 132.13 35.17 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.868 -1.145 . . . . 99.99 111.119 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.8 p -150.83 167.8 26.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.715 -0.615 . . . . 99.99 110.214 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.46 -121.18 0.54 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.36 -1.496 . . . . 99.99 109.36 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.57 ' HG3' ' HD3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.5 25.56 2.24 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.455 -1.026 . . . . 99.99 110.329 179.211 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.73 34.05 3.65 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.044 -1.223 . . . . 99.99 110.044 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.56 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 1.5 tptt -69.85 -54.47 10.15 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.276 -1.132 . . . . 99.99 109.975 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.56 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 50.1 Cg_endo -77.22 132.63 12.71 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 O-C-N 123.763 1.401 . . . . 99.99 109.716 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.47 119.07 6.06 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.781 1.411 . . . . 99.99 110.75 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.9 m -84.14 -178.78 7.06 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.582 -0.698 . . . . 99.99 110.035 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.545 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -75.24 164.58 26.31 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.332 -0.855 . . . . 99.99 110.132 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.58 119.96 9.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.467 -0.771 . . . . 99.99 110.267 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.24 0.88 54.17 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 110.3 -1.12 . . . . 99.99 110.3 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.55 ' CD2' HG22 ' A' ' 33' ' ' VAL . 36.9 m-85 -112.55 133.38 54.63 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.117 -1.225 . . . . 99.99 109.677 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -119.58 144.71 46.94 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.394 -0.816 . . . . 99.99 110.496 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 0.8 OUTLIER -89.11 160.82 16.84 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.513 -0.742 . . . . 99.99 110.017 179.664 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 m -136.69 125.42 23.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.434 -0.792 . . . . 99.99 110.636 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.57 ' HD3' ' HG3' ' A' ' 13' ' ' ARG . 9.9 ttpt -76.55 -40.55 49.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.517 -0.739 . . . . 99.99 109.244 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.8 m -65.2 -38.68 91.22 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.738 -0.601 . . . . 99.99 109.623 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.464 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 42.8 m0 -81.49 -45.29 16.19 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.644 -0.66 . . . . 99.99 109.456 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.72 16.28 31.72 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.763 -0.935 . . . . 99.99 110.763 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.464 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.5 p90 -151.21 -179.11 7.06 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.903 -1.351 . . . . 99.99 111.359 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.568 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 8.4 t -121.7 128.39 51.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.676 -0.64 . . . . 99.99 110.447 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -148.41 165.54 30.81 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.753 -0.592 . . . . 99.99 110.143 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.55 HG22 ' CD2' ' A' ' 22' ' ' TYR . 67.2 t . . . . . 0 N--CA 1.497 1.918 0 O-C-N 121.249 -0.907 . . . . 99.99 110.175 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.572 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.485 0.66 . . . . 99.99 110.433 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -111.9 -99.2 2.45 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.614 -1.794 . . . . 99.99 108.614 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.545 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -149.14 -154.95 6.52 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.327 -1.509 . . . . 99.99 109.327 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.562 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 12.2 m-85 -90.9 -30.26 17.01 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.418 -1.049 . . . . 99.99 110.484 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -142.65 68.87 1.31 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.511 -0.743 . . . . 99.99 109.44 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.545 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 17.3 m0 -99.25 154.14 18.4 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.366 -0.834 . . . . 99.99 109.786 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -88.48 134.93 33.71 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.042 -1.036 . . . . 99.99 111.133 -179.307 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.474 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 31.3 p -150.72 177.05 10.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.589 -0.694 . . . . 99.99 110.528 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.79 -120.28 0.45 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 108.945 -1.662 . . . . 99.99 108.945 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.424 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -87.71 -38.47 15.8 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.454 -1.027 . . . . 99.99 109.56 179.02 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -174.05 37.88 0.12 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.489 -1.444 . . . . 99.99 109.489 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.6 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 1.7 mtpm? -72.45 -69.7 0.32 Allowed Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 121.44 -1.035 . . . . 99.99 110.813 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.6 ' CD ' ' CB ' ' A' ' 15' ' ' LYS . 48.4 Cg_endo -74.02 125.36 9.79 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.391 1.206 . . . . 99.99 109.9 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -74.3 103.89 1.76 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.894 1.47 . . . . 99.99 111.495 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 t -64.95 164.87 11.83 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.437 -0.949 . . . . 99.99 108.437 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.572 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -53.02 149.62 6.43 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.96 -1.087 . . . . 99.99 110.621 -179.489 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -50.21 120.64 4.67 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.626 -0.671 . . . . 99.99 110.011 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.83 -25.48 10.85 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.168 -1.573 . . . . 99.99 109.168 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.562 ' CE2' ' HA ' ' A' ' 7' ' ' PHE . 31.0 m-85 -99.71 132.88 44.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.514 -0.992 . . . . 99.99 109.229 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -114.64 154.92 27.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.269 -0.894 . . . . 99.99 110.243 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.647 ' SG ' ' HB3' ' A' ' 31' ' ' CYS . 0.9 OUTLIER -89.18 151.19 22.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.444 -0.785 . . . . 99.99 109.58 179.703 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.508 ' CB ' ' HB2' ' A' ' 28' ' ' TRP . 3.1 m -125.44 130.68 52.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.448 -0.783 . . . . 99.99 110.739 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.424 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 0.5 OUTLIER -75.25 -42.46 55.11 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.523 -0.736 . . . . 99.99 109.351 179.136 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.1 m -68.19 -38.13 81.66 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.87 -0.519 . . . . 99.99 109.819 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.508 ' HB2' ' CB ' ' A' ' 25' ' ' SER . 38.0 m0 -79.35 -46.3 17.92 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.596 -0.69 . . . . 99.99 109.453 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.45 17.92 34.88 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.462 -1.055 . . . . 99.99 110.462 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 2.9 p90 -151.35 178.26 9.45 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.025 -1.279 . . . . 99.99 111.091 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.647 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 2.4 p -119.32 123.6 44.59 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.918 0.866 . . . . 99.99 110.202 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.424 ' HA ' ' HD2' ' A' ' 22' ' ' TYR . . . -150.72 -179.69 7.47 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.146 -0.687 . . . . 99.99 109.146 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.522 HG23 ' CE2' ' A' ' 22' ' ' TYR . 92.5 t . . . . . 0 N--CA 1.498 1.975 0 O-C-N 121.091 -1.006 . . . . 99.99 109.751 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.559 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 121.065 0.459 . . . . 99.99 110.121 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.484 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -80.36 -120.66 0.42 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.025 -1.23 . . . . 99.99 110.025 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.49 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -152.91 -142.68 3.52 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.778 -1.329 . . . . 99.99 109.778 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.51 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 48.8 t80 -90.27 -38.72 13.22 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.462 -1.023 . . . . 99.99 110.71 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -139.11 74.24 1.46 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.278 -0.889 . . . . 99.99 109.672 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.49 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 13.9 m0 -102.09 155.25 18.31 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.457 -0.777 . . . . 99.99 109.487 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -89.71 132.89 34.95 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.91 -1.119 . . . . 99.99 111.56 -179.013 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.477 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 27.8 p -151.57 174.72 13.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.788 -0.57 . . . . 99.99 110.382 178.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.4 -114.97 3.08 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.152 -1.579 . . . . 99.99 109.152 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.602 ' HD3' ' HD3' ' A' ' 26' ' ' LYS . 30.5 tpt180 -90.59 38.08 0.93 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.521 -0.988 . . . . 99.99 109.701 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.25 35.13 7.16 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.792 -1.323 . . . . 99.99 109.792 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.514 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -66.7 -59.86 7.33 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 121.514 -0.992 . . . . 99.99 110.044 179.68 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.514 ' HD3' ' CB ' ' A' ' 15' ' ' LYS . 48.0 Cg_endo -74.69 139.01 24.62 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 O-C-N 123.774 1.408 . . . . 99.99 110.037 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.4 115.66 4.37 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.927 1.488 . . . . 99.99 110.947 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 95.1 m -84.97 176.26 8.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.49 -0.757 . . . . 99.99 110.02 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.563 ' HB2' ' CD1' ' A' ' 22' ' ' TYR . 3.7 m -86.55 165.43 16.22 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.213 -0.93 . . . . 99.99 109.957 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -56.33 126.75 27.66 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.411 -0.805 . . . . 99.99 111.059 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.32 -24.07 33.72 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.163 -1.175 . . . . 99.99 110.163 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.563 ' CD1' ' HB2' ' A' ' 19' ' ' CYS . 78.7 m-85 -95.83 129.01 43.19 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.279 -1.13 . . . . 99.99 110.238 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -118.42 150.79 38.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.64 -0.663 . . . . 99.99 109.866 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 0.9 OUTLIER -89.35 158.68 17.69 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.361 -0.837 . . . . 99.99 110.553 -179.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.37 113.95 12.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.467 -0.771 . . . . 99.99 110.737 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.602 ' HD3' ' HD3' ' A' ' 13' ' ' ARG . 12.0 tttt -70.55 -36.56 73.73 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.456 -0.778 . . . . 99.99 109.763 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.5 m -61.54 -42.02 98.2 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.549 -0.72 . . . . 99.99 109.904 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.578 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 47.7 m0 -85.75 -56.85 3.29 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.738 -0.601 . . . . 99.99 109.516 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.12 20.77 4.33 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 120.458 -0.877 . . . . 99.99 111.185 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.578 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.8 p90 -151.11 -174.66 4.88 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 119.064 1.432 . . . . 99.99 111.519 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 6.5 t -128.13 127.49 43.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.689 -0.632 . . . . 99.99 110.29 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -150.49 174.19 13.22 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.287 -0.565 . . . . 99.99 110.239 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.465 HG22 ' CE2' ' A' ' 22' ' ' TYR . 66.4 t . . . . . 0 N--CA 1.498 1.957 0 O-C-N 121.361 -0.837 . . . . 99.99 110.122 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 121.326 0.584 . . . . 99.99 110.037 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.473 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -105.01 -109.3 3.4 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.065 -1.614 . . . . 99.99 109.065 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.548 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -153.56 -159.37 9.09 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.883 -1.287 . . . . 99.99 109.883 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 71.2 t80 -80.74 -33.21 35.3 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.554 -0.968 . . . . 99.99 110.616 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 30.3 t90 -141.98 78.41 1.63 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.297 -0.877 . . . . 99.99 109.931 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.548 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 14.0 m0 -108.2 156.26 19.54 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.548 -0.72 . . . . 99.99 109.374 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -89.63 134.32 34.2 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.794 -1.191 . . . . 99.99 111.067 -179.271 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.522 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 21.4 p -151.06 166.78 29.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.673 -0.642 . . . . 99.99 110.305 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.07 -111.88 1.08 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.266 -1.534 . . . . 99.99 109.266 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.461 ' HG3' ' HB3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.73 29.08 1.38 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.47 -1.018 . . . . 99.99 109.87 179.1 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.09 35.36 4.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.718 -1.353 . . . . 99.99 109.718 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.517 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -63.97 -61.09 7.42 Favored Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.313 -1.11 . . . . 99.99 110.363 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.522 ' HD2' ' HB2' ' A' ' 11' ' ' CYS . 47.9 Cg_endo -74.71 129.23 12.41 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.643 1.338 . . . . 99.99 109.72 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.47 114.91 4.08 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.692 1.364 . . . . 99.99 110.175 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.4 m -82.02 171.72 14.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.519 -0.738 . . . . 99.99 110.145 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.89 148.46 49.38 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.304 -0.873 . . . . 99.99 109.862 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.49 133.4 24.94 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.556 -0.715 . . . . 99.99 110.981 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.0 -27.77 18.94 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.611 -1.396 . . . . 99.99 109.611 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.409 ' CD1' HG22 ' A' ' 33' ' ' VAL . 12.5 m-30 -90.72 154.23 19.7 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.425 -1.044 . . . . 99.99 110.124 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -136.3 151.69 49.89 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.542 -0.724 . . . . 99.99 109.912 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 0.8 OUTLIER -89.81 162.92 15.26 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.299 -0.876 . . . . 99.99 110.045 179.798 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.546 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 0.6 OUTLIER -131.6 101.19 5.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.502 -0.749 . . . . 99.99 110.457 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.461 ' HB3' ' HG3' ' A' ' 13' ' ' ARG . 11.2 pttm -60.36 -33.55 72.6 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.606 -0.684 . . . . 99.99 110.186 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.7 m -70.51 -39.86 73.85 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.618 -0.676 . . . . 99.99 110.235 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.546 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 46.6 m0 -82.64 -52.31 6.92 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.588 -0.695 . . . . 99.99 109.804 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.42 18.55 6.58 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 111.023 -0.831 . . . . 99.99 111.023 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.474 ' CH2' ' HB3' ' A' ' 28' ' ' TRP . 5.0 p90 -151.13 -170.6 3.7 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.753 -1.44 . . . . 99.99 111.464 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.507 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 8.9 t -132.87 130.98 40.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.604 -0.685 . . . . 99.99 110.414 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -149.4 -175.93 5.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.666 -0.646 . . . . 99.99 109.921 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.409 HG22 ' CD1' ' A' ' 22' ' ' TYR . 12.5 t . . . . . 0 N--CA 1.5 2.057 0 O-C-N 121.228 -0.92 . . . . 99.99 109.538 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.585 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 121.139 0.495 . . . . 99.99 109.961 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.431 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -86.44 -126.34 1.96 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.781 -1.328 . . . . 99.99 109.781 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.551 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -145.77 -148.67 4.84 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.401 -1.48 . . . . 99.99 109.401 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.436 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 44.7 t80 -86.55 -27.3 24.03 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.343 -1.092 . . . . 99.99 110.855 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -151.06 68.69 0.94 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.432 -0.793 . . . . 99.99 109.833 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.551 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 16.9 m0 -96.64 160.31 14.45 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.454 -0.779 . . . . 99.99 109.629 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -90.14 130.84 36.24 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.999 -1.063 . . . . 99.99 111.391 -179.076 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.7 p -151.73 179.39 8.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.762 -0.586 . . . . 99.99 110.522 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.61 -121.42 4.61 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.417 -1.473 . . . . 99.99 109.417 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.72 53.39 2.4 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.554 -0.968 . . . . 99.99 109.899 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.413 ' HA2' ' HB2' ' A' ' 24' ' ' CYS . . . 77.93 37.81 28.48 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.702 -1.359 . . . . 99.99 109.702 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.527 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 0.3 OUTLIER -71.09 -58.37 4.11 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.493 -1.004 . . . . 99.99 110.199 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 48.4 Cg_endo -76.42 143.42 24.71 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 O-C-N 123.736 1.388 . . . . 99.99 109.958 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.403 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 48.8 Cg_endo -73.9 99.06 1.12 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.757 1.398 . . . . 99.99 110.762 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.67 177.04 3.18 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.266 -0.896 . . . . 99.99 109.376 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.585 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 2.7 m -81.16 161.61 23.98 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.137 -0.977 . . . . 99.99 109.654 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -55.95 120.46 7.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.391 -0.818 . . . . 99.99 110.457 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.0 -14.72 44.63 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.45 -1.06 . . . . 99.99 110.45 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.52 ' CD1' ' HB2' ' A' ' 19' ' ' CYS . 66.8 m-85 -102.59 131.63 49.22 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.051 -1.264 . . . . 99.99 110.122 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -117.45 147.36 42.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.57 -0.706 . . . . 99.99 110.24 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 1.1 m -89.36 159.26 17.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.415 -0.803 . . . . 99.99 110.065 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.472 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 2.0 m -130.22 117.77 20.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.576 -0.703 . . . . 99.99 110.483 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -69.82 -37.63 76.31 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.551 -0.718 . . . . 99.99 109.751 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.3 m -71.83 -39.73 69.58 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.625 -0.672 . . . . 99.99 110.255 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.569 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 43.9 m0 -78.9 -48.69 14.14 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.555 -0.716 . . . . 99.99 109.803 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.54 18.08 15.47 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.988 -0.845 . . . . 99.99 110.988 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.569 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.5 p90 -150.85 -179.23 7.1 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.856 -1.379 . . . . 99.99 111.157 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.633 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 22.8 t -123.91 129.94 51.79 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.662 -0.649 . . . . 99.99 110.232 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.12 169.65 19.53 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.787 -0.571 . . . . 99.99 110.135 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.461 ' CG2' ' CE2' ' A' ' 22' ' ' TYR . 59.4 t . . . . . 0 N--CA 1.501 2.081 0 O-C-N 121.445 -0.784 . . . . 99.99 110.443 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.58 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.91 0 CA-C-O 121.201 0.524 . . . . 99.99 109.926 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.426 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -94.76 -120.89 3.44 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.594 -1.402 . . . . 99.99 109.594 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.521 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -144.97 -149.6 5.06 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.216 -1.554 . . . . 99.99 109.216 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -88.44 -17.28 30.75 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.305 -1.115 . . . . 99.99 110.685 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 -160.06 68.06 0.38 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.322 -0.861 . . . . 99.99 110.07 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.521 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 20.2 m0 -96.81 173.69 7.18 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.401 -0.812 . . . . 99.99 110.087 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -94.81 133.31 38.65 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.185 -0.947 . . . . 99.99 110.945 -179.486 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 24.8 p -150.75 159.38 44.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.606 -0.684 . . . . 99.99 110.47 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -93.61 -118.0 2.76 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.265 -1.534 . . . . 99.99 109.265 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.531 ' HB2' ' HD2' ' A' ' 26' ' ' LYS . 0.3 OUTLIER -90.78 43.01 1.13 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.528 -0.984 . . . . 99.99 109.723 179.388 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.95 39.92 5.36 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.597 -1.401 . . . . 99.99 109.597 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.569 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 6.4 mttt -76.89 -64.0 0.49 Allowed Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.431 -1.041 . . . . 99.99 110.023 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.569 ' CD ' ' CB ' ' A' ' 15' ' ' LYS . 48.5 Cg_endo -74.39 133.64 17.85 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 O-C-N 123.579 1.305 . . . . 99.99 109.633 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.26 111.51 3.3 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.678 1.357 . . . . 99.99 110.319 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.4 m -77.39 179.2 6.59 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.402 -0.811 . . . . 99.99 110.101 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.58 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 2.7 m -87.4 150.81 23.56 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.382 -0.824 . . . . 99.99 110.078 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.16 118.78 3.46 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.607 -0.683 . . . . 99.99 110.532 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.29 -35.98 3.69 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.621 -1.392 . . . . 99.99 109.621 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.6 m-85 -93.66 152.16 19.17 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.35 -1.088 . . . . 99.99 110.069 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -126.27 146.74 49.88 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.648 -0.658 . . . . 99.99 110.178 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 13.4 t -89.75 159.84 16.85 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.457 -0.777 . . . . 99.99 110.331 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.6 m -140.75 116.69 10.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.653 -0.655 . . . . 99.99 110.559 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.531 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -73.72 -39.25 64.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.419 -0.801 . . . . 99.99 109.19 179.051 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.1 m -62.85 -40.59 97.93 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.364 -0.606 . . . . 99.99 109.364 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.55 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 40.5 m0 -79.98 -38.83 31.39 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.285 -0.635 . . . . 99.99 109.285 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.26 13.97 50.02 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.626 -0.99 . . . . 99.99 110.626 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.55 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.3 p90 -150.92 177.03 10.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.903 -1.351 . . . . 99.99 111.273 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 31.2 t -126.08 121.88 34.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.752 -0.592 . . . . 99.99 109.714 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.75 -178.26 5.34 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.541 -0.725 . . . . 99.99 110.046 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 21.5 t . . . . . 0 N--CA 1.499 2.014 0 O-C-N 121.272 -0.892 . . . . 99.99 110.188 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 121.36 0.6 . . . . 99.99 110.218 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.453 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -95.72 -129.02 5.77 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.418 -1.473 . . . . 99.99 109.418 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.534 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -147.22 -153.73 6.0 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.588 -1.405 . . . . 99.99 109.588 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 77.5 t80 -79.66 -29.63 40.95 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.346 -1.091 . . . . 99.99 110.899 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -149.21 74.92 1.27 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.18 -0.95 . . . . 99.99 109.883 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.534 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 16.3 m0 -105.05 178.32 4.59 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.666 -0.646 . . . . 99.99 109.377 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.98 133.52 35.22 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.93 -1.106 . . . . 99.99 110.778 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.583 ' SG ' ' HD2' ' A' ' 16' ' ' PRO . 40.7 t -151.69 162.36 41.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.653 -0.654 . . . . 99.99 110.372 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -102.57 -119.01 4.52 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 108.889 -1.685 . . . . 99.99 108.889 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.538 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -91.15 31.24 1.13 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.322 -1.105 . . . . 99.99 110.129 179.153 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.83 36.77 3.61 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.819 -1.312 . . . . 99.99 109.819 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.537 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -76.57 -63.92 0.53 Allowed Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.372 -1.075 . . . . 99.99 110.557 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.583 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 44.1 Cg_endo -71.18 135.28 26.77 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.729 1.384 . . . . 99.99 110.042 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.409 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 45.5 Cg_endo -71.88 100.97 1.13 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.81 1.426 . . . . 99.99 110.844 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.0 m -72.77 169.25 17.11 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.342 -0.848 . . . . 99.99 109.216 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.2 147.9 46.35 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.941 -1.1 . . . . 99.99 110.025 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.55 119.81 4.52 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.638 -0.663 . . . . 99.99 110.571 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.26 -22.61 17.63 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.819 -1.312 . . . . 99.99 109.819 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 12.4 m-30 -89.07 157.95 18.15 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.416 -1.05 . . . . 99.99 109.974 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -133.29 151.32 51.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.506 -0.746 . . . . 99.99 109.917 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.3 m -89.12 167.17 13.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.506 -0.746 . . . . 99.99 110.694 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.479 ' CB ' ' HB2' ' A' ' 28' ' ' TRP . 17.3 m -132.66 102.21 5.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.613 -0.679 . . . . 99.99 110.324 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.538 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 1.8 ttpt -65.09 -31.42 72.63 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.555 -0.716 . . . . 99.99 110.841 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.9 m -82.92 -36.13 25.5 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.435 -0.79 . . . . 99.99 110.873 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.583 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 45.0 m0 -79.95 -42.63 23.62 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.477 -0.765 . . . . 99.99 110.236 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.07 16.88 22.18 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.498 -0.858 . . . . 99.99 110.976 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.583 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 2.8 p90 -150.59 178.82 8.71 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.107 -1.231 . . . . 99.99 110.822 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 22.6 t -121.01 135.88 55.11 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.548 -0.72 . . . . 99.99 109.786 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -146.03 -179.59 6.82 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.436 -0.79 . . . . 99.99 110.242 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 11.9 t . . . . . 0 N--CA 1.498 1.956 0 O-C-N 121.388 -0.82 . . . . 99.99 109.802 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 121.431 0.634 . . . . 99.99 110.44 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -66.89 139.96 37.39 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.739 -1.344 . . . . 99.99 109.739 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.39 153.73 41.29 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.613 -0.934 . . . . 99.99 110.367 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.676 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -134.17 153.22 51.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.485 -0.759 . . . . 99.99 109.879 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.409 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -92.13 -118.32 2.41 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.711 -1.356 . . . . 99.99 109.711 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.493 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -147.55 -143.1 3.78 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.238 -1.545 . . . . 99.99 109.238 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.404 ' HA ' ' HE2' ' A' ' 22' ' ' TYR . 27.3 t80 -90.68 -37.78 13.51 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.296 -1.12 . . . . 99.99 110.59 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.82 70.49 1.35 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.513 -0.742 . . . . 99.99 109.808 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.493 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 16.7 m0 -96.85 166.19 11.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.36 -0.838 . . . . 99.99 109.734 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -92.12 134.74 34.57 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.166 -0.958 . . . . 99.99 110.919 -179.55 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 31.2 p -151.07 159.03 44.76 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 120.036 -0.666 . . . . 99.99 110.579 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.82 -115.89 1.0 Allowed Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.427 -1.469 . . . . 99.99 109.427 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.517 ' HG3' ' HB3' ' A' ' 26' ' ' LYS . 1.0 OUTLIER -90.66 29.58 1.29 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.435 -1.038 . . . . 99.99 110.044 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.92 38.68 3.31 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.147 -1.581 . . . . 99.99 109.147 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.575 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -74.16 -57.34 2.31 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.406 -1.055 . . . . 99.99 110.572 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 46.9 Cg_endo -74.58 134.99 19.3 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 O-C-N 123.719 1.378 . . . . 99.99 109.975 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -71.84 105.77 1.87 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.92 1.484 . . . . 99.99 110.693 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.0 m -74.79 176.57 6.92 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.397 -0.814 . . . . 99.99 109.761 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.676 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.1 m -81.2 161.9 23.81 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.28 -0.887 . . . . 99.99 110.301 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -56.24 125.66 22.77 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.562 -0.711 . . . . 99.99 110.543 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.6 -18.73 54.71 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.122 -1.191 . . . . 99.99 110.122 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.51 ' CD1' ' HB2' ' A' ' 19' ' ' CYS . 52.8 m-85 -94.58 142.47 27.4 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.253 -1.145 . . . . 99.99 110.153 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -124.82 140.81 52.59 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.426 -0.796 . . . . 99.99 110.349 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 14.1 t -89.44 159.56 17.22 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.51 -0.744 . . . . 99.99 110.158 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -138.14 123.27 19.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.62 -0.675 . . . . 99.99 111.031 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.517 ' HB3' ' HG3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -76.63 -35.12 58.24 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.658 -0.651 . . . . 99.99 110.003 179.157 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.4 m -69.99 -38.75 76.1 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.46 -0.775 . . . . 99.99 109.389 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.526 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 40.3 m0 -80.02 -40.85 26.94 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.4 -0.592 . . . . 99.99 109.4 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.48 16.37 43.3 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.412 -1.075 . . . . 99.99 110.412 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.526 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.0 p90 -151.0 177.84 9.77 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.999 -1.295 . . . . 99.99 111.021 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 25.2 t -127.27 128.37 45.88 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.698 -0.626 . . . . 99.99 110.235 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.48 172.83 14.34 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.605 -0.684 . . . . 99.99 110.096 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.459 HG22 ' CE2' ' A' ' 22' ' ' TYR . 99.1 t -58.89 138.53 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.389 -0.82 . . . . 99.99 110.018 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.59 72.45 10.67 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.591 -0.693 . . . . 99.99 110.252 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.458 ' N ' ' HD2' ' A' ' 36' ' ' PRO . . . -70.59 -54.55 8.29 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.491 -0.756 . . . . 99.99 110.377 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 35' ' ' ALA . 46.3 Cg_endo . . . . . 0 C--N 1.318 -1.034 0 O-C-N 123.551 1.29 . . . . 99.99 110.69 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.1 t70 . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 121.227 0.537 . . . . 99.99 110.187 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 113.61 -137.98 14.57 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.593 -1.403 . . . . 99.99 109.593 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -145.2 50.92 1.22 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.475 -1.015 . . . . 99.99 110.222 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.478 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -148.65 154.9 40.32 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.39 -0.819 . . . . 99.99 109.958 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.548 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -78.84 -142.87 2.31 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.149 -1.18 . . . . 99.99 110.149 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.502 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -142.7 -151.48 5.5 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.7 -1.36 . . . . 99.99 109.7 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -76.92 -29.33 55.63 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.34 -1.094 . . . . 99.99 111.059 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -153.83 69.97 0.81 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.315 -0.866 . . . . 99.99 110.233 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.548 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 20.8 m0 -98.62 176.07 5.77 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.494 -0.754 . . . . 99.99 109.704 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.77 138.93 31.06 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.143 -0.973 . . . . 99.99 110.393 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 33.6 t -150.99 161.01 43.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.541 -0.724 . . . . 99.99 110.442 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -103.49 -121.43 4.93 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.471 -1.452 . . . . 99.99 109.471 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.575 ' HA ' ' HB3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.71 37.37 0.92 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.364 -1.08 . . . . 99.99 110.347 179.638 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.17 34.55 7.09 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.74 -1.344 . . . . 99.99 109.74 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.568 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 1.4 tptp -77.58 -58.97 0.87 Allowed Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.319 -1.107 . . . . 99.99 110.19 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 47.2 Cg_endo -75.07 133.4 16.43 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.694 1.365 . . . . 99.99 110.018 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.63 104.93 1.68 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 O-C-N 123.899 1.473 . . . . 99.99 110.589 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.2 m -72.38 166.36 22.7 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.414 -0.804 . . . . 99.99 109.728 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -67.77 155.97 38.09 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.255 -0.903 . . . . 99.99 110.407 -179.689 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.02 128.67 28.18 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.667 -0.646 . . . . 99.99 111.138 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.65 -20.42 50.73 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.479 -1.048 . . . . 99.99 110.479 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.458 ' N ' ' CD1' ' A' ' 22' ' ' TYR . 12.3 m-30 -89.7 150.89 22.13 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.168 -1.195 . . . . 99.99 110.31 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.39 142.42 51.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.671 -0.643 . . . . 99.99 109.852 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 18.3 t -89.3 159.69 17.26 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.447 -0.783 . . . . 99.99 110.622 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.0 m -138.64 106.92 5.78 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.635 -0.666 . . . . 99.99 110.424 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.575 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -72.99 -33.4 65.79 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.371 -0.83 . . . . 99.99 110.285 179.363 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.6 m -68.87 -36.74 78.46 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.471 -0.768 . . . . 99.99 109.83 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.573 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 47.0 m0 -84.04 -40.16 18.71 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.747 -0.595 . . . . 99.99 109.565 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.96 14.91 25.46 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 111.032 -0.827 . . . . 99.99 111.032 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.573 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 2.6 p90 -151.46 177.77 9.96 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.843 -1.387 . . . . 99.99 111.458 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 15.8 t -126.89 126.53 43.44 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.45 -0.574 . . . . 99.99 109.45 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.9 177.91 7.63 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.555 -0.715 . . . . 99.99 110.498 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 17.6 t -69.34 137.31 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.452 -0.78 . . . . 99.99 110.208 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.23 52.23 1.57 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.367 -0.833 . . . . 99.99 110.236 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.52 116.15 63.03 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.261 -0.899 . . . . 99.99 109.947 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 C--N 1.313 -1.322 0 O-C-N 123.888 1.467 . . . . 99.99 110.794 -179.774 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.3 t70 . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 121.4 0.619 . . . . 99.99 110.278 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.76 125.72 3.2 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.771 -1.331 . . . . 99.99 109.771 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.31 -166.14 1.36 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.538 -0.978 . . . . 99.99 110.285 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -88.49 150.95 22.85 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.431 -0.793 . . . . 99.99 109.92 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.537 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -77.22 -149.61 3.49 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.331 -1.108 . . . . 99.99 110.331 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.443 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -139.49 -139.56 3.8 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.66 -1.376 . . . . 99.99 109.66 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -90.25 -19.22 24.39 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.447 -1.031 . . . . 99.99 111.242 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -161.85 65.01 0.25 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.27 -0.894 . . . . 99.99 109.679 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.537 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 20.7 m0 -97.15 162.19 13.47 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.472 -0.767 . . . . 99.99 109.697 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -90.79 134.41 34.46 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.994 -1.066 . . . . 99.99 110.873 -179.555 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.1 p -150.79 169.85 20.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.516 -0.74 . . . . 99.99 110.471 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.6 -131.02 2.53 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.687 -1.365 . . . . 99.99 109.687 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.588 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.45 55.02 2.89 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.478 -1.013 . . . . 99.99 110.026 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 78.68 35.4 32.22 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.061 -1.216 . . . . 99.99 110.061 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.5 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 2.3 mttt -76.36 -60.32 0.94 Allowed Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.327 -1.102 . . . . 99.99 110.356 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.5 ' CD ' ' CB ' ' A' ' 15' ' ' LYS . 47.3 Cg_endo -73.2 141.36 32.27 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.651 1.343 . . . . 99.99 110.168 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.442 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 42.9 Cg_endo -71.78 103.23 1.43 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.856 1.45 . . . . 99.99 110.867 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.493 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 24.7 m -71.27 162.16 29.88 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.366 -0.834 . . . . 99.99 109.659 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.423 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -63.93 148.99 48.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.125 -0.985 . . . . 99.99 109.681 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.54 126.0 18.16 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.618 -0.676 . . . . 99.99 111.101 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.34 -29.21 9.82 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.096 -1.202 . . . . 99.99 110.096 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 5.5 m-85 -95.26 152.87 18.0 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.299 -1.118 . . . . 99.99 110.497 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -128.78 146.97 50.76 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.648 -0.658 . . . . 99.99 110.143 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.563 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 0.8 OUTLIER -91.82 160.87 15.1 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.435 -0.79 . . . . 99.99 110.566 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.539 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 0.5 OUTLIER -135.88 122.33 20.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.647 -0.658 . . . . 99.99 110.392 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.588 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -73.68 -42.02 61.88 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.456 -0.777 . . . . 99.99 109.38 179.189 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.8 m -63.27 -40.0 96.17 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.686 -0.634 . . . . 99.99 109.782 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.539 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 42.4 m0 -80.18 -46.07 17.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.773 -0.579 . . . . 99.99 109.5 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.7 18.45 23.01 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.785 -0.926 . . . . 99.99 110.785 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.508 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.8 p90 -151.38 -176.54 5.62 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.924 -1.339 . . . . 99.99 111.394 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.563 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 6.6 t -126.46 125.56 42.33 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.414 -0.588 . . . . 99.99 109.414 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.58 174.33 10.67 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.442 -0.786 . . . . 99.99 110.668 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.0 t -75.45 146.42 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.485 -0.759 . . . . 99.99 110.07 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -74.68 151.43 39.26 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.488 -0.758 . . . . 99.99 110.185 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.08 115.8 29.25 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.527 -0.733 . . . . 99.99 110.396 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo . . . . . 0 C--N 1.314 -1.272 0 O-C-N 124.002 1.527 . . . . 99.99 110.813 -179.884 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 19.4 t70 . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.165 0.507 . . . . 99.99 110.139 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -119.5 -117.42 2.66 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.39 -1.484 . . . . 99.99 109.39 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -115.91 -168.42 1.42 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.528 -0.984 . . . . 99.99 110.312 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -89.01 153.73 20.78 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.449 -0.782 . . . . 99.99 109.976 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.473 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -81.07 -149.45 6.57 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.224 -1.151 . . . . 99.99 110.224 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.441 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -131.44 -140.9 4.67 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.44 -1.464 . . . . 99.99 109.44 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.556 ' HA ' ' CE1' ' A' ' 22' ' ' TYR . 20.6 p90 -90.51 -22.03 21.54 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.402 -1.058 . . . . 99.99 110.901 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 32.4 t90 -156.59 69.44 0.61 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.247 -0.908 . . . . 99.99 109.701 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.473 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 17.8 m0 -99.69 174.37 6.26 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.441 -0.787 . . . . 99.99 109.662 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.9 mtmm -90.15 138.52 31.45 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.955 -1.091 . . . . 99.99 110.261 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.422 ' SG ' ' HD2' ' A' ' 16' ' ' PRO . 13.9 t -150.67 162.44 40.69 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.972 -0.691 . . . . 99.99 110.256 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -102.27 -117.65 4.31 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.375 -1.49 . . . . 99.99 109.375 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.595 ' HA ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -91.25 28.99 1.51 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.42 -1.047 . . . . 99.99 110.305 179.362 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.15 32.54 5.52 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.596 -1.402 . . . . 99.99 109.596 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.572 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 4.8 tptt -72.22 -58.7 3.03 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.373 -1.075 . . . . 99.99 110.2 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 49.1 Cg_endo -75.85 131.89 13.78 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.701 1.369 . . . . 99.99 109.974 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.41 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 42.8 Cg_endo -71.82 100.95 1.12 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.767 1.404 . . . . 99.99 110.167 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.8 m -67.92 161.32 26.71 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.33 -0.856 . . . . 99.99 109.994 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -64.7 156.47 30.22 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.462 -0.774 . . . . 99.99 110.087 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.53 128.38 35.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.445 -0.784 . . . . 99.99 110.616 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.28 -28.0 16.19 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.893 -1.283 . . . . 99.99 109.893 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.556 ' CE1' ' HA ' ' A' ' 7' ' ' PHE . 88.9 m-85 -94.36 142.98 26.79 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.503 -0.998 . . . . 99.99 110.112 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.41 148.81 43.29 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.549 -0.719 . . . . 99.99 110.056 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.5 t -88.73 160.96 17.07 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.495 -0.753 . . . . 99.99 110.266 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.7 m -140.05 102.24 4.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.651 -0.656 . . . . 99.99 110.701 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.595 ' HB2' ' HA ' ' A' ' 13' ' ' ARG . 2.1 tptp -69.12 -36.31 77.35 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.311 -0.868 . . . . 99.99 109.76 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.4 m -62.26 -37.79 86.8 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.619 -0.676 . . . . 99.99 110.185 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.56 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 45.7 m0 -88.44 -50.23 6.44 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.622 -0.674 . . . . 99.99 109.952 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.54 16.08 6.66 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.524 -0.846 . . . . 99.99 111.209 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.56 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.4 p90 -150.51 -177.85 6.2 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.831 -1.394 . . . . 99.99 111.281 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 22.5 t -129.92 126.23 37.39 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.671 -0.643 . . . . 99.99 110.233 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.19 173.22 14.17 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.672 -0.642 . . . . 99.99 110.191 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.5 t -56.58 134.37 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.272 -0.892 . . . . 99.99 109.904 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.54 -62.9 1.42 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.493 -0.755 . . . . 99.99 110.764 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.88 149.97 42.09 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.513 -0.742 . . . . 99.99 110.612 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo . . . . . 0 C--N 1.314 -1.288 0 O-C-N 123.96 1.505 . . . . 99.99 110.685 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 14.4 t70 . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 121.213 0.53 . . . . 99.99 110.167 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.53 56.45 0.06 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.404 -1.478 . . . . 99.99 109.404 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.549 ' HG2' ' HG2' ' A' ' 17' ' ' PRO . 6.6 pt-20 -144.56 -169.75 3.22 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.612 -0.934 . . . . 99.99 110.44 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.494 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -129.71 153.9 47.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.405 -0.809 . . . . 99.99 110.239 179.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.454 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -92.56 -126.09 3.9 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.183 -1.567 . . . . 99.99 109.183 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.51 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -147.66 -142.41 3.67 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.219 -1.552 . . . . 99.99 109.219 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.404 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 44.5 m-85 -90.57 -32.66 16.2 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.443 -1.033 . . . . 99.99 110.528 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -145.02 70.52 1.27 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.497 -0.752 . . . . 99.99 109.93 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.51 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 15.6 m0 -100.52 175.51 5.65 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.425 -0.797 . . . . 99.99 109.983 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt -89.8 138.76 31.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.133 -0.979 . . . . 99.99 110.55 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.461 ' SG ' ' HD2' ' A' ' 16' ' ' PRO . 29.1 t -151.61 161.85 41.98 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.546 -0.721 . . . . 99.99 110.38 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.56 -117.1 3.92 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.171 -1.572 . . . . 99.99 109.171 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.428 ' HA ' ' HB2' ' A' ' 26' ' ' LYS . 13.6 tpt180 -90.7 21.69 3.92 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.393 -1.063 . . . . 99.99 109.898 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.51 34.18 3.41 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.473 -1.451 . . . . 99.99 109.473 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.534 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -77.28 -54.7 1.45 Allowed Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.361 -1.082 . . . . 99.99 110.824 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 47.5 Cg_endo -74.28 132.38 16.37 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.678 1.357 . . . . 99.99 110.115 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.549 ' HG2' ' HG2' ' A' ' 3' ' ' GLU . 50.4 Cg_endo -71.45 104.57 1.59 Allowed 'Trans proline' 0 C--N 1.314 -1.271 0 O-C-N 123.771 1.406 . . . . 99.99 110.667 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.2 m -75.26 167.2 22.37 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.404 -0.81 . . . . 99.99 109.386 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -64.37 165.1 10.2 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.25 -0.906 . . . . 99.99 110.303 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.0 126.17 27.19 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.322 -0.861 . . . . 99.99 110.195 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.44 4.97 54.7 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.547 -1.021 . . . . 99.99 110.547 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 87.9 m-85 -118.28 150.71 39.01 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.082 -1.246 . . . . 99.99 109.507 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -127.84 147.21 50.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.325 -0.86 . . . . 99.99 110.589 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.4 t -88.97 162.08 16.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.585 -0.697 . . . . 99.99 110.539 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.461 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 7.7 t -139.26 113.6 8.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.652 -0.655 . . . . 99.99 110.63 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 13' ' ' ARG . 14.2 tptm -74.01 -39.83 63.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.496 -0.753 . . . . 99.99 110.213 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.3 m -65.5 -36.93 85.31 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.487 -0.758 . . . . 99.99 110.306 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.515 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 49.0 m0 -83.86 -46.9 11.64 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.613 -0.679 . . . . 99.99 110.027 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.02 19.98 10.26 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 120.373 -0.918 . . . . 99.99 111.174 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.515 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.7 p90 -150.79 -175.28 5.06 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.864 -1.374 . . . . 99.99 110.991 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 18.5 t -133.39 125.22 28.64 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.507 -0.746 . . . . 99.99 110.214 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.29 168.16 24.87 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.779 -0.575 . . . . 99.99 109.727 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 81.5 t -55.57 143.52 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 O-C-N 121.315 -0.866 . . . . 99.99 109.753 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.22 101.44 0.23 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.425 -0.797 . . . . 99.99 110.718 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.448 ' N ' ' HD2' ' A' ' 36' ' ' PRO . . . -76.49 -56.02 1.54 Allowed Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.673 -0.642 . . . . 99.99 110.732 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 35' ' ' ALA . 46.1 Cg_endo . . . . . 0 N--CA 1.486 1.056 0 O-C-N 123.405 1.213 . . . . 99.99 110.88 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 N--CA 1.497 1.901 0 CA-C-O 121.17 0.509 . . . . 99.99 110.48 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -143.64 43.81 0.98 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.064 -1.214 . . . . 99.99 110.064 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 55.02 87.77 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.741 -0.858 . . . . 99.99 110.691 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.495 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -140.18 160.43 39.97 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.553 -0.717 . . . . 99.99 110.646 -179.629 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.434 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -106.44 -112.16 3.66 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.299 -1.52 . . . . 99.99 109.299 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.533 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -152.77 -148.98 5.01 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.482 -1.447 . . . . 99.99 109.482 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.444 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 3.1 t80 -89.62 -35.87 15.61 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.3 -1.118 . . . . 99.99 110.585 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -137.28 78.37 1.69 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.326 -0.859 . . . . 99.99 108.954 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.533 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 11.7 m0 -109.33 166.97 10.46 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.401 -0.812 . . . . 99.99 110.069 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.08 137.64 32.24 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.016 -1.053 . . . . 99.99 110.814 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.8 p -150.87 166.72 29.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.581 -0.7 . . . . 99.99 110.419 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.12 -118.6 3.69 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.358 -1.497 . . . . 99.99 109.358 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.572 ' HA ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.93 38.36 0.95 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.508 -0.995 . . . . 99.99 110.097 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.95 37.08 5.81 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.725 -1.35 . . . . 99.99 109.725 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.552 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 2.0 tttt -80.11 -56.55 0.72 Allowed Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.366 -1.079 . . . . 99.99 110.771 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.552 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 48.7 Cg_endo -75.94 126.39 9.33 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.647 1.341 . . . . 99.99 110.266 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.03 114.61 4.09 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.901 1.474 . . . . 99.99 110.55 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 81.1 m -83.4 -179.16 7.29 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.581 -0.699 . . . . 99.99 110.128 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.495 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.4 OUTLIER -72.42 158.64 35.38 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.261 -0.899 . . . . 99.99 110.243 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -54.99 122.47 10.98 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.454 -0.779 . . . . 99.99 110.07 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.2 -26.3 22.36 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.635 -1.386 . . . . 99.99 109.635 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.48 ' CE2' ' CG2' ' A' ' 33' ' ' VAL . 88.3 m-85 -89.72 135.97 33.31 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.408 -1.054 . . . . 99.99 109.492 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.426 ' HB3' ' CG ' ' A' ' 34' ' ' GLU . . . -123.2 148.56 45.67 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.272 -0.892 . . . . 99.99 110.34 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 7.1 t -89.04 159.49 17.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.517 -0.74 . . . . 99.99 110.251 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.403 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 2.4 m -137.41 113.41 9.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.679 -0.638 . . . . 99.99 110.465 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.572 ' HB2' ' HA ' ' A' ' 13' ' ' ARG . 3.3 ttpt -70.79 -39.76 72.96 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.531 -0.731 . . . . 99.99 109.57 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.0 m -62.05 -39.09 91.17 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.658 -0.651 . . . . 99.99 109.666 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.489 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 42.5 m0 -82.22 -41.6 20.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.727 -0.608 . . . . 99.99 109.626 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.5 14.92 33.68 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.423 -1.071 . . . . 99.99 110.423 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.489 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.7 p90 -151.62 -179.95 7.86 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.013 -1.287 . . . . 99.99 110.941 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 49.2 t -126.43 127.2 45.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.62 -0.675 . . . . 99.99 110.209 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -148.04 174.74 11.62 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.511 -0.743 . . . . 99.99 109.915 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.48 ' CG2' ' CE2' ' A' ' 22' ' ' TYR . 87.2 t -61.32 145.04 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.238 -0.914 . . . . 99.99 110.424 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.426 ' CG ' ' HB3' ' A' ' 23' ' ' ALA . 5.8 mm-40 -99.64 63.5 1.24 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.519 -0.738 . . . . 99.99 109.77 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.09 113.17 65.81 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.314 -0.866 . . . . 99.99 110.343 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo . . . . . 0 C--N 1.312 -1.345 0 O-C-N 123.846 1.445 . . . . 99.99 110.762 179.746 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.173 0.511 . . . . 99.99 110.439 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 110.69 137.6 7.55 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.532 -1.427 . . . . 99.99 109.532 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -91.36 -166.99 1.69 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.544 -0.974 . . . . 99.99 110.327 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.544 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -88.31 151.35 22.68 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.313 -0.867 . . . . 99.99 110.245 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.529 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -83.93 -134.9 2.71 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.737 -1.345 . . . . 99.99 109.737 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.464 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -146.47 -147.11 4.5 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.517 -1.433 . . . . 99.99 109.517 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -77.07 -30.14 55.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.326 -1.102 . . . . 99.99 111.26 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -153.65 72.8 0.93 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.242 -0.911 . . . . 99.99 110.186 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.529 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 18.1 m0 -102.49 174.86 5.71 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.46 -0.775 . . . . 99.99 109.444 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.16 145.47 25.41 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.028 -1.045 . . . . 99.99 110.199 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.557 ' SG ' ' HG2' ' A' ' 16' ' ' PRO . 44.4 t -151.04 160.38 43.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.55 -0.719 . . . . 99.99 110.714 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.02 -123.84 4.64 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.029 -1.628 . . . . 99.99 109.029 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.65 ' HA ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -88.71 -37.96 15.11 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.377 -1.073 . . . . 99.99 109.789 179.391 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.02 36.2 0.13 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.389 -1.484 . . . . 99.99 109.389 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.629 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 5.0 mttp -89.72 -69.15 0.1 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.371 -1.076 . . . . 99.99 110.534 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.629 ' HD3' ' CB ' ' A' ' 15' ' ' LYS . 49.6 Cg_endo -77.25 113.07 3.51 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 O-C-N 123.525 1.276 . . . . 99.99 109.913 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.408 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 49.5 Cg_endo -77.24 116.47 4.16 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.834 1.439 . . . . 99.99 110.7 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 22' ' ' TYR . 0.5 OUTLIER -68.4 157.39 35.88 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.978 -0.749 . . . . 99.99 108.978 179.117 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.544 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -60.7 153.1 24.93 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.083 -1.011 . . . . 99.99 110.461 -179.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -45.07 127.85 6.91 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.795 -0.566 . . . . 99.99 111.076 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.66 -29.04 10.35 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.902 -1.279 . . . . 99.99 109.902 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.44 ' CD1' HG22 ' A' ' 33' ' ' VAL . 4.1 m-85 -104.1 129.84 51.8 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.41 -1.053 . . . . 99.99 110.245 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.446 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . . . -101.31 148.54 25.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.47 -0.769 . . . . 99.99 109.538 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 2.8 t -89.15 159.41 17.51 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.17 -0.956 . . . . 99.99 110.27 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.522 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 0.3 OUTLIER -143.96 121.2 11.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.585 -0.697 . . . . 99.99 111.289 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.65 ' HB2' ' HA ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -75.92 -41.43 51.85 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.536 -0.727 . . . . 99.99 109.402 178.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.6 m -58.92 -37.29 76.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.74 -0.6 . . . . 99.99 109.702 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.522 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 42.5 m0 -86.15 -37.29 18.9 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.275 -0.639 . . . . 99.99 109.275 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.38 16.1 47.99 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.375 -1.09 . . . . 99.99 110.375 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.492 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 2.6 p90 -152.01 178.15 9.74 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.001 -1.294 . . . . 99.99 110.779 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 9.8 p -130.66 127.27 38.56 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.433 -0.792 . . . . 99.99 110.117 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.8 -178.22 6.33 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.682 -0.636 . . . . 99.99 110.124 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.44 HG22 ' CD1' ' A' ' 22' ' ' TYR . 24.8 t -60.07 137.3 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.222 -0.924 . . . . 99.99 110.302 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.446 ' HG3' ' HB2' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -112.66 111.83 22.91 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.516 -0.74 . . . . 99.99 110.365 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.477 ' N ' ' HD2' ' A' ' 36' ' ' PRO . . . -69.05 -53.76 13.39 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.619 -0.676 . . . . 99.99 110.867 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 35' ' ' ALA . 45.0 Cg_endo . . . . . 0 N--CA 1.487 1.135 0 O-C-N 123.507 1.267 . . . . 99.99 110.902 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.7 t70 . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 121.096 0.474 . . . . 99.99 110.367 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -64.83 -57.79 11.46 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.338 -1.505 . . . . 99.99 109.338 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.24 103.88 12.63 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.582 -0.952 . . . . 99.99 109.688 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.425 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -144.88 160.15 41.76 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.414 -0.804 . . . . 99.99 110.494 -179.447 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.421 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -105.78 -112.27 3.68 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.053 -1.619 . . . . 99.99 109.053 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.55 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -151.06 -153.62 6.23 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.483 -1.447 . . . . 99.99 109.483 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -85.13 -33.42 22.36 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.221 -1.164 . . . . 99.99 110.706 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 16.8 t90 -142.76 75.01 1.47 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.332 -0.855 . . . . 99.99 109.593 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.55 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 14.5 m0 -104.51 166.16 10.58 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.651 -0.656 . . . . 99.99 109.447 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -90.61 136.83 32.81 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.999 -1.063 . . . . 99.99 110.568 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.1 p -150.84 171.81 16.63 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.976 -0.69 . . . . 99.99 110.723 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.33 -123.23 3.17 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.835 -1.306 . . . . 99.99 109.835 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.428 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -91.11 24.86 2.67 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.416 -1.05 . . . . 99.99 110.441 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.76 37.3 2.06 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.595 -1.402 . . . . 99.99 109.595 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.434 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 0.5 OUTLIER -82.43 -56.86 0.5 Allowed Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.4 -1.059 . . . . 99.99 111.062 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' A' ' 15' ' ' LYS . 46.9 Cg_endo -73.93 130.89 14.95 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 O-C-N 123.568 1.299 . . . . 99.99 110.517 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -73.14 113.06 3.68 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.785 1.413 . . . . 99.99 110.951 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.8 m -85.27 -178.99 6.89 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.638 -0.664 . . . . 99.99 110.221 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.425 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -74.93 151.78 38.86 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.235 -0.916 . . . . 99.99 110.211 179.709 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.33 115.6 2.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.703 -0.623 . . . . 99.99 110.638 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.83 -33.77 3.8 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.557 -1.417 . . . . 99.99 109.557 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -94.7 149.99 20.67 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.507 -0.996 . . . . 99.99 110.304 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -126.19 150.05 48.59 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.569 -0.707 . . . . 99.99 109.789 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 15.9 t -89.06 158.22 18.05 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.226 -0.921 . . . . 99.99 110.395 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.1 m -141.51 131.59 24.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.651 -0.655 . . . . 99.99 110.77 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.428 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 11.6 tptp -84.73 -44.48 13.32 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.669 -0.644 . . . . 99.99 109.34 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.2 m -59.12 -38.94 80.82 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 109.251 -0.648 . . . . 99.99 109.251 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.48 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 44.3 m0 -81.88 -41.57 20.77 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.342 -0.614 . . . . 99.99 109.342 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.61 16.81 41.13 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.892 -0.883 . . . . 99.99 110.892 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.48 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 2.9 p90 -151.18 178.33 9.33 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.94 -1.329 . . . . 99.99 111.302 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 17.5 t -123.26 119.02 28.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.764 -0.585 . . . . 99.99 110.148 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.16 178.49 8.93 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.828 -0.545 . . . . 99.99 110.012 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.9 t -59.51 117.88 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.31 -0.869 . . . . 99.99 110.27 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.62 116.13 5.37 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.592 -0.692 . . . . 99.99 110.667 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 54.06 86.56 0.16 Allowed Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 121.716 -0.615 . . . . 99.99 110.882 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo . . . . . 0 C--N 1.314 -1.286 0 O-C-N 123.739 1.389 . . . . 99.99 110.702 -179.831 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 121.138 0.494 . . . . 99.99 110.119 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 150.06 151.81 5.62 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.805 -1.318 . . . . 99.99 109.805 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.409 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 2.0 tt0 -76.92 101.11 5.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.483 -1.01 . . . . 99.99 110.068 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.483 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -137.93 159.77 41.1 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.588 -0.695 . . . . 99.99 110.229 -179.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.525 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -98.02 -133.89 8.12 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.012 -1.235 . . . . 99.99 110.012 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.557 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -144.7 -150.76 5.29 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.681 -1.368 . . . . 99.99 109.681 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -85.35 -24.38 27.63 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.37 -1.077 . . . . 99.99 111.438 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.419 ' CD1' ' N ' ' A' ' 8' ' ' TRP . 17.5 p-90 -149.45 61.03 1.02 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.062 -1.024 . . . . 99.99 110.046 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.557 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 17.2 m0 -94.23 154.7 17.41 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.24 -0.912 . . . . 99.99 109.43 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -88.89 132.76 34.54 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.885 -1.135 . . . . 99.99 111.379 -178.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.406 ' HB2' ' CG ' ' A' ' 16' ' ' PRO . 31.4 p -150.87 173.66 13.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.819 -0.551 . . . . 99.99 110.28 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.38 -132.16 3.11 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.551 -1.419 . . . . 99.99 109.551 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.51 54.16 2.65 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.474 -1.015 . . . . 99.99 109.819 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.8 41.12 7.82 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.765 -1.334 . . . . 99.99 109.765 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.525 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -81.76 -61.01 0.38 Allowed Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.444 -1.033 . . . . 99.99 110.585 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.525 ' HD3' ' CB ' ' A' ' 15' ' ' LYS . 51.2 Cg_endo -76.38 140.44 21.81 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.668 1.352 . . . . 99.99 110.267 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.409 ' HG2' ' HB3' ' A' ' 3' ' ' GLU . 46.8 Cg_endo -72.45 113.8 3.82 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.799 1.42 . . . . 99.99 110.779 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.56 176.6 8.91 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.43 -0.794 . . . . 99.99 109.818 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.483 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -71.32 151.96 43.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.274 -0.892 . . . . 99.99 109.31 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.08 124.05 11.98 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.194 -0.941 . . . . 99.99 110.331 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.7 -24.84 27.41 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.119 -1.192 . . . . 99.99 110.119 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.461 ' CE2' ' CG2' ' A' ' 33' ' ' VAL . 85.3 m-85 -91.11 136.76 32.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.199 -1.177 . . . . 99.99 110.057 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -121.34 150.0 42.11 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.586 -0.697 . . . . 99.99 110.145 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.604 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 1.0 OUTLIER -89.46 162.39 15.76 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.322 -0.861 . . . . 99.99 110.228 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.572 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 0.4 OUTLIER -137.12 120.33 16.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.451 -0.78 . . . . 99.99 110.648 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -36.36 63.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.433 -0.792 . . . . 99.99 109.542 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.8 m -64.49 -43.29 94.61 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.672 -0.643 . . . . 99.99 109.735 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.572 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 42.2 m0 -81.83 -46.92 13.49 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.796 -0.565 . . . . 99.99 109.645 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.71 18.14 15.0 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.629 -0.989 . . . . 99.99 110.629 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.51 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.7 p90 -150.85 -175.65 5.21 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.011 -1.287 . . . . 99.99 111.194 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.604 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 46.1 t -122.58 130.88 53.49 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.536 -0.728 . . . . 99.99 110.576 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.53 174.42 10.78 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.962 -0.462 . . . . 99.99 109.98 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.461 ' CG2' ' CE2' ' A' ' 22' ' ' TYR . 97.5 t -67.99 142.64 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.224 -0.922 . . . . 99.99 110.044 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -72.14 112.68 8.44 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.518 -0.739 . . . . 99.99 110.193 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.01 127.59 18.27 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.495 -0.753 . . . . 99.99 110.195 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo . . . . . 0 C--N 1.313 -1.29 0 O-C-N 123.803 1.423 . . . . 99.99 110.658 -179.978 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 121.119 0.485 . . . . 99.99 110.199 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.01 91.89 0.11 Allowed Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.424 -1.47 . . . . 99.99 109.424 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -113.24 90.11 3.26 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.439 -1.036 . . . . 99.99 110.735 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -140.33 151.97 45.46 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.416 -0.802 . . . . 99.99 109.949 179.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.489 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -86.64 -122.63 1.48 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.053 -1.219 . . . . 99.99 110.053 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.491 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -151.54 -145.34 4.11 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.29 -1.524 . . . . 99.99 109.29 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.41 -27.28 19.4 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.221 -1.164 . . . . 99.99 110.817 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 33.0 t90 -149.13 73.84 1.22 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.411 -0.806 . . . . 99.99 109.623 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.491 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 15.4 m0 -104.56 159.05 16.07 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.456 -0.778 . . . . 99.99 109.428 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 1.9 mptt -90.7 132.99 35.48 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.852 -1.155 . . . . 99.99 111.311 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 23.7 p -150.82 170.35 19.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.61 -0.681 . . . . 99.99 110.604 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -117.58 1.87 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.633 -1.387 . . . . 99.99 109.633 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.568 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.73 41.48 1.06 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.533 -0.98 . . . . 99.99 110.176 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.17 33.4 17.7 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.808 -1.317 . . . . 99.99 109.808 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.573 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 0.2 OUTLIER -69.57 -55.27 9.56 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.247 -1.149 . . . . 99.99 110.489 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 47.9 Cg_endo -74.38 135.87 20.98 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 O-C-N 123.586 1.308 . . . . 99.99 109.729 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.42 107.39 2.27 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.704 1.371 . . . . 99.99 110.986 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.88 174.99 8.49 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.346 -0.846 . . . . 99.99 109.327 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.557 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 2.2 m -80.22 147.11 31.38 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.931 -1.106 . . . . 99.99 108.799 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -44.78 127.51 6.32 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.466 -0.771 . . . . 99.99 111.278 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.6 -25.81 21.75 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.317 -1.113 . . . . 99.99 110.317 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.561 ' CD1' HG22 ' A' ' 33' ' ' VAL . 7.9 m-30 -99.33 136.64 38.98 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.079 -1.248 . . . . 99.99 110.19 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -118.29 149.79 40.56 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.413 -0.804 . . . . 99.99 109.778 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.701 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 0.8 OUTLIER -89.28 160.07 17.08 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.353 -0.842 . . . . 99.99 110.694 -179.742 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.4 m -132.56 110.84 10.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.582 -0.699 . . . . 99.99 110.517 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.568 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 39.7 tptt -68.86 -36.8 78.55 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.478 -0.764 . . . . 99.99 110.061 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.9 m -66.27 -37.69 86.05 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.637 -0.665 . . . . 99.99 109.921 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.517 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 42.7 m0 -86.07 -48.17 8.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.717 -0.614 . . . . 99.99 109.949 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.24 16.35 12.44 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.661 -0.781 . . . . 99.99 111.186 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.517 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.0 p90 -150.87 179.46 8.21 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.717 -1.461 . . . . 99.99 111.426 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.701 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 49.1 t -121.39 128.99 52.77 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.633 -0.667 . . . . 99.99 110.028 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -146.9 174.86 11.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.711 -0.618 . . . . 99.99 110.087 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.561 HG22 ' CD1' ' A' ' 22' ' ' TYR . 12.5 t -70.26 105.94 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.371 -0.831 . . . . 99.99 109.875 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -80.09 89.68 5.4 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.418 -0.801 . . . . 99.99 109.906 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -153.0 151.98 27.25 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.544 -0.722 . . . . 99.99 110.348 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 C--N 1.313 -1.334 0 O-C-N 123.944 1.497 . . . . 99.99 110.638 179.987 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.9 t70 . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 121.022 0.439 . . . . 99.99 110.159 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.2 109.65 0.25 Allowed Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.622 -1.391 . . . . 99.99 109.622 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -107.17 57.61 0.63 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.538 -0.977 . . . . 99.99 110.8 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -116.15 155.25 28.58 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.207 -0.933 . . . . 99.99 110.025 179.548 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.524 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -81.48 -128.84 0.99 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.93 -1.268 . . . . 99.99 109.93 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.461 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -146.77 -140.13 3.39 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.461 -1.456 . . . . 99.99 109.461 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.56 -33.5 15.87 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.288 -1.125 . . . . 99.99 110.769 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -146.75 68.31 1.17 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.405 -0.81 . . . . 99.99 109.788 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.524 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 18.1 m0 -94.92 161.83 13.99 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.453 -0.78 . . . . 99.99 109.844 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 1.2 mttp -89.68 136.54 32.97 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.108 -0.995 . . . . 99.99 111.062 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.1 p -151.06 156.52 41.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.702 -0.624 . . . . 99.99 110.172 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.92 -118.45 0.84 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.297 -1.521 . . . . 99.99 109.297 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.457 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.86 34.04 0.92 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.414 -1.05 . . . . 99.99 110.001 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.51 39.72 3.37 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.61 -1.396 . . . . 99.99 109.61 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.48 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 3.8 mtpt -77.81 -58.74 0.86 Allowed Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.368 -1.078 . . . . 99.99 110.814 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.48 ' HD3' ' CB ' ' A' ' 15' ' ' LYS . 46.5 Cg_endo -74.56 136.9 22.03 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 O-C-N 123.652 1.343 . . . . 99.99 110.369 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.94 115.8 4.48 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.934 1.492 . . . . 99.99 110.701 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 96.1 m -84.91 -179.42 7.07 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.395 -0.816 . . . . 99.99 110.168 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.547 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 2.1 m -88.28 165.81 14.75 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.357 -0.839 . . . . 99.99 110.238 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp -58.18 124.77 20.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.388 -0.82 . . . . 99.99 110.223 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.8 -25.79 27.03 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.708 -1.357 . . . . 99.99 109.708 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.481 ' CD1' ' HB2' ' A' ' 19' ' ' CYS . 80.0 m-85 -92.13 133.44 35.77 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.552 -0.969 . . . . 99.99 110.066 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.92 145.27 47.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.543 -0.723 . . . . 99.99 109.89 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 9.1 t -88.82 160.34 17.29 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.581 -0.699 . . . . 99.99 110.089 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.413 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 2.5 m -142.6 122.9 13.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.587 -0.696 . . . . 99.99 111.208 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.457 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -73.77 -41.35 62.56 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.059 -0.719 . . . . 99.99 109.059 178.824 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.1 m -61.98 -40.28 95.07 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.692 -0.63 . . . . 99.99 109.599 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.493 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 34.9 m0 -80.28 -38.43 30.82 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.277 -0.638 . . . . 99.99 109.277 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.61 14.84 56.29 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.272 -1.131 . . . . 99.99 110.272 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.493 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 2.5 p90 -151.94 176.72 11.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.987 -1.302 . . . . 99.99 111.021 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 37.3 t -124.28 125.89 45.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.516 -0.74 . . . . 99.99 110.118 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.53 -178.25 5.99 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.671 -0.643 . . . . 99.99 109.785 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.6 t -59.96 156.8 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.138 -0.976 . . . . 99.99 110.155 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -62.17 -85.88 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.516 -0.74 . . . . 99.99 110.675 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -170.56 136.23 1.16 Allowed Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.192 -0.943 . . . . 99.99 110.281 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo . . . . . 0 C--N 1.314 -1.249 0 O-C-N 123.784 1.412 . . . . 99.99 110.726 179.936 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 15.9 t70 . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.22 0.533 . . . . 99.99 110.254 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.72 69.76 0.86 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.742 -1.343 . . . . 99.99 109.742 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -85.75 97.75 10.33 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.553 -0.969 . . . . 99.99 109.824 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.31 158.89 43.33 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.355 -0.84 . . . . 99.99 110.47 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.95 -122.45 3.79 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.498 -1.441 . . . . 99.99 109.498 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.554 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -151.31 -150.08 5.23 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.741 -1.344 . . . . 99.99 109.741 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 30.0 t80 -81.32 -42.68 20.21 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.316 -1.108 . . . . 99.99 110.824 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 8.8 t90 -136.98 74.85 1.5 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.397 -0.814 . . . . 99.99 109.944 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.554 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 13.5 m0 -102.44 173.92 6.14 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.619 -0.676 . . . . 99.99 109.744 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.05 139.17 30.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.019 -1.051 . . . . 99.99 110.242 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.2 t -151.08 160.75 43.7 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.474 -0.766 . . . . 99.99 110.209 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.43 -116.43 3.73 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.954 -1.658 . . . . 99.99 108.954 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.628 ' HA ' ' HB3' ' A' ' 26' ' ' LYS . 7.6 mmt180 -90.5 29.19 1.33 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.312 -1.11 . . . . 99.99 110.122 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.77 34.69 4.28 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.782 -1.327 . . . . 99.99 109.782 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.501 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -76.73 -59.99 0.9 Allowed Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.308 -1.113 . . . . 99.99 110.105 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.501 ' HD3' ' CB ' ' A' ' 15' ' ' LYS . 47.5 Cg_endo -75.13 128.67 11.57 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.654 1.344 . . . . 99.99 110.081 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.52 111.61 3.01 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.852 1.449 . . . . 99.99 110.588 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 79.3 m -83.72 161.64 20.96 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.606 -0.684 . . . . 99.99 110.018 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.461 ' HB2' ' CD2' ' A' ' 22' ' ' TYR . 0.1 OUTLIER -62.25 150.15 39.9 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.522 -0.736 . . . . 99.99 110.653 -179.74 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.39 123.11 12.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.602 -0.686 . . . . 99.99 110.269 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.11 -26.66 11.07 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.65 -1.38 . . . . 99.99 109.65 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.467 ' N ' ' CD1' ' A' ' 22' ' ' TYR . 11.4 m-30 -89.21 160.52 16.91 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.378 -1.072 . . . . 99.99 109.809 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.19 144.68 50.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.457 -0.777 . . . . 99.99 110.308 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.4 ' SG ' ' N ' ' A' ' 25' ' ' SER . 25.7 t -89.57 162.62 15.57 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.624 -0.673 . . . . 99.99 110.271 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.4 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 15.6 m -138.9 94.68 2.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.409 -0.807 . . . . 99.99 110.81 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.628 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -61.58 -32.02 72.1 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.221 -0.925 . . . . 99.99 110.323 179.278 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.5 m -72.1 -38.58 69.3 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.583 -0.698 . . . . 99.99 110.186 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.549 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 46.2 m0 -82.96 -48.19 10.94 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.631 -0.668 . . . . 99.99 109.638 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.36 15.53 9.62 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.584 -0.817 . . . . 99.99 111.206 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.549 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.0 p90 -150.95 178.7 8.91 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.758 -1.437 . . . . 99.99 110.995 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 9.2 t -127.62 130.43 48.97 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.657 -0.652 . . . . 99.99 109.758 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -149.89 179.75 7.79 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.497 -0.752 . . . . 99.99 110.781 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 39.0 t -71.26 127.71 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.452 -0.78 . . . . 99.99 110.021 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.09 -17.21 29.73 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.519 -0.738 . . . . 99.99 111.05 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 57.42 81.78 0.25 Allowed Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.462 -0.774 . . . . 99.99 110.798 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo . . . . . 0 C--N 1.312 -1.378 0 O-C-N 123.797 1.419 . . . . 99.99 110.636 -179.987 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 121.211 0.529 . . . . 99.99 110.488 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -175.03 99.06 0.13 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.716 -1.354 . . . . 99.99 109.716 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.454 ' HG2' ' HG3' ' A' ' 17' ' ' PRO . 1.5 mt-10 -138.35 73.02 1.42 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.48 -1.012 . . . . 99.99 110.243 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -151.25 156.26 40.49 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.497 0.665 . . . . 99.99 110.572 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.452 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -113.24 -106.53 2.77 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 108.794 -1.722 . . . . 99.99 108.794 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.554 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -152.7 -161.22 10.12 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.637 -1.385 . . . . 99.99 109.637 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 36.5 p90 -82.56 -19.81 37.79 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.347 -1.09 . . . . 99.99 111.219 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 22.8 t90 -154.44 72.59 0.87 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.28 -0.888 . . . . 99.99 109.637 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.554 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 17.6 m0 -104.41 169.2 8.61 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.471 -0.768 . . . . 99.99 110.151 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -91.32 136.67 32.94 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.193 -0.942 . . . . 99.99 110.607 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.4 p -150.77 156.71 41.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.489 -0.757 . . . . 99.99 110.426 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.32 -117.72 1.63 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.245 -1.542 . . . . 99.99 109.245 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.564 ' HA ' ' HB3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.4 50.82 1.9 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.419 -1.048 . . . . 99.99 109.906 179.425 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.61 38.19 21.35 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.678 -1.369 . . . . 99.99 109.678 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.488 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -77.46 -60.03 0.78 Allowed Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.383 -1.069 . . . . 99.99 110.707 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 15' ' ' LYS . 47.3 Cg_endo -75.07 131.95 14.79 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 123.615 1.324 . . . . 99.99 110.273 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.454 ' HG3' ' HG2' ' A' ' 3' ' ' GLU . 47.4 Cg_endo -74.21 119.69 5.93 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.833 1.438 . . . . 99.99 110.653 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -89.47 171.18 9.9 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.597 -0.689 . . . . 99.99 110.095 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -68.23 149.36 49.61 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.371 -0.831 . . . . 99.99 110.243 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.99 109.13 0.38 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.687 -0.633 . . . . 99.99 110.401 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.84 -39.24 1.82 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.588 -1.405 . . . . 99.99 109.588 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.493 ' CD1' HG22 ' A' ' 33' ' ' VAL . 4.6 m-85 -90.99 141.83 28.42 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.42 -1.047 . . . . 99.99 110.001 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -118.54 150.87 38.9 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.547 -0.721 . . . . 99.99 110.234 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 10.8 t -89.61 160.61 16.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.42 -0.8 . . . . 99.99 110.224 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.407 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 56.7 m -135.03 105.22 6.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.572 -0.705 . . . . 99.99 110.966 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.564 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -66.12 -31.61 72.56 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.458 -0.776 . . . . 99.99 110.064 179.211 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.541 ' N ' ' HG2' ' A' ' 26' ' ' LYS . 54.6 m -67.05 -39.9 87.03 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.696 -0.627 . . . . 99.99 110.168 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.614 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 43.4 m0 -86.76 -48.6 8.1 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.601 -0.687 . . . . 99.99 109.842 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.44 14.89 8.58 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.851 -0.9 . . . . 99.99 110.851 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.614 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.1 p90 -151.5 177.37 10.38 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.925 -1.338 . . . . 99.99 111.057 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 8.2 t -126.0 130.57 51.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.456 -0.777 . . . . 99.99 110.204 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -147.71 -172.22 3.99 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.597 -0.689 . . . . 99.99 110.184 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.493 HG22 ' CD1' ' A' ' 22' ' ' TYR . 10.6 t -73.64 122.73 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.35 -0.843 . . . . 99.99 110.022 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.13 167.45 15.73 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.505 -0.747 . . . . 99.99 110.719 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.52 130.21 23.62 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.496 -0.753 . . . . 99.99 110.185 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo . . . . . 0 C--N 1.315 -1.232 0 O-C-N 123.888 1.468 . . . . 99.99 110.729 179.836 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 . . . . . 0 N--CA 1.497 1.882 0 CA-C-O 121.193 0.521 . . . . 99.99 110.414 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -101.4 103.41 2.54 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.534 -1.427 . . . . 99.99 109.534 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.467 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 13.1 mt-10 -72.62 130.6 40.96 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.471 -1.017 . . . . 99.99 110.419 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.545 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -134.84 160.79 37.09 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.51 -0.743 . . . . 99.99 109.906 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.456 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -101.25 -124.28 5.35 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.59 -1.404 . . . . 99.99 109.59 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.542 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -150.29 -154.77 6.57 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.29 -1.524 . . . . 99.99 109.29 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 1.5 t80 -77.8 -36.14 50.63 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.212 -1.169 . . . . 99.99 110.962 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 38.7 t90 -142.8 77.58 1.58 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.408 -0.808 . . . . 99.99 109.856 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.542 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 15.3 m0 -105.66 156.68 18.04 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.545 -0.722 . . . . 99.99 109.169 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.46 132.13 35.17 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.868 -1.145 . . . . 99.99 111.119 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.8 p -150.83 167.8 26.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.715 -0.615 . . . . 99.99 110.214 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.46 -121.18 0.54 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.36 -1.496 . . . . 99.99 109.36 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.57 ' HG3' ' HD3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.5 25.56 2.24 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.455 -1.026 . . . . 99.99 110.329 179.211 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.73 34.05 3.65 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.044 -1.223 . . . . 99.99 110.044 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.56 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 1.5 tptt -69.85 -54.47 10.15 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.276 -1.132 . . . . 99.99 109.975 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.56 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 50.1 Cg_endo -77.22 132.63 12.71 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 O-C-N 123.763 1.401 . . . . 99.99 109.716 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.467 ' HG2' ' HB3' ' A' ' 3' ' ' GLU . 44.3 Cg_endo -70.47 119.07 6.06 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.781 1.411 . . . . 99.99 110.75 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.9 m -84.14 -178.78 7.06 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.582 -0.698 . . . . 99.99 110.035 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.545 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -75.24 164.58 26.31 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.332 -0.855 . . . . 99.99 110.132 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.58 119.96 9.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.467 -0.771 . . . . 99.99 110.267 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.24 0.88 54.17 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 110.3 -1.12 . . . . 99.99 110.3 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.55 ' CD2' HG22 ' A' ' 33' ' ' VAL . 36.9 m-85 -112.55 133.38 54.63 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.117 -1.225 . . . . 99.99 109.677 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -119.58 144.71 46.94 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.394 -0.816 . . . . 99.99 110.496 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 0.8 OUTLIER -89.11 160.82 16.84 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.513 -0.742 . . . . 99.99 110.017 179.664 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 m -136.69 125.42 23.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.434 -0.792 . . . . 99.99 110.636 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.57 ' HD3' ' HG3' ' A' ' 13' ' ' ARG . 9.9 ttpt -76.55 -40.55 49.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.517 -0.739 . . . . 99.99 109.244 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.8 m -65.2 -38.68 91.22 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.738 -0.601 . . . . 99.99 109.623 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.464 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 42.8 m0 -81.49 -45.29 16.19 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.644 -0.66 . . . . 99.99 109.456 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.72 16.28 31.72 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.763 -0.935 . . . . 99.99 110.763 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.464 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.5 p90 -151.21 -179.11 7.06 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.903 -1.351 . . . . 99.99 111.359 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.568 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 8.4 t -121.7 128.39 51.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.676 -0.64 . . . . 99.99 110.447 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -148.41 165.54 30.81 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.753 -0.592 . . . . 99.99 110.143 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.55 HG22 ' CD2' ' A' ' 22' ' ' TYR . 67.2 t -64.68 146.27 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.249 -0.907 . . . . 99.99 110.175 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.38 83.9 3.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.403 -0.811 . . . . 99.99 110.003 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.422 ' N ' ' HD2' ' A' ' 36' ' ' PRO . . . -65.95 -57.22 14.14 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.436 -0.79 . . . . 99.99 110.529 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 35' ' ' ALA . 46.8 Cg_endo . . . . . 0 N--CA 1.488 1.153 0 O-C-N 123.511 1.269 . . . . 99.99 110.559 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.229 0.538 . . . . 99.99 110.426 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -175.46 67.22 0.1 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.601 -1.4 . . . . 99.99 109.601 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.28 174.59 7.61 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.617 -0.931 . . . . 99.99 110.367 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.572 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -136.12 156.58 48.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.552 -0.718 . . . . 99.99 110.433 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -111.9 -99.2 2.45 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.614 -1.794 . . . . 99.99 108.614 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.545 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -149.14 -154.95 6.52 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.327 -1.509 . . . . 99.99 109.327 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.562 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 12.2 m-85 -90.9 -30.26 17.01 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.418 -1.049 . . . . 99.99 110.484 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -142.65 68.87 1.31 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.511 -0.743 . . . . 99.99 109.44 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.545 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 17.3 m0 -99.25 154.14 18.4 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.366 -0.834 . . . . 99.99 109.786 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -88.48 134.93 33.71 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.042 -1.036 . . . . 99.99 111.133 -179.307 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.474 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 31.3 p -150.72 177.05 10.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.589 -0.694 . . . . 99.99 110.528 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.79 -120.28 0.45 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 108.945 -1.662 . . . . 99.99 108.945 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.424 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -87.71 -38.47 15.8 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.454 -1.027 . . . . 99.99 109.56 179.02 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -174.05 37.88 0.12 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.489 -1.444 . . . . 99.99 109.489 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.6 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 1.7 mtpm? -72.45 -69.7 0.32 Allowed Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 121.44 -1.035 . . . . 99.99 110.813 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.6 ' CD ' ' CB ' ' A' ' 15' ' ' LYS . 48.4 Cg_endo -74.02 125.36 9.79 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.391 1.206 . . . . 99.99 109.9 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -74.3 103.89 1.76 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.894 1.47 . . . . 99.99 111.495 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 t -64.95 164.87 11.83 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.437 -0.949 . . . . 99.99 108.437 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.572 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -53.02 149.62 6.43 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.96 -1.087 . . . . 99.99 110.621 -179.489 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -50.21 120.64 4.67 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.626 -0.671 . . . . 99.99 110.011 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.83 -25.48 10.85 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.168 -1.573 . . . . 99.99 109.168 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.562 ' CE2' ' HA ' ' A' ' 7' ' ' PHE . 31.0 m-85 -99.71 132.88 44.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.514 -0.992 . . . . 99.99 109.229 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -114.64 154.92 27.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.269 -0.894 . . . . 99.99 110.243 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.647 ' SG ' ' HB3' ' A' ' 31' ' ' CYS . 0.9 OUTLIER -89.18 151.19 22.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.444 -0.785 . . . . 99.99 109.58 179.703 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.508 ' CB ' ' HB2' ' A' ' 28' ' ' TRP . 3.1 m -125.44 130.68 52.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.448 -0.783 . . . . 99.99 110.739 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.424 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 0.5 OUTLIER -75.25 -42.46 55.11 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.523 -0.736 . . . . 99.99 109.351 179.136 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.1 m -68.19 -38.13 81.66 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.87 -0.519 . . . . 99.99 109.819 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.508 ' HB2' ' CB ' ' A' ' 25' ' ' SER . 38.0 m0 -79.35 -46.3 17.92 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.596 -0.69 . . . . 99.99 109.453 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.45 17.92 34.88 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.462 -1.055 . . . . 99.99 110.462 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 2.9 p90 -151.35 178.26 9.45 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.025 -1.279 . . . . 99.99 111.091 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.647 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 2.4 p -119.32 123.6 44.59 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.918 0.866 . . . . 99.99 110.202 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.424 ' HA ' ' HD2' ' A' ' 22' ' ' TYR . . . -150.72 -179.69 7.47 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.146 -0.687 . . . . 99.99 109.146 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.522 HG23 ' CE2' ' A' ' 22' ' ' TYR . 92.5 t -69.96 117.13 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.091 -1.006 . . . . 99.99 109.751 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.79 152.04 45.26 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.51 -0.744 . . . . 99.99 110.852 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 50.08 63.68 9.68 Favored Pre-proline 0 N--CA 1.501 2.08 0 O-C-N 121.724 -0.61 . . . . 99.99 110.751 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo . . . . . 0 C--N 1.314 -1.271 0 O-C-N 123.813 1.428 . . . . 99.99 110.79 -179.976 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 121.162 0.506 . . . . 99.99 110.323 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 112.28 -41.64 2.17 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.648 -1.381 . . . . 99.99 109.648 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.97 55.22 3.06 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.43 -1.041 . . . . 99.99 110.516 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.559 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -121.88 155.86 34.53 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.151 -0.968 . . . . 99.99 110.121 179.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.484 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -80.36 -120.66 0.42 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.025 -1.23 . . . . 99.99 110.025 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.49 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -152.91 -142.68 3.52 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.778 -1.329 . . . . 99.99 109.778 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.51 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 48.8 t80 -90.27 -38.72 13.22 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.462 -1.023 . . . . 99.99 110.71 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -139.11 74.24 1.46 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.278 -0.889 . . . . 99.99 109.672 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.49 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 13.9 m0 -102.09 155.25 18.31 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.457 -0.777 . . . . 99.99 109.487 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -89.71 132.89 34.95 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.91 -1.119 . . . . 99.99 111.56 -179.013 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.477 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 27.8 p -151.57 174.72 13.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.788 -0.57 . . . . 99.99 110.382 178.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.4 -114.97 3.08 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.152 -1.579 . . . . 99.99 109.152 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.602 ' HD3' ' HD3' ' A' ' 26' ' ' LYS . 30.5 tpt180 -90.59 38.08 0.93 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.521 -0.988 . . . . 99.99 109.701 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.25 35.13 7.16 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.792 -1.323 . . . . 99.99 109.792 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.514 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -66.7 -59.86 7.33 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 121.514 -0.992 . . . . 99.99 110.044 179.68 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.514 ' HD3' ' CB ' ' A' ' 15' ' ' LYS . 48.0 Cg_endo -74.69 139.01 24.62 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 O-C-N 123.774 1.408 . . . . 99.99 110.037 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.4 115.66 4.37 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.927 1.488 . . . . 99.99 110.947 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 95.1 m -84.97 176.26 8.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.49 -0.757 . . . . 99.99 110.02 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.563 ' HB2' ' CD1' ' A' ' 22' ' ' TYR . 3.7 m -86.55 165.43 16.22 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.213 -0.93 . . . . 99.99 109.957 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -56.33 126.75 27.66 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.411 -0.805 . . . . 99.99 111.059 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.32 -24.07 33.72 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.163 -1.175 . . . . 99.99 110.163 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.563 ' CD1' ' HB2' ' A' ' 19' ' ' CYS . 78.7 m-85 -95.83 129.01 43.19 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.279 -1.13 . . . . 99.99 110.238 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -118.42 150.79 38.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.64 -0.663 . . . . 99.99 109.866 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 0.9 OUTLIER -89.35 158.68 17.69 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.361 -0.837 . . . . 99.99 110.553 -179.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.37 113.95 12.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.467 -0.771 . . . . 99.99 110.737 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.602 ' HD3' ' HD3' ' A' ' 13' ' ' ARG . 12.0 tttt -70.55 -36.56 73.73 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.456 -0.778 . . . . 99.99 109.763 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.5 m -61.54 -42.02 98.2 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.549 -0.72 . . . . 99.99 109.904 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.578 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 47.7 m0 -85.75 -56.85 3.29 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.738 -0.601 . . . . 99.99 109.516 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.12 20.77 4.33 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 120.458 -0.877 . . . . 99.99 111.185 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.578 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.8 p90 -151.11 -174.66 4.88 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 119.064 1.432 . . . . 99.99 111.519 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 6.5 t -128.13 127.49 43.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.689 -0.632 . . . . 99.99 110.29 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -150.49 174.19 13.22 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.287 -0.565 . . . . 99.99 110.239 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.465 HG22 ' CE2' ' A' ' 22' ' ' TYR . 66.4 t -56.92 152.07 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.361 -0.837 . . . . 99.99 110.122 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.05 94.83 6.02 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.373 -0.83 . . . . 99.99 110.236 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.57 149.04 19.48 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.517 -0.74 . . . . 99.99 110.593 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo . . . . . 0 C--N 1.313 -1.335 0 O-C-N 123.966 1.508 . . . . 99.99 110.784 179.647 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.032 0.444 . . . . 99.99 110.31 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.29 129.97 13.08 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.822 -1.311 . . . . 99.99 109.822 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.72 53.65 2.64 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.399 -1.059 . . . . 99.99 110.464 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.94 157.66 41.68 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.291 -0.88 . . . . 99.99 110.037 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.473 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -105.01 -109.3 3.4 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.065 -1.614 . . . . 99.99 109.065 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.548 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -153.56 -159.37 9.09 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.883 -1.287 . . . . 99.99 109.883 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 71.2 t80 -80.74 -33.21 35.3 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.554 -0.968 . . . . 99.99 110.616 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 30.3 t90 -141.98 78.41 1.63 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.297 -0.877 . . . . 99.99 109.931 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.548 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 14.0 m0 -108.2 156.26 19.54 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.548 -0.72 . . . . 99.99 109.374 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -89.63 134.32 34.2 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.794 -1.191 . . . . 99.99 111.067 -179.271 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.522 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 21.4 p -151.06 166.78 29.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.673 -0.642 . . . . 99.99 110.305 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.07 -111.88 1.08 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.266 -1.534 . . . . 99.99 109.266 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.461 ' HG3' ' HB3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.73 29.08 1.38 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.47 -1.018 . . . . 99.99 109.87 179.1 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.09 35.36 4.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.718 -1.353 . . . . 99.99 109.718 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.517 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -63.97 -61.09 7.42 Favored Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.313 -1.11 . . . . 99.99 110.363 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.522 ' HD2' ' HB2' ' A' ' 11' ' ' CYS . 47.9 Cg_endo -74.71 129.23 12.41 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.643 1.338 . . . . 99.99 109.72 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.47 114.91 4.08 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.692 1.364 . . . . 99.99 110.175 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.4 m -82.02 171.72 14.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.519 -0.738 . . . . 99.99 110.145 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.89 148.46 49.38 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.304 -0.873 . . . . 99.99 109.862 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.49 133.4 24.94 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.556 -0.715 . . . . 99.99 110.981 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.0 -27.77 18.94 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.611 -1.396 . . . . 99.99 109.611 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.409 ' CD1' HG22 ' A' ' 33' ' ' VAL . 12.5 m-30 -90.72 154.23 19.7 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.425 -1.044 . . . . 99.99 110.124 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.437 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . . . -136.3 151.69 49.89 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.542 -0.724 . . . . 99.99 109.912 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 0.8 OUTLIER -89.81 162.92 15.26 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.299 -0.876 . . . . 99.99 110.045 179.798 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.546 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 0.6 OUTLIER -131.6 101.19 5.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.502 -0.749 . . . . 99.99 110.457 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.461 ' HB3' ' HG3' ' A' ' 13' ' ' ARG . 11.2 pttm -60.36 -33.55 72.6 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.606 -0.684 . . . . 99.99 110.186 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.7 m -70.51 -39.86 73.85 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.618 -0.676 . . . . 99.99 110.235 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.546 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 46.6 m0 -82.64 -52.31 6.92 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.588 -0.695 . . . . 99.99 109.804 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.42 18.55 6.58 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 111.023 -0.831 . . . . 99.99 111.023 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.474 ' CH2' ' HB3' ' A' ' 28' ' ' TRP . 5.0 p90 -151.13 -170.6 3.7 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.753 -1.44 . . . . 99.99 111.464 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.507 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 8.9 t -132.87 130.98 40.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.604 -0.685 . . . . 99.99 110.414 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -149.4 -175.93 5.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.666 -0.646 . . . . 99.99 109.921 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.409 HG22 ' CD1' ' A' ' 22' ' ' TYR . 12.5 t -72.84 91.73 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.228 -0.92 . . . . 99.99 109.538 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' HB2' ' CB ' ' A' ' 23' ' ' ALA . 30.9 mt-10 -107.79 -30.99 8.22 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.46 -0.775 . . . . 99.99 110.868 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.99 155.26 55.43 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.277 -0.89 . . . . 99.99 110.44 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 C--N 1.313 -1.328 0 O-C-N 123.904 1.476 . . . . 99.99 110.619 -179.953 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 121.197 0.522 . . . . 99.99 110.411 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.69 -74.45 0.2 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.764 -1.334 . . . . 99.99 109.764 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -107.22 95.18 5.52 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.404 -1.056 . . . . 99.99 110.33 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.585 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -139.51 154.51 47.7 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.567 -0.708 . . . . 99.99 109.961 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.431 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -86.44 -126.34 1.96 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.781 -1.328 . . . . 99.99 109.781 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.551 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -145.77 -148.67 4.84 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.401 -1.48 . . . . 99.99 109.401 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.436 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 44.7 t80 -86.55 -27.3 24.03 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.343 -1.092 . . . . 99.99 110.855 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -151.06 68.69 0.94 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.432 -0.793 . . . . 99.99 109.833 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.551 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 16.9 m0 -96.64 160.31 14.45 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.454 -0.779 . . . . 99.99 109.629 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -90.14 130.84 36.24 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.999 -1.063 . . . . 99.99 111.391 -179.076 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.7 p -151.73 179.39 8.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.762 -0.586 . . . . 99.99 110.522 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.61 -121.42 4.61 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.417 -1.473 . . . . 99.99 109.417 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.72 53.39 2.4 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.554 -0.968 . . . . 99.99 109.899 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.413 ' HA2' ' HB2' ' A' ' 24' ' ' CYS . . . 77.93 37.81 28.48 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.702 -1.359 . . . . 99.99 109.702 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.527 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 0.3 OUTLIER -71.09 -58.37 4.11 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.493 -1.004 . . . . 99.99 110.199 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 48.4 Cg_endo -76.42 143.42 24.71 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 O-C-N 123.736 1.388 . . . . 99.99 109.958 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.403 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 48.8 Cg_endo -73.9 99.06 1.12 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.757 1.398 . . . . 99.99 110.762 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.67 177.04 3.18 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.266 -0.896 . . . . 99.99 109.376 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.585 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 2.7 m -81.16 161.61 23.98 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.137 -0.977 . . . . 99.99 109.654 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -55.95 120.46 7.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.391 -0.818 . . . . 99.99 110.457 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.0 -14.72 44.63 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.45 -1.06 . . . . 99.99 110.45 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.52 ' CD1' ' HB2' ' A' ' 19' ' ' CYS . 66.8 m-85 -102.59 131.63 49.22 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.051 -1.264 . . . . 99.99 110.122 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.411 ' HB3' ' HG2' ' A' ' 34' ' ' GLU . . . -117.45 147.36 42.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.57 -0.706 . . . . 99.99 110.24 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 1.1 m -89.36 159.26 17.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.415 -0.803 . . . . 99.99 110.065 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.472 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 2.0 m -130.22 117.77 20.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.576 -0.703 . . . . 99.99 110.483 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -69.82 -37.63 76.31 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.551 -0.718 . . . . 99.99 109.751 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.3 m -71.83 -39.73 69.58 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.625 -0.672 . . . . 99.99 110.255 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.569 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 43.9 m0 -78.9 -48.69 14.14 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.555 -0.716 . . . . 99.99 109.803 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.54 18.08 15.47 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.988 -0.845 . . . . 99.99 110.988 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.569 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.5 p90 -150.85 -179.23 7.1 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.856 -1.379 . . . . 99.99 111.157 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.633 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 22.8 t -123.91 129.94 51.79 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.662 -0.649 . . . . 99.99 110.232 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.12 169.65 19.53 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.787 -0.571 . . . . 99.99 110.135 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.461 ' CG2' ' CE2' ' A' ' 22' ' ' TYR . 59.4 t -60.1 157.01 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.445 -0.784 . . . . 99.99 110.443 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.411 ' HG2' ' HB3' ' A' ' 23' ' ' ALA . 6.1 mm-40 -94.97 34.06 1.42 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.44 -0.788 . . . . 99.99 110.795 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.495 ' N ' ' HD2' ' A' ' 36' ' ' PRO . . . -71.56 -51.15 9.73 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.278 -0.889 . . . . 99.99 110.478 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 35' ' ' ALA . 47.9 Cg_endo . . . . . 0 N--CA 1.486 1.058 0 O-C-N 123.405 1.213 . . . . 99.99 110.791 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 N--CA 1.498 1.949 0 CA-C-O 121.201 0.524 . . . . 99.99 110.351 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -134.07 70.21 0.52 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.526 -1.429 . . . . 99.99 109.526 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 17' ' ' PRO . 0.5 OUTLIER -120.99 168.7 11.23 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.579 -0.954 . . . . 99.99 110.296 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.58 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -123.76 155.75 37.34 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.353 -0.842 . . . . 99.99 109.926 179.598 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.426 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -94.76 -120.89 3.44 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.594 -1.402 . . . . 99.99 109.594 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.521 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -144.97 -149.6 5.06 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.216 -1.554 . . . . 99.99 109.216 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -88.44 -17.28 30.75 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.305 -1.115 . . . . 99.99 110.685 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 -160.06 68.06 0.38 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.322 -0.861 . . . . 99.99 110.07 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.521 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 20.2 m0 -96.81 173.69 7.18 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.401 -0.812 . . . . 99.99 110.087 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -94.81 133.31 38.65 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.185 -0.947 . . . . 99.99 110.945 -179.486 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 24.8 p -150.75 159.38 44.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.606 -0.684 . . . . 99.99 110.47 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -93.61 -118.0 2.76 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.265 -1.534 . . . . 99.99 109.265 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.531 ' HB2' ' HD2' ' A' ' 26' ' ' LYS . 0.3 OUTLIER -90.78 43.01 1.13 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.528 -0.984 . . . . 99.99 109.723 179.388 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.95 39.92 5.36 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.597 -1.401 . . . . 99.99 109.597 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.569 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 6.4 mttt -76.89 -64.0 0.49 Allowed Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.431 -1.041 . . . . 99.99 110.023 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.569 ' CD ' ' CB ' ' A' ' 15' ' ' LYS . 48.5 Cg_endo -74.39 133.64 17.85 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 O-C-N 123.579 1.305 . . . . 99.99 109.633 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.478 ' HB2' ' O ' ' A' ' 3' ' ' GLU . 50.6 Cg_endo -73.26 111.51 3.3 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.678 1.357 . . . . 99.99 110.319 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.4 m -77.39 179.2 6.59 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.402 -0.811 . . . . 99.99 110.101 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.58 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 2.7 m -87.4 150.81 23.56 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.382 -0.824 . . . . 99.99 110.078 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.16 118.78 3.46 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.607 -0.683 . . . . 99.99 110.532 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.29 -35.98 3.69 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.621 -1.392 . . . . 99.99 109.621 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.6 m-85 -93.66 152.16 19.17 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.35 -1.088 . . . . 99.99 110.069 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -126.27 146.74 49.88 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.648 -0.658 . . . . 99.99 110.178 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 13.4 t -89.75 159.84 16.85 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.457 -0.777 . . . . 99.99 110.331 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.6 m -140.75 116.69 10.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.653 -0.655 . . . . 99.99 110.559 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.531 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -73.72 -39.25 64.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.419 -0.801 . . . . 99.99 109.19 179.051 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.1 m -62.85 -40.59 97.93 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.364 -0.606 . . . . 99.99 109.364 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.55 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 40.5 m0 -79.98 -38.83 31.39 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.285 -0.635 . . . . 99.99 109.285 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.26 13.97 50.02 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.626 -0.99 . . . . 99.99 110.626 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.55 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.3 p90 -150.92 177.03 10.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.903 -1.351 . . . . 99.99 111.273 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 31.2 t -126.08 121.88 34.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.752 -0.592 . . . . 99.99 109.714 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.75 -178.26 5.34 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.541 -0.725 . . . . 99.99 110.046 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 21.5 t -63.72 156.82 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.272 -0.892 . . . . 99.99 110.188 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -54.98 102.04 0.06 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.638 -0.663 . . . . 99.99 110.235 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -161.31 148.24 11.7 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.416 -0.803 . . . . 99.99 110.501 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo . . . . . 0 C--N 1.314 -1.285 0 O-C-N 123.954 1.502 . . . . 99.99 110.58 179.728 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 121.347 0.594 . . . . 99.99 110.202 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.9 -155.45 52.83 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.737 -1.345 . . . . 99.99 109.737 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -159.31 85.92 0.8 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.352 -1.087 . . . . 99.99 110.382 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -145.09 154.24 42.27 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.469 -0.77 . . . . 99.99 110.218 179.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.453 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -95.72 -129.02 5.77 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.418 -1.473 . . . . 99.99 109.418 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.534 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -147.22 -153.73 6.0 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.588 -1.405 . . . . 99.99 109.588 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 77.5 t80 -79.66 -29.63 40.95 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.346 -1.091 . . . . 99.99 110.899 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -149.21 74.92 1.27 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.18 -0.95 . . . . 99.99 109.883 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.534 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 16.3 m0 -105.05 178.32 4.59 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.666 -0.646 . . . . 99.99 109.377 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.98 133.52 35.22 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.93 -1.106 . . . . 99.99 110.778 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.583 ' SG ' ' HD2' ' A' ' 16' ' ' PRO . 40.7 t -151.69 162.36 41.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.653 -0.654 . . . . 99.99 110.372 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -102.57 -119.01 4.52 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 108.889 -1.685 . . . . 99.99 108.889 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.538 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -91.15 31.24 1.13 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.322 -1.105 . . . . 99.99 110.129 179.153 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.83 36.77 3.61 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.819 -1.312 . . . . 99.99 109.819 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.537 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -76.57 -63.92 0.53 Allowed Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.372 -1.075 . . . . 99.99 110.557 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.583 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 44.1 Cg_endo -71.18 135.28 26.77 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.729 1.384 . . . . 99.99 110.042 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.409 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 45.5 Cg_endo -71.88 100.97 1.13 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.81 1.426 . . . . 99.99 110.844 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.0 m -72.77 169.25 17.11 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.342 -0.848 . . . . 99.99 109.216 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.2 147.9 46.35 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.941 -1.1 . . . . 99.99 110.025 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.55 119.81 4.52 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.638 -0.663 . . . . 99.99 110.571 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.26 -22.61 17.63 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.819 -1.312 . . . . 99.99 109.819 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 12.4 m-30 -89.07 157.95 18.15 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.416 -1.05 . . . . 99.99 109.974 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -133.29 151.32 51.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.506 -0.746 . . . . 99.99 109.917 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.3 m -89.12 167.17 13.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.506 -0.746 . . . . 99.99 110.694 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.479 ' CB ' ' HB2' ' A' ' 28' ' ' TRP . 17.3 m -132.66 102.21 5.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.613 -0.679 . . . . 99.99 110.324 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.538 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 1.8 ttpt -65.09 -31.42 72.63 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.555 -0.716 . . . . 99.99 110.841 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.9 m -82.92 -36.13 25.5 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.435 -0.79 . . . . 99.99 110.873 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.583 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 45.0 m0 -79.95 -42.63 23.62 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.477 -0.765 . . . . 99.99 110.236 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.07 16.88 22.18 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.498 -0.858 . . . . 99.99 110.976 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.583 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 2.8 p90 -150.59 178.82 8.71 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.107 -1.231 . . . . 99.99 110.822 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 22.6 t -121.01 135.88 55.11 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.548 -0.72 . . . . 99.99 109.786 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -146.03 -179.59 6.82 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.436 -0.79 . . . . 99.99 110.242 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 11.9 t -75.01 151.64 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.388 -0.82 . . . . 99.99 109.802 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -68.86 -26.4 65.13 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.51 -0.744 . . . . 99.99 110.813 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.26 150.51 95.55 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.379 -0.826 . . . . 99.99 110.437 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 C--N 1.312 -1.384 0 O-C-N 123.892 1.47 . . . . 99.99 110.863 179.971 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.643 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.314 0.578 . . . . 0.0 109.879 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.421 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -92.13 -118.32 2.41 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.492 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -147.55 -143.1 3.78 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -90.68 -37.78 13.51 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.296 -1.12 . . . . 0.0 110.59 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.82 70.49 1.35 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.513 -0.742 . . . . 0.0 109.808 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.492 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 16.7 m0 -96.85 166.19 11.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.36 -0.838 . . . . 0.0 109.734 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -92.12 134.74 34.57 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.166 -0.958 . . . . 0.0 110.919 -179.55 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 31.2 p -151.07 159.03 44.76 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.579 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.82 -115.89 1.0 Allowed Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.554 ' HG3' ' HB3' ' A' ' 26' ' ' LYS . 1.0 OUTLIER -90.66 29.58 1.29 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.435 -1.038 . . . . 0.0 110.044 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.92 38.68 3.31 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.594 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -74.16 -57.34 2.31 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.406 -1.055 . . . . 0.0 110.572 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 46.9 Cg_endo -74.58 134.99 19.3 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 O-C-N 123.719 1.378 . . . . 0.0 109.975 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -71.84 105.77 1.87 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.92 1.484 . . . . 0.0 110.693 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.0 m -74.79 176.57 6.92 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.397 -0.814 . . . . 0.0 109.761 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.643 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.1 m -81.2 161.9 23.81 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.28 -0.887 . . . . 0.0 110.301 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -56.24 125.66 22.77 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.562 -0.711 . . . . 0.0 110.543 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.6 -18.73 54.71 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.52 ' CD1' ' HB2' ' A' ' 19' ' ' CYS . 52.8 m-85 -94.58 142.47 27.4 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.253 -1.145 . . . . 0.0 110.153 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -124.82 140.81 52.59 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.426 -0.796 . . . . 0.0 110.349 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 14.1 t -89.44 159.56 17.22 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.51 -0.744 . . . . 0.0 110.158 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -138.14 123.27 19.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.62 -0.675 . . . . 0.0 111.031 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.554 ' HB3' ' HG3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -76.63 -35.12 58.24 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.658 -0.651 . . . . 0.0 110.003 179.157 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.4 m -69.99 -38.75 76.1 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.46 -0.775 . . . . 0.0 109.389 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.528 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 40.3 m0 -80.02 -40.85 26.94 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.48 16.37 43.3 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.528 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.0 p90 -151.0 177.84 9.77 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.999 -1.295 . . . . 0.0 111.021 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 25.2 t -127.27 128.37 45.88 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.698 -0.626 . . . . 0.0 110.235 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.48 172.83 14.34 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.605 -0.684 . . . . 0.0 110.096 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.444 HG23 ' CE2' ' A' ' 22' ' ' TYR . 99.1 t . . . . . 0 N--CA 1.501 2.108 0 O-C-N 121.389 -0.82 . . . . 0.0 110.018 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.442 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.081 0.467 . . . . 0.0 109.958 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.565 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -78.84 -142.87 2.31 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.5 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -142.7 -151.48 5.5 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -76.92 -29.33 55.63 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.34 -1.094 . . . . 0.0 111.059 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -153.83 69.97 0.81 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.315 -0.866 . . . . 0.0 110.233 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.565 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 20.8 m0 -98.62 176.07 5.77 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.494 -0.754 . . . . 0.0 109.704 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.77 138.93 31.06 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.143 -0.973 . . . . 0.0 110.393 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.4 ' SG ' ' HD2' ' A' ' 16' ' ' PRO . 33.6 t -150.99 161.01 43.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.541 -0.724 . . . . 0.0 110.442 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -103.49 -121.43 4.93 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.556 ' HA ' ' HB3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.71 37.37 0.92 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.364 -1.08 . . . . 0.0 110.347 179.638 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.17 34.55 7.09 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.585 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 1.4 tptp -77.58 -58.97 0.87 Allowed Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.319 -1.107 . . . . 0.0 110.19 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 47.2 Cg_endo -75.07 133.4 16.43 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.694 1.365 . . . . 0.0 110.018 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.63 104.93 1.68 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 O-C-N 123.899 1.473 . . . . 0.0 110.589 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.2 m -72.38 166.36 22.7 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.414 -0.804 . . . . 0.0 109.728 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.442 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -67.77 155.97 38.09 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.255 -0.903 . . . . 0.0 110.407 -179.689 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.02 128.67 28.18 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.667 -0.646 . . . . 0.0 111.138 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.65 -20.42 50.73 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.856 ' CE1' HG22 ' A' ' 33' ' ' VAL . 12.3 m-30 -89.7 150.89 22.13 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.168 -1.195 . . . . 0.0 110.31 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.39 142.42 51.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.671 -0.643 . . . . 0.0 109.852 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 18.3 t -89.3 159.69 17.26 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.447 -0.783 . . . . 0.0 110.622 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.0 m -138.64 106.92 5.78 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.635 -0.666 . . . . 0.0 110.424 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.556 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -72.99 -33.4 65.79 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.371 -0.83 . . . . 0.0 110.285 179.363 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.6 m -68.87 -36.74 78.46 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.471 -0.768 . . . . 0.0 109.83 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.583 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 47.0 m0 -84.04 -40.16 18.71 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.747 -0.595 . . . . 0.0 109.565 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.96 14.91 25.46 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.583 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 2.6 p90 -151.46 177.77 9.96 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.843 -1.387 . . . . 0.0 111.458 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 15.8 t -126.89 126.53 43.44 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.9 177.91 7.63 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.555 -0.715 . . . . 0.0 110.498 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.856 HG22 ' CE1' ' A' ' 22' ' ' TYR . 17.6 t . . . . . 0 N--CA 1.496 1.87 0 O-C-N 121.452 -0.78 . . . . 0.0 110.208 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 121.281 0.563 . . . . 0.0 109.92 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.544 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -77.22 -149.61 3.49 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.437 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -139.49 -139.56 3.8 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -90.25 -19.22 24.39 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.447 -1.031 . . . . 0.0 111.242 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -161.85 65.01 0.25 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.27 -0.894 . . . . 0.0 109.679 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.544 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 20.7 m0 -97.15 162.19 13.47 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.472 -0.767 . . . . 0.0 109.697 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -90.79 134.41 34.46 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.994 -1.066 . . . . 0.0 110.873 -179.555 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.1 p -150.79 169.85 20.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.516 -0.74 . . . . 0.0 110.471 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.6 -131.02 2.53 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.626 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.45 55.02 2.89 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.478 -1.013 . . . . 0.0 110.026 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 78.68 35.4 32.22 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.5 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 2.3 mttt -76.36 -60.32 0.94 Allowed Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.327 -1.102 . . . . 0.0 110.356 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.5 ' CD ' ' CB ' ' A' ' 15' ' ' LYS . 47.3 Cg_endo -73.2 141.36 32.27 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.651 1.343 . . . . 0.0 110.168 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.465 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 42.9 Cg_endo -71.78 103.23 1.43 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.856 1.45 . . . . 0.0 110.867 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.493 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 24.7 m -71.27 162.16 29.88 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.366 -0.834 . . . . 0.0 109.659 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 148.99 48.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.125 -0.985 . . . . 0.0 109.681 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.54 126.0 18.16 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.618 -0.676 . . . . 0.0 111.101 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.34 -29.21 9.82 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.789 ' CE1' HG22 ' A' ' 33' ' ' VAL . 5.5 m-85 -95.26 152.87 18.0 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.299 -1.118 . . . . 0.0 110.497 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -128.78 146.97 50.76 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.648 -0.658 . . . . 0.0 110.143 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.55 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 0.8 OUTLIER -91.82 160.87 15.1 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.435 -0.79 . . . . 0.0 110.566 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.553 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 0.5 OUTLIER -135.88 122.33 20.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.647 -0.658 . . . . 0.0 110.392 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.626 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -73.68 -42.02 61.88 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.456 -0.777 . . . . 0.0 109.38 179.189 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.8 m -63.27 -40.0 96.17 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.686 -0.634 . . . . 0.0 109.782 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.553 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 42.4 m0 -80.18 -46.07 17.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.773 -0.579 . . . . 0.0 109.5 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.7 18.45 23.01 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.51 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.8 p90 -151.38 -176.54 5.62 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.924 -1.339 . . . . 0.0 111.394 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.55 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 6.6 t -126.46 125.56 42.33 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.58 174.33 10.67 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.442 -0.786 . . . . 0.0 110.668 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.789 HG22 ' CE1' ' A' ' 22' ' ' TYR . 19.0 t . . . . . 0 N--CA 1.497 1.887 0 O-C-N 121.485 -0.759 . . . . 0.0 110.07 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 121.268 0.556 . . . . 0.0 109.976 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.486 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -81.07 -149.45 6.57 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.432 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -131.44 -140.9 4.67 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.542 ' HA ' ' CE1' ' A' ' 22' ' ' TYR . 20.6 p90 -90.51 -22.03 21.54 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.402 -1.058 . . . . 0.0 110.901 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 32.4 t90 -156.59 69.44 0.61 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.247 -0.908 . . . . 0.0 109.701 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.486 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 17.8 m0 -99.69 174.37 6.26 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.441 -0.787 . . . . 0.0 109.662 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.9 mtmm -90.15 138.52 31.45 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.955 -1.091 . . . . 0.0 110.261 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.424 ' SG ' ' HD2' ' A' ' 16' ' ' PRO . 13.9 t -150.67 162.44 40.69 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.256 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -102.27 -117.65 4.31 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.572 ' HA ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -91.25 28.99 1.51 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.42 -1.047 . . . . 0.0 110.305 179.362 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.15 32.54 5.52 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.592 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 4.8 tptt -72.22 -58.7 3.03 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.373 -1.075 . . . . 0.0 110.2 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.592 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 49.1 Cg_endo -75.85 131.89 13.78 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.701 1.369 . . . . 0.0 109.974 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.448 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 42.8 Cg_endo -71.82 100.95 1.12 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.767 1.404 . . . . 0.0 110.167 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.8 m -67.92 161.32 26.71 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.33 -0.856 . . . . 0.0 109.994 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.407 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -64.7 156.47 30.22 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.462 -0.774 . . . . 0.0 110.087 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.53 128.38 35.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.445 -0.784 . . . . 0.0 110.616 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.28 -28.0 16.19 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.542 ' CE1' ' HA ' ' A' ' 7' ' ' PHE . 88.9 m-85 -94.36 142.98 26.79 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.503 -0.998 . . . . 0.0 110.112 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.41 148.81 43.29 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.549 -0.719 . . . . 0.0 110.056 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.5 t -88.73 160.96 17.07 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.495 -0.753 . . . . 0.0 110.266 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.7 m -140.05 102.24 4.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.651 -0.656 . . . . 0.0 110.701 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.572 ' HB2' ' HA ' ' A' ' 13' ' ' ARG . 2.1 tptp -69.12 -36.31 77.35 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.311 -0.868 . . . . 0.0 109.76 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.4 m -62.26 -37.79 86.8 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.619 -0.676 . . . . 0.0 110.185 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.576 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 45.7 m0 -88.44 -50.23 6.44 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.622 -0.674 . . . . 0.0 109.952 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.54 16.08 6.66 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.209 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.576 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.4 p90 -150.51 -177.85 6.2 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.831 -1.394 . . . . 0.0 111.281 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 22.5 t -129.92 126.23 37.39 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.671 -0.643 . . . . 0.0 110.233 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.19 173.22 14.17 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.672 -0.642 . . . . 0.0 110.191 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.421 HG23 ' CE1' ' A' ' 22' ' ' TYR . 98.5 t . . . . . 0 N--CA 1.501 2.106 0 O-C-N 121.272 -0.892 . . . . 0.0 109.904 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.576 0.703 . . . . 0.0 110.239 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.47 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -92.56 -126.09 3.9 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.509 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -147.66 -142.41 3.67 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -90.57 -32.66 16.2 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.443 -1.033 . . . . 0.0 110.528 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -145.02 70.52 1.27 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.497 -0.752 . . . . 0.0 109.93 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.509 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 15.6 m0 -100.52 175.51 5.65 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.425 -0.797 . . . . 0.0 109.983 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt -89.8 138.76 31.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.133 -0.979 . . . . 0.0 110.55 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.462 ' SG ' ' HD2' ' A' ' 16' ' ' PRO . 29.1 t -151.61 161.85 41.98 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.546 -0.721 . . . . 0.0 110.38 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.56 -117.1 3.92 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.437 ' HD2' ' HB2' ' A' ' 26' ' ' LYS . 13.6 tpt180 -90.7 21.69 3.92 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.393 -1.063 . . . . 0.0 109.898 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.51 34.18 3.41 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.556 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -77.28 -54.7 1.45 Allowed Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.361 -1.082 . . . . 0.0 110.824 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 47.5 Cg_endo -74.28 132.38 16.37 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.678 1.357 . . . . 0.0 110.115 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -71.45 104.57 1.59 Allowed 'Trans proline' 0 C--N 1.314 -1.271 0 O-C-N 123.771 1.406 . . . . 0.0 110.667 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.2 m -75.26 167.2 22.37 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.404 -0.81 . . . . 0.0 109.386 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.459 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -64.37 165.1 10.2 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.25 -0.906 . . . . 0.0 110.303 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.0 126.17 27.19 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.322 -0.861 . . . . 0.0 110.195 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.44 4.97 54.7 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 87.9 m-85 -118.28 150.71 39.01 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.082 -1.246 . . . . 0.0 109.507 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -127.84 147.21 50.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.325 -0.86 . . . . 0.0 110.589 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.4 t -88.97 162.08 16.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.585 -0.697 . . . . 0.0 110.539 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.478 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 7.7 t -139.26 113.6 8.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.652 -0.655 . . . . 0.0 110.63 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.437 ' HB2' ' HD2' ' A' ' 13' ' ' ARG . 14.2 tptm -74.01 -39.83 63.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.496 -0.753 . . . . 0.0 110.213 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.3 m -65.5 -36.93 85.31 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.487 -0.758 . . . . 0.0 110.306 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.518 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 49.0 m0 -83.86 -46.9 11.64 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.613 -0.679 . . . . 0.0 110.027 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.02 19.98 10.26 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.174 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.518 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.7 p90 -150.79 -175.28 5.06 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.864 -1.374 . . . . 0.0 110.991 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 18.5 t -133.39 125.22 28.64 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.507 -0.746 . . . . 0.0 110.214 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.29 168.16 24.87 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.779 -0.575 . . . . 0.0 109.727 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 81.5 t . . . . . 0 N--CA 1.502 2.125 0 O-C-N 121.315 -0.866 . . . . 0.0 109.753 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 121.3 0.572 . . . . 0.0 110.646 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.449 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -106.44 -112.16 3.66 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.533 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -152.77 -148.98 5.01 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.436 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 3.1 t80 -89.62 -35.87 15.61 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.3 -1.118 . . . . 0.0 110.585 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -137.28 78.37 1.69 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.326 -0.859 . . . . 0.0 108.954 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.533 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 11.7 m0 -109.33 166.97 10.46 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.401 -0.812 . . . . 0.0 110.069 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.08 137.64 32.24 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.016 -1.053 . . . . 0.0 110.814 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.8 p -150.87 166.72 29.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.581 -0.7 . . . . 0.0 110.419 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.12 -118.6 3.69 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.553 ' HA ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.93 38.36 0.95 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.508 -0.995 . . . . 0.0 110.097 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.95 37.08 5.81 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.568 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 2.0 tttt -80.11 -56.55 0.72 Allowed Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.366 -1.079 . . . . 0.0 110.771 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 48.7 Cg_endo -75.94 126.39 9.33 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.647 1.341 . . . . 0.0 110.266 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.03 114.61 4.09 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.901 1.474 . . . . 0.0 110.55 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.407 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 81.1 m -83.4 -179.16 7.29 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.581 -0.699 . . . . 0.0 110.128 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.464 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.4 OUTLIER -72.42 158.64 35.38 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.261 -0.899 . . . . 0.0 110.243 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -54.99 122.47 10.98 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.454 -0.779 . . . . 0.0 110.07 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.2 -26.3 22.36 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.48 ' CE2' ' CG2' ' A' ' 33' ' ' VAL . 88.3 m-85 -89.72 135.97 33.31 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.408 -1.054 . . . . 0.0 109.492 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -123.2 148.56 45.67 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.272 -0.892 . . . . 0.0 110.34 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 7.1 t -89.04 159.49 17.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.517 -0.74 . . . . 0.0 110.251 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.403 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 2.4 m -137.41 113.41 9.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.679 -0.638 . . . . 0.0 110.465 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.553 ' HB2' ' HA ' ' A' ' 13' ' ' ARG . 3.3 ttpt -70.79 -39.76 72.96 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.531 -0.731 . . . . 0.0 109.57 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.0 m -62.05 -39.09 91.17 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.658 -0.651 . . . . 0.0 109.666 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.491 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 42.5 m0 -82.22 -41.6 20.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.727 -0.608 . . . . 0.0 109.626 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.5 14.92 33.68 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.491 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.7 p90 -151.62 -179.95 7.86 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.013 -1.287 . . . . 0.0 110.941 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 49.2 t -126.43 127.2 45.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.62 -0.675 . . . . 0.0 110.209 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -148.04 174.74 11.62 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.511 -0.743 . . . . 0.0 109.915 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.48 ' CG2' ' CE2' ' A' ' 22' ' ' TYR . 87.2 t . . . . . 0 N--CA 1.499 2.008 0 O-C-N 121.238 -0.914 . . . . 0.0 110.424 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.524 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 121.455 0.645 . . . . 0.0 110.245 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.543 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -83.93 -134.9 2.71 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.457 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -146.47 -147.11 4.5 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -77.07 -30.14 55.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.326 -1.102 . . . . 0.0 111.26 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -153.65 72.8 0.93 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.242 -0.911 . . . . 0.0 110.186 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.543 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 18.1 m0 -102.49 174.86 5.71 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.46 -0.775 . . . . 0.0 109.444 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.16 145.47 25.41 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.028 -1.045 . . . . 0.0 110.199 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.559 ' SG ' ' HG2' ' A' ' 16' ' ' PRO . 44.4 t -151.04 160.38 43.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.55 -0.719 . . . . 0.0 110.714 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.02 -123.84 4.64 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.637 ' HA ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -88.71 -37.96 15.11 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.377 -1.073 . . . . 0.0 109.789 179.391 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.02 36.2 0.13 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.641 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 5.0 mttp -89.72 -69.15 0.1 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.371 -1.076 . . . . 0.0 110.534 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.641 ' HD3' ' CB ' ' A' ' 15' ' ' LYS . 49.6 Cg_endo -77.25 113.07 3.51 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 O-C-N 123.525 1.276 . . . . 0.0 109.913 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.452 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 49.5 Cg_endo -77.24 116.47 4.16 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.834 1.439 . . . . 0.0 110.7 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.434 ' SG ' ' HB2' ' A' ' 22' ' ' TYR . 0.5 OUTLIER -68.4 157.39 35.88 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.117 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.524 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -60.7 153.1 24.93 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.083 -1.011 . . . . 0.0 110.461 -179.412 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -45.07 127.85 6.91 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.795 -0.566 . . . . 0.0 111.076 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.66 -29.04 10.35 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.693 ' CD1' HG22 ' A' ' 33' ' ' VAL . 4.1 m-85 -104.1 129.84 51.8 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.41 -1.053 . . . . 0.0 110.245 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -101.31 148.54 25.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.47 -0.769 . . . . 0.0 109.538 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 2.8 t -89.15 159.41 17.51 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.17 -0.956 . . . . 0.0 110.27 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.534 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 0.3 OUTLIER -143.96 121.2 11.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.585 -0.697 . . . . 0.0 111.289 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.637 ' HB2' ' HA ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -75.92 -41.43 51.85 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.536 -0.727 . . . . 0.0 109.402 178.795 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.6 m -58.92 -37.29 76.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.74 -0.6 . . . . 0.0 109.702 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.534 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 42.5 m0 -86.15 -37.29 18.9 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.38 16.1 47.99 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.493 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 2.6 p90 -152.01 178.15 9.74 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.001 -1.294 . . . . 0.0 110.779 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.426 ' O ' ' SG ' ' A' ' 31' ' ' CYS . 9.8 p -130.66 127.27 38.56 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.433 -0.792 . . . . 0.0 110.117 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.8 -178.22 6.33 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.682 -0.636 . . . . 0.0 110.124 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.693 HG22 ' CD1' ' A' ' 22' ' ' TYR . 24.8 t . . . . . 0 N--CA 1.503 2.184 0 O-C-N 121.222 -0.924 . . . . 0.0 110.302 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 121.28 0.562 . . . . 0.0 110.494 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.434 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -105.78 -112.27 3.68 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.549 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -151.06 -153.62 6.23 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -85.13 -33.42 22.36 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.221 -1.164 . . . . 0.0 110.706 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 16.8 t90 -142.76 75.01 1.47 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.332 -0.855 . . . . 0.0 109.593 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.549 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 14.5 m0 -104.51 166.16 10.58 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.651 -0.656 . . . . 0.0 109.447 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -90.61 136.83 32.81 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.999 -1.063 . . . . 0.0 110.568 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.1 p -150.84 171.81 16.63 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.723 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.33 -123.23 3.17 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.461 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -91.11 24.86 2.67 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.416 -1.05 . . . . 0.0 110.441 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.415 ' HA2' ' HB3' ' A' ' 24' ' ' CYS . . . 108.76 37.3 2.06 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.434 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 0.5 OUTLIER -82.43 -56.86 0.5 Allowed Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.4 -1.059 . . . . 0.0 111.062 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' A' ' 15' ' ' LYS . 46.9 Cg_endo -73.93 130.89 14.95 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 O-C-N 123.568 1.299 . . . . 0.0 110.517 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -73.14 113.06 3.68 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.785 1.413 . . . . 0.0 110.951 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.41 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 84.8 m -85.27 -178.99 6.89 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.638 -0.664 . . . . 0.0 110.221 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.93 151.78 38.86 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.235 -0.916 . . . . 0.0 110.211 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.33 115.6 2.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.703 -0.623 . . . . 0.0 110.638 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.83 -33.77 3.8 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.549 ' HD1' HG22 ' A' ' 33' ' ' VAL . 5.3 m-85 -94.7 149.99 20.67 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.507 -0.996 . . . . 0.0 110.304 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -126.19 150.05 48.59 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.569 -0.707 . . . . 0.0 109.789 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 15.9 t -89.06 158.22 18.05 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.226 -0.921 . . . . 0.0 110.395 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.1 m -141.51 131.59 24.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.651 -0.655 . . . . 0.0 110.77 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.461 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 11.6 tptp -84.73 -44.48 13.32 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.669 -0.644 . . . . 0.0 109.34 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.2 m -59.12 -38.94 80.82 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.482 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 44.3 m0 -81.88 -41.57 20.77 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.61 16.81 41.13 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.482 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 2.9 p90 -151.18 178.33 9.33 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.94 -1.329 . . . . 0.0 111.302 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 17.5 t -123.26 119.02 28.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.764 -0.585 . . . . 0.0 110.148 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.16 178.49 8.93 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.828 -0.545 . . . . 0.0 110.012 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.549 HG22 ' HD1' ' A' ' 22' ' ' TYR . 63.9 t . . . . . 0 N--CA 1.5 2.071 0 O-C-N 121.31 -0.869 . . . . 0.0 110.27 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.451 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 121.206 0.527 . . . . 0.0 110.229 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.542 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -98.02 -133.89 8.12 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.555 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -144.7 -150.76 5.29 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -85.35 -24.38 27.63 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.37 -1.077 . . . . 0.0 111.438 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.419 ' CD1' ' N ' ' A' ' 8' ' ' TRP . 17.5 p-90 -149.45 61.03 1.02 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.062 -1.024 . . . . 0.0 110.046 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.555 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 17.2 m0 -94.23 154.7 17.41 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.24 -0.912 . . . . 0.0 109.43 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -88.89 132.76 34.54 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.885 -1.135 . . . . 0.0 111.379 -178.732 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.436 ' HB2' ' CG ' ' A' ' 16' ' ' PRO . 31.4 p -150.87 173.66 13.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.819 -0.551 . . . . 0.0 110.28 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.38 -132.16 3.11 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.51 54.16 2.65 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.474 -1.015 . . . . 0.0 109.819 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.8 41.12 7.82 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.538 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -81.76 -61.01 0.38 Allowed Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.444 -1.033 . . . . 0.0 110.585 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.538 ' HD3' ' CB ' ' A' ' 15' ' ' LYS . 51.2 Cg_endo -76.38 140.44 21.81 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.668 1.352 . . . . 0.0 110.267 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.45 113.8 3.82 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.799 1.42 . . . . 0.0 110.779 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.418 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 0.1 OUTLIER -83.56 176.6 8.91 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.43 -0.794 . . . . 0.0 109.818 179.395 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.451 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -71.32 151.96 43.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.274 -0.892 . . . . 0.0 109.31 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.08 124.05 11.98 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.194 -0.941 . . . . 0.0 110.331 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.7 -24.84 27.41 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.461 ' CE2' ' CG2' ' A' ' 33' ' ' VAL . 85.3 m-85 -91.11 136.76 32.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.199 -1.177 . . . . 0.0 110.057 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -121.34 150.0 42.11 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.586 -0.697 . . . . 0.0 110.145 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 1.0 OUTLIER -89.46 162.39 15.76 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.322 -0.861 . . . . 0.0 110.228 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.582 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 0.4 OUTLIER -137.12 120.33 16.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.451 -0.78 . . . . 0.0 110.648 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -36.36 63.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.433 -0.792 . . . . 0.0 109.542 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.8 m -64.49 -43.29 94.61 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.672 -0.643 . . . . 0.0 109.735 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.582 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 42.2 m0 -81.83 -46.92 13.49 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.796 -0.565 . . . . 0.0 109.645 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.71 18.14 15.0 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.629 -0.989 . . . . 0.0 110.629 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.516 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.7 p90 -150.85 -175.65 5.21 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.011 -1.287 . . . . 0.0 111.194 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.602 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 46.1 t -122.58 130.88 53.49 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.536 -0.728 . . . . 0.0 110.576 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.53 174.42 10.78 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.962 -0.462 . . . . 0.0 109.98 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.461 ' CG2' ' CE2' ' A' ' 22' ' ' TYR . 97.5 t . . . . . 0 N--CA 1.5 2.059 0 O-C-N 121.224 -0.922 . . . . 0.0 110.044 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.535 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 121.208 0.528 . . . . 0.0 109.949 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.506 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -86.64 -122.63 1.48 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.485 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -151.54 -145.34 4.11 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.424 ' HE1' ' HH ' ' A' ' 22' ' ' TYR . 0.2 OUTLIER -90.41 -27.28 19.4 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.221 -1.164 . . . . 0.0 110.817 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 33.0 t90 -149.13 73.84 1.22 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.411 -0.806 . . . . 0.0 109.623 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.506 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 15.4 m0 -104.56 159.05 16.07 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.456 -0.778 . . . . 0.0 109.428 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 1.9 mptt -90.7 132.99 35.48 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.852 -1.155 . . . . 0.0 111.311 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 23.7 p -150.82 170.35 19.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.61 -0.681 . . . . 0.0 110.604 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -117.58 1.87 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.574 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.73 41.48 1.06 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.533 -0.98 . . . . 0.0 110.176 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.17 33.4 17.7 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.595 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 0.2 OUTLIER -69.57 -55.27 9.56 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.247 -1.149 . . . . 0.0 110.489 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 47.9 Cg_endo -74.38 135.87 20.98 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 O-C-N 123.586 1.308 . . . . 0.0 109.729 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.42 107.39 2.27 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.704 1.371 . . . . 0.0 110.986 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.46 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 0.1 OUTLIER -74.88 174.99 8.49 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.346 -0.846 . . . . 0.0 109.327 179.072 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.535 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 2.2 m -80.22 147.11 31.38 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.931 -1.106 . . . . 0.0 108.799 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -44.78 127.51 6.32 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.466 -0.771 . . . . 0.0 111.278 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.6 -25.81 21.75 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.827 ' CD1' HG22 ' A' ' 33' ' ' VAL . 7.9 m-30 -99.33 136.64 38.98 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.079 -1.248 . . . . 0.0 110.19 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -118.29 149.79 40.56 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.413 -0.804 . . . . 0.0 109.778 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.702 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 0.8 OUTLIER -89.28 160.07 17.08 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.353 -0.842 . . . . 0.0 110.694 -179.742 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.4 m -132.56 110.84 10.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.582 -0.699 . . . . 0.0 110.517 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.574 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 39.7 tptt -68.86 -36.8 78.55 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.478 -0.764 . . . . 0.0 110.061 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.9 m -66.27 -37.69 86.05 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.637 -0.665 . . . . 0.0 109.921 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.524 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 42.7 m0 -86.07 -48.17 8.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.717 -0.614 . . . . 0.0 109.949 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.24 16.35 12.44 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.186 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.524 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.0 p90 -150.87 179.46 8.21 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.717 -1.461 . . . . 0.0 111.426 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.702 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 49.1 t -121.39 128.99 52.77 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.633 -0.667 . . . . 0.0 110.028 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -146.9 174.86 11.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.711 -0.618 . . . . 0.0 110.087 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.827 HG22 ' CD1' ' A' ' 22' ' ' TYR . 12.5 t . . . . . 0 N--CA 1.498 1.954 0 O-C-N 121.371 -0.831 . . . . 0.0 109.875 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 121.312 0.577 . . . . 0.0 110.025 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.542 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -81.48 -128.84 0.99 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.457 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -146.77 -140.13 3.39 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.56 -33.5 15.87 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.288 -1.125 . . . . 0.0 110.769 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -146.75 68.31 1.17 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.405 -0.81 . . . . 0.0 109.788 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.542 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 18.1 m0 -94.92 161.83 13.99 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.453 -0.78 . . . . 0.0 109.844 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 1.2 mttp -89.68 136.54 32.97 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.108 -0.995 . . . . 0.0 111.062 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.1 p -151.06 156.52 41.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.702 -0.624 . . . . 0.0 110.172 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.92 -118.45 0.84 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.45 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.86 34.04 0.92 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.414 -1.05 . . . . 0.0 110.001 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.51 39.72 3.37 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.486 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 3.8 mtpt -77.81 -58.74 0.86 Allowed Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.368 -1.078 . . . . 0.0 110.814 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.486 ' HD3' ' CB ' ' A' ' 15' ' ' LYS . 46.5 Cg_endo -74.56 136.9 22.03 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 O-C-N 123.652 1.343 . . . . 0.0 110.369 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.94 115.8 4.48 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.934 1.492 . . . . 0.0 110.701 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.467 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 96.1 m -84.91 -179.42 7.07 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.395 -0.816 . . . . 0.0 110.168 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.515 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 2.1 m -88.28 165.81 14.75 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.357 -0.839 . . . . 0.0 110.238 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp -58.18 124.77 20.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.388 -0.82 . . . . 0.0 110.223 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.8 -25.79 27.03 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.488 ' CD1' ' HB2' ' A' ' 19' ' ' CYS . 80.0 m-85 -92.13 133.44 35.77 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.552 -0.969 . . . . 0.0 110.066 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.92 145.27 47.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.543 -0.723 . . . . 0.0 109.89 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 9.1 t -88.82 160.34 17.29 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.581 -0.699 . . . . 0.0 110.089 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.413 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 2.5 m -142.6 122.9 13.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.587 -0.696 . . . . 0.0 111.208 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.45 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -73.77 -41.35 62.56 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.824 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.1 m -61.98 -40.28 95.07 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.692 -0.63 . . . . 0.0 109.599 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.497 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 34.9 m0 -80.28 -38.43 30.82 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.61 14.84 56.29 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.497 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 2.5 p90 -151.94 176.72 11.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.987 -1.302 . . . . 0.0 111.021 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 37.3 t -124.28 125.89 45.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.516 -0.74 . . . . 0.0 110.118 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.53 -178.25 5.99 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.671 -0.643 . . . . 0.0 109.785 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.428 HG23 ' CE2' ' A' ' 22' ' ' TYR . 98.6 t . . . . . 0 N--CA 1.501 2.087 0 O-C-N 121.138 -0.976 . . . . 0.0 110.155 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 121.303 0.573 . . . . 0.0 110.47 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.95 -122.45 3.79 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.552 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -151.31 -150.08 5.23 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 30.0 t80 -81.32 -42.68 20.21 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.316 -1.108 . . . . 0.0 110.824 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 8.8 t90 -136.98 74.85 1.5 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.397 -0.814 . . . . 0.0 109.944 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.552 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 13.5 m0 -102.44 173.92 6.14 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.619 -0.676 . . . . 0.0 109.744 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.05 139.17 30.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.019 -1.051 . . . . 0.0 110.242 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.402 ' SG ' ' HD2' ' A' ' 16' ' ' PRO . 43.2 t -151.08 160.75 43.7 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.474 -0.766 . . . . 0.0 110.209 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.43 -116.43 3.73 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.617 ' HA ' ' HB3' ' A' ' 26' ' ' LYS . 7.6 mmt180 -90.5 29.19 1.33 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.312 -1.11 . . . . 0.0 110.122 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.77 34.69 4.28 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.512 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -76.73 -59.99 0.9 Allowed Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.308 -1.113 . . . . 0.0 110.105 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.512 ' HD3' ' CB ' ' A' ' 15' ' ' LYS . 47.5 Cg_endo -75.13 128.67 11.57 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.654 1.344 . . . . 0.0 110.081 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.52 111.61 3.01 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.852 1.449 . . . . 0.0 110.588 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 79.3 m -83.72 161.64 20.96 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.606 -0.684 . . . . 0.0 110.018 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.484 ' HB2' ' CD2' ' A' ' 22' ' ' TYR . 0.1 OUTLIER -62.25 150.15 39.9 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.522 -0.736 . . . . 0.0 110.653 -179.74 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.39 123.11 12.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.602 -0.686 . . . . 0.0 110.269 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.11 -26.66 11.07 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.769 ' CE1' HG22 ' A' ' 33' ' ' VAL . 11.4 m-30 -89.21 160.52 16.91 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.378 -1.072 . . . . 0.0 109.809 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.19 144.68 50.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.457 -0.777 . . . . 0.0 110.308 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.4 ' SG ' ' N ' ' A' ' 25' ' ' SER . 25.7 t -89.57 162.62 15.57 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.624 -0.673 . . . . 0.0 110.271 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.4 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 15.6 m -138.9 94.68 2.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.409 -0.807 . . . . 0.0 110.81 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.617 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -61.58 -32.02 72.1 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.221 -0.925 . . . . 0.0 110.323 179.278 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.5 m -72.1 -38.58 69.3 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.583 -0.698 . . . . 0.0 110.186 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.56 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 46.2 m0 -82.96 -48.19 10.94 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.631 -0.668 . . . . 0.0 109.638 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.36 15.53 9.62 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.206 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.56 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.0 p90 -150.95 178.7 8.91 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.758 -1.437 . . . . 0.0 110.995 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 9.2 t -127.62 130.43 48.97 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.657 -0.652 . . . . 0.0 109.758 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -149.89 179.75 7.79 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.497 -0.752 . . . . 0.0 110.781 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.769 HG22 ' CE1' ' A' ' 22' ' ' TYR . 39.0 t . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.452 -0.78 . . . . 0.0 110.021 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 121.497 0.665 . . . . 0.0 110.572 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.465 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -113.24 -106.53 2.77 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.553 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -152.7 -161.22 10.12 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 36.5 p90 -82.56 -19.81 37.79 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.347 -1.09 . . . . 0.0 111.219 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 22.8 t90 -154.44 72.59 0.87 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.28 -0.888 . . . . 0.0 109.637 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.553 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 17.6 m0 -104.41 169.2 8.61 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.471 -0.768 . . . . 0.0 110.151 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -91.32 136.67 32.94 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.193 -0.942 . . . . 0.0 110.607 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.4 p -150.77 156.71 41.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.489 -0.757 . . . . 0.0 110.426 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.32 -117.72 1.63 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.588 ' HA ' ' HB3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.4 50.82 1.9 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.419 -1.048 . . . . 0.0 109.906 179.425 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.61 38.19 21.35 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.493 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -77.46 -60.03 0.78 Allowed Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.383 -1.069 . . . . 0.0 110.707 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.493 ' HD3' ' CB ' ' A' ' 15' ' ' LYS . 47.3 Cg_endo -75.07 131.95 14.79 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 123.615 1.324 . . . . 0.0 110.273 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.21 119.69 5.93 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.833 1.438 . . . . 0.0 110.653 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -89.47 171.18 9.9 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.597 -0.689 . . . . 0.0 110.095 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.23 149.36 49.61 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.371 -0.831 . . . . 0.0 110.243 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.99 109.13 0.38 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.687 -0.633 . . . . 0.0 110.401 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.84 -39.24 1.82 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.804 ' CD1' HG22 ' A' ' 33' ' ' VAL . 4.6 m-85 -90.99 141.83 28.42 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.42 -1.047 . . . . 0.0 110.001 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -118.54 150.87 38.9 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.547 -0.721 . . . . 0.0 110.234 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 10.8 t -89.61 160.61 16.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.42 -0.8 . . . . 0.0 110.224 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.407 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 56.7 m -135.03 105.22 6.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.572 -0.705 . . . . 0.0 110.966 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.588 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -66.12 -31.61 72.56 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.458 -0.776 . . . . 0.0 110.064 179.211 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.543 ' N ' ' HG2' ' A' ' 26' ' ' LYS . 54.6 m -67.05 -39.9 87.03 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.696 -0.627 . . . . 0.0 110.168 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.629 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 43.4 m0 -86.76 -48.6 8.1 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.601 -0.687 . . . . 0.0 109.842 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.44 14.89 8.58 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.629 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.1 p90 -151.5 177.37 10.38 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.925 -1.338 . . . . 0.0 111.057 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 8.2 t -126.0 130.57 51.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.456 -0.777 . . . . 0.0 110.204 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -147.71 -172.22 3.99 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.597 -0.689 . . . . 0.0 110.184 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.804 HG22 ' CD1' ' A' ' 22' ' ' TYR . 10.6 t . . . . . 0 N--CA 1.5 2.027 0 O-C-N 121.35 -0.843 . . . . 0.0 110.022 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.909 0 CA-C-O 121.163 0.506 . . . . 0.0 109.906 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.473 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -101.25 -124.28 5.35 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.539 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -150.29 -154.77 6.57 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -77.8 -36.14 50.63 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.212 -1.169 . . . . 0.0 110.962 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 38.7 t90 -142.8 77.58 1.58 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.408 -0.808 . . . . 0.0 109.856 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.539 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 15.3 m0 -105.66 156.68 18.04 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.545 -0.722 . . . . 0.0 109.169 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.46 132.13 35.17 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.868 -1.145 . . . . 0.0 111.119 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.8 p -150.83 167.8 26.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.715 -0.615 . . . . 0.0 110.214 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.46 -121.18 0.54 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.591 ' HG3' ' HD3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.5 25.56 2.24 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.455 -1.026 . . . . 0.0 110.329 179.211 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.73 34.05 3.65 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.58 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 1.5 tptt -69.85 -54.47 10.15 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.276 -1.132 . . . . 0.0 109.975 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 50.1 Cg_endo -77.22 132.63 12.71 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 O-C-N 123.763 1.401 . . . . 0.0 109.716 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.47 119.07 6.06 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.781 1.411 . . . . 0.0 110.75 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.402 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 94.9 m -84.14 -178.78 7.06 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.582 -0.698 . . . . 0.0 110.035 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.515 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -75.24 164.58 26.31 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.332 -0.855 . . . . 0.0 110.132 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.58 119.96 9.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.467 -0.771 . . . . 0.0 110.267 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.24 0.88 54.17 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 36.9 m-85 -112.55 133.38 54.63 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.117 -1.225 . . . . 0.0 109.677 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -119.58 144.71 46.94 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.394 -0.816 . . . . 0.0 110.496 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.559 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 0.8 OUTLIER -89.11 160.82 16.84 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.513 -0.742 . . . . 0.0 110.017 179.664 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 m -136.69 125.42 23.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.434 -0.792 . . . . 0.0 110.636 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.591 ' HD3' ' HG3' ' A' ' 13' ' ' ARG . 9.9 ttpt -76.55 -40.55 49.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.517 -0.739 . . . . 0.0 109.244 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.8 m -65.2 -38.68 91.22 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.738 -0.601 . . . . 0.0 109.623 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.462 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 42.8 m0 -81.49 -45.29 16.19 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.644 -0.66 . . . . 0.0 109.456 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.72 16.28 31.72 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.462 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.5 p90 -151.21 -179.11 7.06 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.903 -1.351 . . . . 0.0 111.359 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.559 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 8.4 t -121.7 128.39 51.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.676 -0.64 . . . . 0.0 110.447 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.41 165.54 30.81 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.753 -0.592 . . . . 0.0 110.143 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 67.2 t . . . . . 0 N--CA 1.497 1.918 0 O-C-N 121.249 -0.907 . . . . 0.0 110.175 -179.94 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.485 0.66 . . . . 0.0 110.433 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -111.9 -99.2 2.45 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.552 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -149.14 -154.95 6.52 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.578 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 12.2 m-85 -90.9 -30.26 17.01 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.418 -1.049 . . . . 0.0 110.484 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -142.65 68.87 1.31 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.511 -0.743 . . . . 0.0 109.44 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.552 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 17.3 m0 -99.25 154.14 18.4 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.366 -0.834 . . . . 0.0 109.786 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -88.48 134.93 33.71 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.042 -1.036 . . . . 0.0 111.133 -179.307 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.498 ' CB ' ' HG2' ' A' ' 16' ' ' PRO . 31.3 p -150.72 177.05 10.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.589 -0.694 . . . . 0.0 110.528 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.79 -120.28 0.45 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.447 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -87.71 -38.47 15.8 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.454 -1.027 . . . . 0.0 109.56 179.02 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -174.05 37.88 0.12 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.6 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 1.7 mtpm? -72.45 -69.7 0.32 Allowed Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 121.44 -1.035 . . . . 0.0 110.813 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.6 ' CD ' ' CB ' ' A' ' 15' ' ' LYS . 48.4 Cg_endo -74.02 125.36 9.79 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.391 1.206 . . . . 0.0 109.9 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -74.3 103.89 1.76 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.894 1.47 . . . . 0.0 111.495 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 t -64.95 164.87 11.83 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.554 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -53.02 149.62 6.43 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.96 -1.087 . . . . 0.0 110.621 -179.489 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -50.21 120.64 4.67 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.626 -0.671 . . . . 0.0 110.011 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.83 -25.48 10.85 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.768 ' CE2' HG23 ' A' ' 33' ' ' VAL . 31.0 m-85 -99.71 132.88 44.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.514 -0.992 . . . . 0.0 109.229 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -114.64 154.92 27.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.269 -0.894 . . . . 0.0 110.243 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 31' ' ' CYS . 0.9 OUTLIER -89.18 151.19 22.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.444 -0.785 . . . . 0.0 109.58 179.703 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.512 ' CB ' ' HB2' ' A' ' 28' ' ' TRP . 3.1 m -125.44 130.68 52.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.448 -0.783 . . . . 0.0 110.739 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.447 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 0.5 OUTLIER -75.25 -42.46 55.11 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.523 -0.736 . . . . 0.0 109.351 179.136 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.1 m -68.19 -38.13 81.66 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.87 -0.519 . . . . 0.0 109.819 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.512 ' HB2' ' CB ' ' A' ' 25' ' ' SER . 38.0 m0 -79.35 -46.3 17.92 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.596 -0.69 . . . . 0.0 109.453 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.45 17.92 34.88 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.528 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 2.9 p90 -151.35 178.26 9.45 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.025 -1.279 . . . . 0.0 111.091 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.668 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 2.4 p -119.32 123.6 44.59 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.918 0.866 . . . . 0.0 110.202 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.475 ' HA ' ' HD2' ' A' ' 22' ' ' TYR . . . -150.72 -179.69 7.47 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.768 HG23 ' CE2' ' A' ' 22' ' ' TYR . 92.5 t . . . . . 0 N--CA 1.498 1.975 0 O-C-N 121.091 -1.006 . . . . 0.0 109.751 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.532 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 121.065 0.459 . . . . 0.0 110.121 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.495 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -80.36 -120.66 0.42 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.486 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -152.91 -142.68 3.52 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.505 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 48.8 t80 -90.27 -38.72 13.22 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.462 -1.023 . . . . 0.0 110.71 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -139.11 74.24 1.46 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.278 -0.889 . . . . 0.0 109.672 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.495 ' CZ3' ' HA2' ' A' ' 5' ' ' GLY . 13.9 m0 -102.09 155.25 18.31 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.457 -0.777 . . . . 0.0 109.487 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -89.71 132.89 34.95 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.91 -1.119 . . . . 0.0 111.56 -179.013 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.499 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 27.8 p -151.57 174.72 13.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.788 -0.57 . . . . 0.0 110.382 178.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.4 -114.97 3.08 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.615 ' HD3' ' HD3' ' A' ' 26' ' ' LYS . 30.5 tpt180 -90.59 38.08 0.93 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.521 -0.988 . . . . 0.0 109.701 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.25 35.13 7.16 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.528 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -66.7 -59.86 7.33 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 121.514 -0.992 . . . . 0.0 110.044 179.68 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 48.0 Cg_endo -74.69 139.01 24.62 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 O-C-N 123.774 1.408 . . . . 0.0 110.037 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.4 115.66 4.37 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.927 1.488 . . . . 0.0 110.947 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.432 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 95.1 m -84.97 176.26 8.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.49 -0.757 . . . . 0.0 110.02 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.57 ' HB2' ' CD1' ' A' ' 22' ' ' TYR . 3.7 m -86.55 165.43 16.22 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.213 -0.93 . . . . 0.0 109.957 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -56.33 126.75 27.66 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.411 -0.805 . . . . 0.0 111.059 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.32 -24.07 33.72 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.57 ' CD1' ' HB2' ' A' ' 19' ' ' CYS . 78.7 m-85 -95.83 129.01 43.19 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.279 -1.13 . . . . 0.0 110.238 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -118.42 150.79 38.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.64 -0.663 . . . . 0.0 109.866 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.513 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 0.9 OUTLIER -89.35 158.68 17.69 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.361 -0.837 . . . . 0.0 110.553 -179.725 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.37 113.95 12.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.467 -0.771 . . . . 0.0 110.737 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.615 ' HD3' ' HD3' ' A' ' 13' ' ' ARG . 12.0 tttt -70.55 -36.56 73.73 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.456 -0.778 . . . . 0.0 109.763 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.5 m -61.54 -42.02 98.2 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.549 -0.72 . . . . 0.0 109.904 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.59 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 47.7 m0 -85.75 -56.85 3.29 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.738 -0.601 . . . . 0.0 109.516 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.12 20.77 4.33 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.185 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.59 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.8 p90 -151.11 -174.66 4.88 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 119.064 1.432 . . . . 0.0 111.519 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.513 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 6.5 t -128.13 127.49 43.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.689 -0.632 . . . . 0.0 110.29 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -150.49 174.19 13.22 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.239 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 N--CA 1.498 1.957 0 O-C-N 121.361 -0.837 . . . . 0.0 110.122 179.901 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 121.326 0.584 . . . . 0.0 110.037 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.487 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -105.01 -109.3 3.4 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.545 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -153.56 -159.37 9.09 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 71.2 t80 -80.74 -33.21 35.3 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.554 -0.968 . . . . 0.0 110.616 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 30.3 t90 -141.98 78.41 1.63 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.297 -0.877 . . . . 0.0 109.931 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.545 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 14.0 m0 -108.2 156.26 19.54 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.548 -0.72 . . . . 0.0 109.374 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -89.63 134.32 34.2 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.794 -1.191 . . . . 0.0 111.067 -179.271 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.554 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 21.4 p -151.06 166.78 29.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.673 -0.642 . . . . 0.0 110.305 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.07 -111.88 1.08 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.478 ' HG3' ' HB3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.73 29.08 1.38 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.47 -1.018 . . . . 0.0 109.87 179.1 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.09 35.36 4.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.519 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -63.97 -61.09 7.42 Favored Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.313 -1.11 . . . . 0.0 110.363 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' A' ' 11' ' ' CYS . 47.9 Cg_endo -74.71 129.23 12.41 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.643 1.338 . . . . 0.0 109.72 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.47 114.91 4.08 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.692 1.364 . . . . 0.0 110.175 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.423 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 73.4 m -82.02 171.72 14.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.519 -0.738 . . . . 0.0 110.145 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.89 148.46 49.38 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.304 -0.873 . . . . 0.0 109.862 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.49 133.4 24.94 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.556 -0.715 . . . . 0.0 110.981 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.0 -27.77 18.94 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.913 ' CE1' HG22 ' A' ' 33' ' ' VAL . 12.5 m-30 -90.72 154.23 19.7 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.425 -1.044 . . . . 0.0 110.124 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -136.3 151.69 49.89 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.542 -0.724 . . . . 0.0 109.912 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.497 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 0.8 OUTLIER -89.81 162.92 15.26 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.299 -0.876 . . . . 0.0 110.045 179.798 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.562 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 0.6 OUTLIER -131.6 101.19 5.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.502 -0.749 . . . . 0.0 110.457 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.478 ' HB3' ' HG3' ' A' ' 13' ' ' ARG . 11.2 pttm -60.36 -33.55 72.6 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.606 -0.684 . . . . 0.0 110.186 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.7 m -70.51 -39.86 73.85 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.618 -0.676 . . . . 0.0 110.235 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.562 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 46.6 m0 -82.64 -52.31 6.92 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.588 -0.695 . . . . 0.0 109.804 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.42 18.55 6.58 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 5.0 p90 -151.13 -170.6 3.7 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.753 -1.44 . . . . 0.0 111.464 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.497 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 8.9 t -132.87 130.98 40.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.604 -0.685 . . . . 0.0 110.414 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -149.4 -175.93 5.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.666 -0.646 . . . . 0.0 109.921 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.913 HG22 ' CE1' ' A' ' 22' ' ' TYR . 12.5 t . . . . . 0 N--CA 1.5 2.057 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.561 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 121.139 0.495 . . . . 0.0 109.961 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.447 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -86.44 -126.34 1.96 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.551 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -145.77 -148.67 4.84 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.426 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 44.7 t80 -86.55 -27.3 24.03 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.343 -1.092 . . . . 0.0 110.855 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -151.06 68.69 0.94 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.432 -0.793 . . . . 0.0 109.833 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.551 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 16.9 m0 -96.64 160.31 14.45 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.454 -0.779 . . . . 0.0 109.629 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -90.14 130.84 36.24 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.999 -1.063 . . . . 0.0 111.391 -179.076 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.406 ' HB2' ' CD ' ' A' ' 16' ' ' PRO . 29.7 p -151.73 179.39 8.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.762 -0.586 . . . . 0.0 110.522 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.61 -121.42 4.61 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.72 53.39 2.4 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.554 -0.968 . . . . 0.0 109.899 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.437 ' HA2' ' HB2' ' A' ' 24' ' ' CYS . . . 77.93 37.81 28.48 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.547 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 0.3 OUTLIER -71.09 -58.37 4.11 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.493 -1.004 . . . . 0.0 110.199 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.547 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 48.4 Cg_endo -76.42 143.42 24.71 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 O-C-N 123.736 1.388 . . . . 0.0 109.958 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.422 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 48.8 Cg_endo -73.9 99.06 1.12 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.757 1.398 . . . . 0.0 110.762 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.418 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 0.1 OUTLIER -69.67 177.04 3.18 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.266 -0.896 . . . . 0.0 109.376 179.229 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.561 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 2.7 m -81.16 161.61 23.98 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.137 -0.977 . . . . 0.0 109.654 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -55.95 120.46 7.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.391 -0.818 . . . . 0.0 110.457 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.0 -14.72 44.63 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.523 ' CD1' ' HB2' ' A' ' 19' ' ' CYS . 66.8 m-85 -102.59 131.63 49.22 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.051 -1.264 . . . . 0.0 110.122 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -117.45 147.36 42.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.57 -0.706 . . . . 0.0 110.24 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 1.1 m -89.36 159.26 17.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.415 -0.803 . . . . 0.0 110.065 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 2.0 m -130.22 117.77 20.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.576 -0.703 . . . . 0.0 110.483 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -69.82 -37.63 76.31 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.551 -0.718 . . . . 0.0 109.751 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.3 m -71.83 -39.73 69.58 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.625 -0.672 . . . . 0.0 110.255 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.571 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 43.9 m0 -78.9 -48.69 14.14 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.555 -0.716 . . . . 0.0 109.803 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.54 18.08 15.47 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.571 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.5 p90 -150.85 -179.23 7.1 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.856 -1.379 . . . . 0.0 111.157 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.629 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 22.8 t -123.91 129.94 51.79 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.662 -0.649 . . . . 0.0 110.232 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.12 169.65 19.53 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.787 -0.571 . . . . 0.0 110.135 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.461 ' CG2' ' CE2' ' A' ' 22' ' ' TYR . 59.4 t . . . . . 0 N--CA 1.501 2.081 0 O-C-N 121.445 -0.784 . . . . 0.0 110.443 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.545 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.91 0 CA-C-O 121.201 0.524 . . . . 0.0 109.926 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.437 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -94.76 -120.89 3.44 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.524 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -144.97 -149.6 5.06 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -88.44 -17.28 30.75 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.305 -1.115 . . . . 0.0 110.685 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 -160.06 68.06 0.38 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.322 -0.861 . . . . 0.0 110.07 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.524 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 20.2 m0 -96.81 173.69 7.18 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.401 -0.812 . . . . 0.0 110.087 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -94.81 133.31 38.65 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.185 -0.947 . . . . 0.0 110.945 -179.486 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 24.8 p -150.75 159.38 44.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.606 -0.684 . . . . 0.0 110.47 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -93.61 -118.0 2.76 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.551 ' HB2' ' HD2' ' A' ' 26' ' ' LYS . 0.3 OUTLIER -90.78 43.01 1.13 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.528 -0.984 . . . . 0.0 109.723 179.388 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.95 39.92 5.36 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.569 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 6.4 mttt -76.89 -64.0 0.49 Allowed Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.431 -1.041 . . . . 0.0 110.023 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.569 ' CD ' ' CB ' ' A' ' 15' ' ' LYS . 48.5 Cg_endo -74.39 133.64 17.85 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 O-C-N 123.579 1.305 . . . . 0.0 109.633 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.26 111.51 3.3 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.678 1.357 . . . . 0.0 110.319 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.4 m -77.39 179.2 6.59 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.402 -0.811 . . . . 0.0 110.101 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.545 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 2.7 m -87.4 150.81 23.56 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.382 -0.824 . . . . 0.0 110.078 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.16 118.78 3.46 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.607 -0.683 . . . . 0.0 110.532 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.29 -35.98 3.69 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.792 ' CD1' HG22 ' A' ' 33' ' ' VAL . 5.6 m-85 -93.66 152.16 19.17 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.35 -1.088 . . . . 0.0 110.069 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -126.27 146.74 49.88 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.648 -0.658 . . . . 0.0 110.178 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 13.4 t -89.75 159.84 16.85 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.457 -0.777 . . . . 0.0 110.331 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.6 m -140.75 116.69 10.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.653 -0.655 . . . . 0.0 110.559 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.551 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -73.72 -39.25 64.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.419 -0.801 . . . . 0.0 109.19 179.051 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.1 m -62.85 -40.59 97.93 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.555 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 40.5 m0 -79.98 -38.83 31.39 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.26 13.97 50.02 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.555 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.3 p90 -150.92 177.03 10.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.903 -1.351 . . . . 0.0 111.273 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 31.2 t -126.08 121.88 34.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.752 -0.592 . . . . 0.0 109.714 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.75 -178.26 5.34 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.541 -0.725 . . . . 0.0 110.046 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.792 HG22 ' CD1' ' A' ' 22' ' ' TYR . 21.5 t . . . . . 0 N--CA 1.499 2.014 0 O-C-N 121.272 -0.892 . . . . 0.0 110.188 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 121.36 0.6 . . . . 0.0 110.218 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.47 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -95.72 -129.02 5.77 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.53 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -147.22 -153.73 6.0 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 77.5 t80 -79.66 -29.63 40.95 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.346 -1.091 . . . . 0.0 110.899 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -149.21 74.92 1.27 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.18 -0.95 . . . . 0.0 109.883 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.53 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 16.3 m0 -105.05 178.32 4.59 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.666 -0.646 . . . . 0.0 109.377 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.98 133.52 35.22 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.93 -1.106 . . . . 0.0 110.778 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.581 ' SG ' ' HD2' ' A' ' 16' ' ' PRO . 40.7 t -151.69 162.36 41.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.653 -0.654 . . . . 0.0 110.372 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -102.57 -119.01 4.52 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 108.889 -1.685 . . . . 0.0 108.889 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.553 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -91.15 31.24 1.13 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.322 -1.105 . . . . 0.0 110.129 179.153 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.83 36.77 3.61 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.537 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -76.57 -63.92 0.53 Allowed Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.372 -1.075 . . . . 0.0 110.557 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.581 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 44.1 Cg_endo -71.18 135.28 26.77 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.729 1.384 . . . . 0.0 110.042 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.439 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 45.5 Cg_endo -71.88 100.97 1.13 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.81 1.426 . . . . 0.0 110.844 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.0 m -72.77 169.25 17.11 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.342 -0.848 . . . . 0.0 109.216 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.2 147.9 46.35 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.941 -1.1 . . . . 0.0 110.025 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.55 119.81 4.52 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.638 -0.663 . . . . 0.0 110.571 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.26 -22.61 17.63 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.867 ' CE1' HG22 ' A' ' 33' ' ' VAL . 12.4 m-30 -89.07 157.95 18.15 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.416 -1.05 . . . . 0.0 109.974 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -133.29 151.32 51.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.506 -0.746 . . . . 0.0 109.917 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.3 m -89.12 167.17 13.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.506 -0.746 . . . . 0.0 110.694 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.492 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 17.3 m -132.66 102.21 5.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.613 -0.679 . . . . 0.0 110.324 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.553 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 1.8 ttpt -65.09 -31.42 72.63 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.555 -0.716 . . . . 0.0 110.841 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.9 m -82.92 -36.13 25.5 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.435 -0.79 . . . . 0.0 110.873 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.588 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 45.0 m0 -79.95 -42.63 23.62 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.477 -0.765 . . . . 0.0 110.236 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.07 16.88 22.18 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.498 -0.858 . . . . 0.0 110.976 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.588 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 2.8 p90 -150.59 178.82 8.71 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.107 -1.231 . . . . 0.0 110.822 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 22.6 t -121.01 135.88 55.11 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.548 -0.72 . . . . 0.0 109.786 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -146.03 -179.59 6.82 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.436 -0.79 . . . . 0.0 110.242 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.867 HG22 ' CE1' ' A' ' 22' ' ' TYR . 11.9 t . . . . . 0 N--CA 1.498 1.956 0 O-C-N 121.388 -0.82 . . . . 0.0 109.802 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 121.431 0.634 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -66.89 139.96 37.39 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.39 153.73 41.29 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.613 -0.934 . . . . 0.0 110.367 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.643 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -134.17 153.22 51.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.485 -0.759 . . . . 0.0 109.879 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.421 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -92.13 -118.32 2.41 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.492 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -147.55 -143.1 3.78 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -90.68 -37.78 13.51 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.296 -1.12 . . . . 0.0 110.59 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.82 70.49 1.35 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.513 -0.742 . . . . 0.0 109.808 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.492 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 16.7 m0 -96.85 166.19 11.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.36 -0.838 . . . . 0.0 109.734 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -92.12 134.74 34.57 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.166 -0.958 . . . . 0.0 110.919 -179.55 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 31.2 p -151.07 159.03 44.76 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.579 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.82 -115.89 1.0 Allowed Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.554 ' HG3' ' HB3' ' A' ' 26' ' ' LYS . 1.0 OUTLIER -90.66 29.58 1.29 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.435 -1.038 . . . . 0.0 110.044 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.92 38.68 3.31 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.594 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -74.16 -57.34 2.31 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.406 -1.055 . . . . 0.0 110.572 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 46.9 Cg_endo -74.58 134.99 19.3 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 O-C-N 123.719 1.378 . . . . 0.0 109.975 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -71.84 105.77 1.87 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.92 1.484 . . . . 0.0 110.693 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.0 m -74.79 176.57 6.92 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.397 -0.814 . . . . 0.0 109.761 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.643 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.1 m -81.2 161.9 23.81 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.28 -0.887 . . . . 0.0 110.301 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -56.24 125.66 22.77 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.562 -0.711 . . . . 0.0 110.543 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.6 -18.73 54.71 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.52 ' CD1' ' HB2' ' A' ' 19' ' ' CYS . 52.8 m-85 -94.58 142.47 27.4 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.253 -1.145 . . . . 0.0 110.153 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.426 ' HB3' ' HG2' ' A' ' 34' ' ' GLU . . . -124.82 140.81 52.59 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.426 -0.796 . . . . 0.0 110.349 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 14.1 t -89.44 159.56 17.22 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.51 -0.744 . . . . 0.0 110.158 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -138.14 123.27 19.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.62 -0.675 . . . . 0.0 111.031 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.554 ' HB3' ' HG3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -76.63 -35.12 58.24 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.658 -0.651 . . . . 0.0 110.003 179.157 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.4 m -69.99 -38.75 76.1 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.46 -0.775 . . . . 0.0 109.389 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.528 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 40.3 m0 -80.02 -40.85 26.94 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.48 16.37 43.3 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.528 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.0 p90 -151.0 177.84 9.77 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.999 -1.295 . . . . 0.0 111.021 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 25.2 t -127.27 128.37 45.88 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.698 -0.626 . . . . 0.0 110.235 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.48 172.83 14.34 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.605 -0.684 . . . . 0.0 110.096 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.444 HG23 ' CE2' ' A' ' 22' ' ' TYR . 99.1 t -58.89 138.53 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.389 -0.82 . . . . 0.0 110.018 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.426 ' HG2' ' HB3' ' A' ' 23' ' ' ALA . 0.9 OUTLIER -84.59 72.45 10.67 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.591 -0.693 . . . . 0.0 110.252 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.8 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -70.59 -54.55 8.29 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.491 -0.756 . . . . 0.0 110.377 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.8 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 46.3 Cg_endo . . . . . 0 C--N 1.318 -1.034 0 O-C-N 123.551 1.29 . . . . 0.0 110.69 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.1 t70 . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 121.227 0.537 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 113.61 -137.98 14.57 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -145.2 50.92 1.22 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.475 -1.015 . . . . 0.0 110.222 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.442 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -148.65 154.9 40.32 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.39 -0.819 . . . . 0.0 109.958 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.565 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -78.84 -142.87 2.31 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.5 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -142.7 -151.48 5.5 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -76.92 -29.33 55.63 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.34 -1.094 . . . . 0.0 111.059 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -153.83 69.97 0.81 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.315 -0.866 . . . . 0.0 110.233 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.565 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 20.8 m0 -98.62 176.07 5.77 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.494 -0.754 . . . . 0.0 109.704 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.77 138.93 31.06 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.143 -0.973 . . . . 0.0 110.393 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.4 ' SG ' ' HD2' ' A' ' 16' ' ' PRO . 33.6 t -150.99 161.01 43.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.541 -0.724 . . . . 0.0 110.442 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -103.49 -121.43 4.93 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.556 ' HA ' ' HB3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.71 37.37 0.92 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.364 -1.08 . . . . 0.0 110.347 179.638 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.17 34.55 7.09 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.585 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 1.4 tptp -77.58 -58.97 0.87 Allowed Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.319 -1.107 . . . . 0.0 110.19 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 47.2 Cg_endo -75.07 133.4 16.43 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.694 1.365 . . . . 0.0 110.018 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.63 104.93 1.68 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 O-C-N 123.899 1.473 . . . . 0.0 110.589 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.2 m -72.38 166.36 22.7 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.414 -0.804 . . . . 0.0 109.728 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.442 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -67.77 155.97 38.09 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.255 -0.903 . . . . 0.0 110.407 -179.689 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.02 128.67 28.18 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.667 -0.646 . . . . 0.0 111.138 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.65 -20.42 50.73 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.856 ' CE1' HG22 ' A' ' 33' ' ' VAL . 12.3 m-30 -89.7 150.89 22.13 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.168 -1.195 . . . . 0.0 110.31 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.39 142.42 51.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.671 -0.643 . . . . 0.0 109.852 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 18.3 t -89.3 159.69 17.26 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.447 -0.783 . . . . 0.0 110.622 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.0 m -138.64 106.92 5.78 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.635 -0.666 . . . . 0.0 110.424 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.556 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -72.99 -33.4 65.79 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.371 -0.83 . . . . 0.0 110.285 179.363 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.6 m -68.87 -36.74 78.46 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.471 -0.768 . . . . 0.0 109.83 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.583 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 47.0 m0 -84.04 -40.16 18.71 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.747 -0.595 . . . . 0.0 109.565 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.96 14.91 25.46 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.583 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 2.6 p90 -151.46 177.77 9.96 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.843 -1.387 . . . . 0.0 111.458 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 15.8 t -126.89 126.53 43.44 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.9 177.91 7.63 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.555 -0.715 . . . . 0.0 110.498 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.856 HG22 ' CE1' ' A' ' 22' ' ' TYR . 17.6 t -69.34 137.31 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.452 -0.78 . . . . 0.0 110.208 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.23 52.23 1.57 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.367 -0.833 . . . . 0.0 110.236 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.52 116.15 63.03 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.261 -0.899 . . . . 0.0 109.947 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 C--N 1.313 -1.322 0 O-C-N 123.888 1.467 . . . . 0.0 110.794 -179.774 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.3 t70 . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 121.4 0.619 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.76 125.72 3.2 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.31 -166.14 1.36 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.538 -0.978 . . . . 0.0 110.285 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -88.49 150.95 22.85 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.431 -0.793 . . . . 0.0 109.92 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.544 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -77.22 -149.61 3.49 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.437 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -139.49 -139.56 3.8 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -90.25 -19.22 24.39 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.447 -1.031 . . . . 0.0 111.242 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -161.85 65.01 0.25 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.27 -0.894 . . . . 0.0 109.679 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.544 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 20.7 m0 -97.15 162.19 13.47 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.472 -0.767 . . . . 0.0 109.697 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -90.79 134.41 34.46 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.994 -1.066 . . . . 0.0 110.873 -179.555 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.1 p -150.79 169.85 20.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.516 -0.74 . . . . 0.0 110.471 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.6 -131.02 2.53 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.626 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.45 55.02 2.89 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.478 -1.013 . . . . 0.0 110.026 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 78.68 35.4 32.22 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.5 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 2.3 mttt -76.36 -60.32 0.94 Allowed Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.327 -1.102 . . . . 0.0 110.356 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.5 ' CD ' ' CB ' ' A' ' 15' ' ' LYS . 47.3 Cg_endo -73.2 141.36 32.27 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.651 1.343 . . . . 0.0 110.168 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.465 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 42.9 Cg_endo -71.78 103.23 1.43 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.856 1.45 . . . . 0.0 110.867 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.493 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 24.7 m -71.27 162.16 29.88 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.366 -0.834 . . . . 0.0 109.659 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 148.99 48.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.125 -0.985 . . . . 0.0 109.681 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.54 126.0 18.16 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.618 -0.676 . . . . 0.0 111.101 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.34 -29.21 9.82 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.789 ' CE1' HG22 ' A' ' 33' ' ' VAL . 5.5 m-85 -95.26 152.87 18.0 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.299 -1.118 . . . . 0.0 110.497 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -128.78 146.97 50.76 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.648 -0.658 . . . . 0.0 110.143 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.55 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 0.8 OUTLIER -91.82 160.87 15.1 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.435 -0.79 . . . . 0.0 110.566 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.553 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 0.5 OUTLIER -135.88 122.33 20.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.647 -0.658 . . . . 0.0 110.392 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.626 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -73.68 -42.02 61.88 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.456 -0.777 . . . . 0.0 109.38 179.189 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.8 m -63.27 -40.0 96.17 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.686 -0.634 . . . . 0.0 109.782 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.553 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 42.4 m0 -80.18 -46.07 17.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.773 -0.579 . . . . 0.0 109.5 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.7 18.45 23.01 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.51 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.8 p90 -151.38 -176.54 5.62 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.924 -1.339 . . . . 0.0 111.394 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.55 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 6.6 t -126.46 125.56 42.33 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.58 174.33 10.67 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.442 -0.786 . . . . 0.0 110.668 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.789 HG22 ' CE1' ' A' ' 22' ' ' TYR . 19.0 t -75.45 146.42 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.485 -0.759 . . . . 0.0 110.07 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -74.68 151.43 39.26 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.488 -0.758 . . . . 0.0 110.185 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.08 115.8 29.25 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.527 -0.733 . . . . 0.0 110.396 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo . . . . . 0 C--N 1.314 -1.272 0 O-C-N 124.002 1.527 . . . . 0.0 110.813 -179.884 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 19.4 t70 . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.165 0.507 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -119.5 -117.42 2.66 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -115.91 -168.42 1.42 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.528 -0.984 . . . . 0.0 110.312 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -89.01 153.73 20.78 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.449 -0.782 . . . . 0.0 109.976 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.486 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -81.07 -149.45 6.57 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.432 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -131.44 -140.9 4.67 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.542 ' HA ' ' CE1' ' A' ' 22' ' ' TYR . 20.6 p90 -90.51 -22.03 21.54 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.402 -1.058 . . . . 0.0 110.901 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 32.4 t90 -156.59 69.44 0.61 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.247 -0.908 . . . . 0.0 109.701 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.486 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 17.8 m0 -99.69 174.37 6.26 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.441 -0.787 . . . . 0.0 109.662 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.9 mtmm -90.15 138.52 31.45 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.955 -1.091 . . . . 0.0 110.261 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.424 ' SG ' ' HD2' ' A' ' 16' ' ' PRO . 13.9 t -150.67 162.44 40.69 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.256 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -102.27 -117.65 4.31 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.572 ' HA ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -91.25 28.99 1.51 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.42 -1.047 . . . . 0.0 110.305 179.362 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.15 32.54 5.52 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.592 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 4.8 tptt -72.22 -58.7 3.03 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.373 -1.075 . . . . 0.0 110.2 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.592 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 49.1 Cg_endo -75.85 131.89 13.78 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.701 1.369 . . . . 0.0 109.974 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.448 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 42.8 Cg_endo -71.82 100.95 1.12 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.767 1.404 . . . . 0.0 110.167 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.8 m -67.92 161.32 26.71 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.33 -0.856 . . . . 0.0 109.994 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.407 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -64.7 156.47 30.22 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.462 -0.774 . . . . 0.0 110.087 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.53 128.38 35.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.445 -0.784 . . . . 0.0 110.616 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.28 -28.0 16.19 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.542 ' CE1' ' HA ' ' A' ' 7' ' ' PHE . 88.9 m-85 -94.36 142.98 26.79 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.503 -0.998 . . . . 0.0 110.112 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.41 148.81 43.29 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.549 -0.719 . . . . 0.0 110.056 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.5 t -88.73 160.96 17.07 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.495 -0.753 . . . . 0.0 110.266 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.7 m -140.05 102.24 4.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.651 -0.656 . . . . 0.0 110.701 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.572 ' HB2' ' HA ' ' A' ' 13' ' ' ARG . 2.1 tptp -69.12 -36.31 77.35 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.311 -0.868 . . . . 0.0 109.76 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.4 m -62.26 -37.79 86.8 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.619 -0.676 . . . . 0.0 110.185 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.576 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 45.7 m0 -88.44 -50.23 6.44 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.622 -0.674 . . . . 0.0 109.952 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.54 16.08 6.66 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.209 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.576 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.4 p90 -150.51 -177.85 6.2 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.831 -1.394 . . . . 0.0 111.281 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 22.5 t -129.92 126.23 37.39 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.671 -0.643 . . . . 0.0 110.233 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.19 173.22 14.17 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.672 -0.642 . . . . 0.0 110.191 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.421 HG23 ' CE1' ' A' ' 22' ' ' TYR . 98.5 t -56.58 134.37 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.272 -0.892 . . . . 0.0 109.904 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.54 -62.9 1.42 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.493 -0.755 . . . . 0.0 110.764 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.88 149.97 42.09 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.513 -0.742 . . . . 0.0 110.612 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo . . . . . 0 C--N 1.314 -1.288 0 O-C-N 123.96 1.505 . . . . 0.0 110.685 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 14.4 t70 . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 121.213 0.53 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.53 56.45 0.06 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.59 ' HG2' ' HG2' ' A' ' 17' ' ' PRO . 6.6 pt-20 -144.56 -169.75 3.22 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.612 -0.934 . . . . 0.0 110.44 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -129.71 153.9 47.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.405 -0.809 . . . . 0.0 110.239 179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.47 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -92.56 -126.09 3.9 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.509 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -147.66 -142.41 3.67 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -90.57 -32.66 16.2 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.443 -1.033 . . . . 0.0 110.528 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -145.02 70.52 1.27 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.497 -0.752 . . . . 0.0 109.93 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.509 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 15.6 m0 -100.52 175.51 5.65 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.425 -0.797 . . . . 0.0 109.983 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt -89.8 138.76 31.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.133 -0.979 . . . . 0.0 110.55 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.462 ' SG ' ' HD2' ' A' ' 16' ' ' PRO . 29.1 t -151.61 161.85 41.98 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.546 -0.721 . . . . 0.0 110.38 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.56 -117.1 3.92 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.437 ' HD2' ' HB2' ' A' ' 26' ' ' LYS . 13.6 tpt180 -90.7 21.69 3.92 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.393 -1.063 . . . . 0.0 109.898 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.51 34.18 3.41 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.556 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -77.28 -54.7 1.45 Allowed Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.361 -1.082 . . . . 0.0 110.824 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 47.5 Cg_endo -74.28 132.38 16.37 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.678 1.357 . . . . 0.0 110.115 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.59 ' HG2' ' HG2' ' A' ' 3' ' ' GLU . 50.4 Cg_endo -71.45 104.57 1.59 Allowed 'Trans proline' 0 C--N 1.314 -1.271 0 O-C-N 123.771 1.406 . . . . 0.0 110.667 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.2 m -75.26 167.2 22.37 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.404 -0.81 . . . . 0.0 109.386 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.459 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -64.37 165.1 10.2 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.25 -0.906 . . . . 0.0 110.303 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.0 126.17 27.19 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.322 -0.861 . . . . 0.0 110.195 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.44 4.97 54.7 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 87.9 m-85 -118.28 150.71 39.01 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.082 -1.246 . . . . 0.0 109.507 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -127.84 147.21 50.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.325 -0.86 . . . . 0.0 110.589 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.4 t -88.97 162.08 16.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.585 -0.697 . . . . 0.0 110.539 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.478 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 7.7 t -139.26 113.6 8.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.652 -0.655 . . . . 0.0 110.63 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.437 ' HB2' ' HD2' ' A' ' 13' ' ' ARG . 14.2 tptm -74.01 -39.83 63.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.496 -0.753 . . . . 0.0 110.213 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.3 m -65.5 -36.93 85.31 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.487 -0.758 . . . . 0.0 110.306 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.518 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 49.0 m0 -83.86 -46.9 11.64 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.613 -0.679 . . . . 0.0 110.027 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.02 19.98 10.26 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.174 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.518 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.7 p90 -150.79 -175.28 5.06 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.864 -1.374 . . . . 0.0 110.991 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 18.5 t -133.39 125.22 28.64 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.507 -0.746 . . . . 0.0 110.214 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.29 168.16 24.87 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.779 -0.575 . . . . 0.0 109.727 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 81.5 t -55.57 143.52 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 O-C-N 121.315 -0.866 . . . . 0.0 109.753 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.22 101.44 0.23 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.425 -0.797 . . . . 0.0 110.718 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.755 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -76.49 -56.02 1.54 Allowed Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.673 -0.642 . . . . 0.0 110.732 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.755 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 46.1 Cg_endo . . . . . 0 N--CA 1.486 1.056 0 O-C-N 123.405 1.213 . . . . 0.0 110.88 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 N--CA 1.497 1.901 0 CA-C-O 121.17 0.509 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -143.64 43.81 0.98 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 55.02 87.77 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.741 -0.858 . . . . 0.0 110.691 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -140.18 160.43 39.97 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.553 -0.717 . . . . 0.0 110.646 -179.629 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.449 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -106.44 -112.16 3.66 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.533 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -152.77 -148.98 5.01 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.436 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 3.1 t80 -89.62 -35.87 15.61 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.3 -1.118 . . . . 0.0 110.585 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -137.28 78.37 1.69 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.326 -0.859 . . . . 0.0 108.954 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.533 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 11.7 m0 -109.33 166.97 10.46 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.401 -0.812 . . . . 0.0 110.069 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.08 137.64 32.24 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.016 -1.053 . . . . 0.0 110.814 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.8 p -150.87 166.72 29.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.581 -0.7 . . . . 0.0 110.419 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.12 -118.6 3.69 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.553 ' HA ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.93 38.36 0.95 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.508 -0.995 . . . . 0.0 110.097 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.95 37.08 5.81 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.568 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 2.0 tttt -80.11 -56.55 0.72 Allowed Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.366 -1.079 . . . . 0.0 110.771 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 48.7 Cg_endo -75.94 126.39 9.33 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.647 1.341 . . . . 0.0 110.266 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.03 114.61 4.09 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.901 1.474 . . . . 0.0 110.55 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.407 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 81.1 m -83.4 -179.16 7.29 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.581 -0.699 . . . . 0.0 110.128 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.464 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.4 OUTLIER -72.42 158.64 35.38 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.261 -0.899 . . . . 0.0 110.243 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -54.99 122.47 10.98 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.454 -0.779 . . . . 0.0 110.07 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.2 -26.3 22.36 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.48 ' CE2' ' CG2' ' A' ' 33' ' ' VAL . 88.3 m-85 -89.72 135.97 33.31 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.408 -1.054 . . . . 0.0 109.492 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -123.2 148.56 45.67 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.272 -0.892 . . . . 0.0 110.34 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 7.1 t -89.04 159.49 17.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.517 -0.74 . . . . 0.0 110.251 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.403 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 2.4 m -137.41 113.41 9.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.679 -0.638 . . . . 0.0 110.465 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.553 ' HB2' ' HA ' ' A' ' 13' ' ' ARG . 3.3 ttpt -70.79 -39.76 72.96 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.531 -0.731 . . . . 0.0 109.57 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.0 m -62.05 -39.09 91.17 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.658 -0.651 . . . . 0.0 109.666 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.491 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 42.5 m0 -82.22 -41.6 20.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.727 -0.608 . . . . 0.0 109.626 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.5 14.92 33.68 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.491 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.7 p90 -151.62 -179.95 7.86 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.013 -1.287 . . . . 0.0 110.941 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 49.2 t -126.43 127.2 45.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.62 -0.675 . . . . 0.0 110.209 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -148.04 174.74 11.62 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.511 -0.743 . . . . 0.0 109.915 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.48 ' CG2' ' CE2' ' A' ' 22' ' ' TYR . 87.2 t -61.32 145.04 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.238 -0.914 . . . . 0.0 110.424 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -99.64 63.5 1.24 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.519 -0.738 . . . . 0.0 109.77 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.09 113.17 65.81 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.314 -0.866 . . . . 0.0 110.343 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo . . . . . 0 C--N 1.312 -1.345 0 O-C-N 123.846 1.445 . . . . 0.0 110.762 179.746 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.173 0.511 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 110.69 137.6 7.55 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 17' ' ' PRO . 2.0 tt0 -91.36 -166.99 1.69 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.544 -0.974 . . . . 0.0 110.327 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.524 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -88.31 151.35 22.68 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.313 -0.867 . . . . 0.0 110.245 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.543 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -83.93 -134.9 2.71 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.457 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -146.47 -147.11 4.5 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -77.07 -30.14 55.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.326 -1.102 . . . . 0.0 111.26 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -153.65 72.8 0.93 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.242 -0.911 . . . . 0.0 110.186 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.543 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 18.1 m0 -102.49 174.86 5.71 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.46 -0.775 . . . . 0.0 109.444 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.16 145.47 25.41 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.028 -1.045 . . . . 0.0 110.199 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.559 ' SG ' ' HG2' ' A' ' 16' ' ' PRO . 44.4 t -151.04 160.38 43.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.55 -0.719 . . . . 0.0 110.714 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.02 -123.84 4.64 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.637 ' HA ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -88.71 -37.96 15.11 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.377 -1.073 . . . . 0.0 109.789 179.391 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.02 36.2 0.13 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.641 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 5.0 mttp -89.72 -69.15 0.1 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.371 -1.076 . . . . 0.0 110.534 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.641 ' HD3' ' CB ' ' A' ' 15' ' ' LYS . 49.6 Cg_endo -77.25 113.07 3.51 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 O-C-N 123.525 1.276 . . . . 0.0 109.913 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.452 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 49.5 Cg_endo -77.24 116.47 4.16 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.834 1.439 . . . . 0.0 110.7 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.434 ' SG ' ' HB2' ' A' ' 22' ' ' TYR . 0.5 OUTLIER -68.4 157.39 35.88 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.117 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.524 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -60.7 153.1 24.93 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.083 -1.011 . . . . 0.0 110.461 -179.412 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -45.07 127.85 6.91 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.795 -0.566 . . . . 0.0 111.076 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.66 -29.04 10.35 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.693 ' CD1' HG22 ' A' ' 33' ' ' VAL . 4.1 m-85 -104.1 129.84 51.8 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.41 -1.053 . . . . 0.0 110.245 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.52 ' HB3' ' HG3' ' A' ' 34' ' ' GLU . . . -101.31 148.54 25.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.47 -0.769 . . . . 0.0 109.538 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 2.8 t -89.15 159.41 17.51 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.17 -0.956 . . . . 0.0 110.27 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.534 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 0.3 OUTLIER -143.96 121.2 11.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.585 -0.697 . . . . 0.0 111.289 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.637 ' HB2' ' HA ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -75.92 -41.43 51.85 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.536 -0.727 . . . . 0.0 109.402 178.795 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.6 m -58.92 -37.29 76.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.74 -0.6 . . . . 0.0 109.702 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.534 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 42.5 m0 -86.15 -37.29 18.9 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.38 16.1 47.99 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.493 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 2.6 p90 -152.01 178.15 9.74 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.001 -1.294 . . . . 0.0 110.779 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.426 ' O ' ' SG ' ' A' ' 31' ' ' CYS . 9.8 p -130.66 127.27 38.56 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.433 -0.792 . . . . 0.0 110.117 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.8 -178.22 6.33 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.682 -0.636 . . . . 0.0 110.124 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.693 HG22 ' CD1' ' A' ' 22' ' ' TYR . 24.8 t -60.07 137.3 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.222 -0.924 . . . . 0.0 110.302 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.52 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -112.66 111.83 22.91 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.516 -0.74 . . . . 0.0 110.365 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.72 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -69.05 -53.76 13.39 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.619 -0.676 . . . . 0.0 110.867 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.72 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 45.0 Cg_endo . . . . . 0 N--CA 1.487 1.135 0 O-C-N 123.507 1.267 . . . . 0.0 110.902 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.7 t70 . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 121.096 0.474 . . . . 0.0 110.367 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -64.83 -57.79 11.46 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.24 103.88 12.63 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.582 -0.952 . . . . 0.0 109.688 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -144.88 160.15 41.76 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.414 -0.804 . . . . 0.0 110.494 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.434 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -105.78 -112.27 3.68 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.549 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -151.06 -153.62 6.23 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -85.13 -33.42 22.36 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.221 -1.164 . . . . 0.0 110.706 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 16.8 t90 -142.76 75.01 1.47 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.332 -0.855 . . . . 0.0 109.593 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.549 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 14.5 m0 -104.51 166.16 10.58 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.651 -0.656 . . . . 0.0 109.447 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -90.61 136.83 32.81 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.999 -1.063 . . . . 0.0 110.568 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.1 p -150.84 171.81 16.63 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.723 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.33 -123.23 3.17 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.461 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -91.11 24.86 2.67 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.416 -1.05 . . . . 0.0 110.441 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.415 ' HA2' ' HB3' ' A' ' 24' ' ' CYS . . . 108.76 37.3 2.06 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.434 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 0.5 OUTLIER -82.43 -56.86 0.5 Allowed Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.4 -1.059 . . . . 0.0 111.062 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' A' ' 15' ' ' LYS . 46.9 Cg_endo -73.93 130.89 14.95 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 O-C-N 123.568 1.299 . . . . 0.0 110.517 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -73.14 113.06 3.68 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.785 1.413 . . . . 0.0 110.951 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.41 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 84.8 m -85.27 -178.99 6.89 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.638 -0.664 . . . . 0.0 110.221 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.93 151.78 38.86 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.235 -0.916 . . . . 0.0 110.211 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.33 115.6 2.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.703 -0.623 . . . . 0.0 110.638 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.83 -33.77 3.8 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.549 ' HD1' HG22 ' A' ' 33' ' ' VAL . 5.3 m-85 -94.7 149.99 20.67 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.507 -0.996 . . . . 0.0 110.304 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -126.19 150.05 48.59 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.569 -0.707 . . . . 0.0 109.789 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 15.9 t -89.06 158.22 18.05 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.226 -0.921 . . . . 0.0 110.395 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.1 m -141.51 131.59 24.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.651 -0.655 . . . . 0.0 110.77 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.461 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 11.6 tptp -84.73 -44.48 13.32 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.669 -0.644 . . . . 0.0 109.34 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.2 m -59.12 -38.94 80.82 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.482 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 44.3 m0 -81.88 -41.57 20.77 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.61 16.81 41.13 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.482 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 2.9 p90 -151.18 178.33 9.33 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.94 -1.329 . . . . 0.0 111.302 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 17.5 t -123.26 119.02 28.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.764 -0.585 . . . . 0.0 110.148 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.16 178.49 8.93 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.828 -0.545 . . . . 0.0 110.012 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.549 HG22 ' HD1' ' A' ' 22' ' ' TYR . 63.9 t -59.51 117.88 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.31 -0.869 . . . . 0.0 110.27 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.62 116.13 5.37 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.592 -0.692 . . . . 0.0 110.667 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 54.06 86.56 0.16 Allowed Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 121.716 -0.615 . . . . 0.0 110.882 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo . . . . . 0 C--N 1.314 -1.286 0 O-C-N 123.739 1.389 . . . . 0.0 110.702 -179.831 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 121.138 0.494 . . . . 0.0 110.119 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 150.06 151.81 5.62 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.424 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 2.0 tt0 -76.92 101.11 5.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.483 -1.01 . . . . 0.0 110.068 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.451 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -137.93 159.77 41.1 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.588 -0.695 . . . . 0.0 110.229 -179.734 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.542 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -98.02 -133.89 8.12 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.555 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -144.7 -150.76 5.29 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -85.35 -24.38 27.63 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.37 -1.077 . . . . 0.0 111.438 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.419 ' CD1' ' N ' ' A' ' 8' ' ' TRP . 17.5 p-90 -149.45 61.03 1.02 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.062 -1.024 . . . . 0.0 110.046 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.555 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 17.2 m0 -94.23 154.7 17.41 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.24 -0.912 . . . . 0.0 109.43 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -88.89 132.76 34.54 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.885 -1.135 . . . . 0.0 111.379 -178.732 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.436 ' HB2' ' CG ' ' A' ' 16' ' ' PRO . 31.4 p -150.87 173.66 13.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.819 -0.551 . . . . 0.0 110.28 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.38 -132.16 3.11 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.51 54.16 2.65 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.474 -1.015 . . . . 0.0 109.819 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.8 41.12 7.82 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.538 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -81.76 -61.01 0.38 Allowed Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.444 -1.033 . . . . 0.0 110.585 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.538 ' HD3' ' CB ' ' A' ' 15' ' ' LYS . 51.2 Cg_endo -76.38 140.44 21.81 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.668 1.352 . . . . 0.0 110.267 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.424 ' HG2' ' HB3' ' A' ' 3' ' ' GLU . 46.8 Cg_endo -72.45 113.8 3.82 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.799 1.42 . . . . 0.0 110.779 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.418 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 0.1 OUTLIER -83.56 176.6 8.91 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.43 -0.794 . . . . 0.0 109.818 179.395 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.451 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -71.32 151.96 43.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.274 -0.892 . . . . 0.0 109.31 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.08 124.05 11.98 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.194 -0.941 . . . . 0.0 110.331 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.7 -24.84 27.41 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.461 ' CE2' ' CG2' ' A' ' 33' ' ' VAL . 85.3 m-85 -91.11 136.76 32.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.199 -1.177 . . . . 0.0 110.057 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -121.34 150.0 42.11 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.586 -0.697 . . . . 0.0 110.145 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 1.0 OUTLIER -89.46 162.39 15.76 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.322 -0.861 . . . . 0.0 110.228 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.582 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 0.4 OUTLIER -137.12 120.33 16.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.451 -0.78 . . . . 0.0 110.648 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -36.36 63.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.433 -0.792 . . . . 0.0 109.542 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.8 m -64.49 -43.29 94.61 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.672 -0.643 . . . . 0.0 109.735 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.582 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 42.2 m0 -81.83 -46.92 13.49 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.796 -0.565 . . . . 0.0 109.645 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.71 18.14 15.0 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.629 -0.989 . . . . 0.0 110.629 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.516 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.7 p90 -150.85 -175.65 5.21 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.011 -1.287 . . . . 0.0 111.194 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.602 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 46.1 t -122.58 130.88 53.49 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.536 -0.728 . . . . 0.0 110.576 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.53 174.42 10.78 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.962 -0.462 . . . . 0.0 109.98 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.461 ' CG2' ' CE2' ' A' ' 22' ' ' TYR . 97.5 t -67.99 142.64 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.224 -0.922 . . . . 0.0 110.044 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -72.14 112.68 8.44 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.518 -0.739 . . . . 0.0 110.193 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.01 127.59 18.27 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.495 -0.753 . . . . 0.0 110.195 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo . . . . . 0 C--N 1.313 -1.29 0 O-C-N 123.803 1.423 . . . . 0.0 110.658 -179.978 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 121.119 0.485 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.01 91.89 0.11 Allowed Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -113.24 90.11 3.26 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.439 -1.036 . . . . 0.0 110.735 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.535 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -140.33 151.97 45.46 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.416 -0.802 . . . . 0.0 109.949 179.366 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.506 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -86.64 -122.63 1.48 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.485 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -151.54 -145.34 4.11 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.424 ' HE1' ' HH ' ' A' ' 22' ' ' TYR . 0.2 OUTLIER -90.41 -27.28 19.4 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.221 -1.164 . . . . 0.0 110.817 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 33.0 t90 -149.13 73.84 1.22 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.411 -0.806 . . . . 0.0 109.623 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.506 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 15.4 m0 -104.56 159.05 16.07 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.456 -0.778 . . . . 0.0 109.428 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 1.9 mptt -90.7 132.99 35.48 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.852 -1.155 . . . . 0.0 111.311 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 23.7 p -150.82 170.35 19.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.61 -0.681 . . . . 0.0 110.604 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -117.58 1.87 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.574 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.73 41.48 1.06 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.533 -0.98 . . . . 0.0 110.176 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.17 33.4 17.7 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.595 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 0.2 OUTLIER -69.57 -55.27 9.56 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.247 -1.149 . . . . 0.0 110.489 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 47.9 Cg_endo -74.38 135.87 20.98 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 O-C-N 123.586 1.308 . . . . 0.0 109.729 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.42 107.39 2.27 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.704 1.371 . . . . 0.0 110.986 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.46 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 0.1 OUTLIER -74.88 174.99 8.49 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.346 -0.846 . . . . 0.0 109.327 179.072 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.535 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 2.2 m -80.22 147.11 31.38 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.931 -1.106 . . . . 0.0 108.799 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -44.78 127.51 6.32 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.466 -0.771 . . . . 0.0 111.278 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.6 -25.81 21.75 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.827 ' CD1' HG22 ' A' ' 33' ' ' VAL . 7.9 m-30 -99.33 136.64 38.98 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.079 -1.248 . . . . 0.0 110.19 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.528 ' HB3' ' HG3' ' A' ' 34' ' ' GLU . . . -118.29 149.79 40.56 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.413 -0.804 . . . . 0.0 109.778 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.702 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 0.8 OUTLIER -89.28 160.07 17.08 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.353 -0.842 . . . . 0.0 110.694 -179.742 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.4 m -132.56 110.84 10.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.582 -0.699 . . . . 0.0 110.517 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.574 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 39.7 tptt -68.86 -36.8 78.55 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.478 -0.764 . . . . 0.0 110.061 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.9 m -66.27 -37.69 86.05 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.637 -0.665 . . . . 0.0 109.921 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.524 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 42.7 m0 -86.07 -48.17 8.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.717 -0.614 . . . . 0.0 109.949 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.24 16.35 12.44 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.186 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.524 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.0 p90 -150.87 179.46 8.21 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.717 -1.461 . . . . 0.0 111.426 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.702 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 49.1 t -121.39 128.99 52.77 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.633 -0.667 . . . . 0.0 110.028 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -146.9 174.86 11.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.711 -0.618 . . . . 0.0 110.087 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.827 HG22 ' CD1' ' A' ' 22' ' ' TYR . 12.5 t -70.26 105.94 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.371 -0.831 . . . . 0.0 109.875 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.528 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 5.9 mm-40 -80.09 89.68 5.4 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.418 -0.801 . . . . 0.0 109.906 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -153.0 151.98 27.25 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.544 -0.722 . . . . 0.0 110.348 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 C--N 1.313 -1.334 0 O-C-N 123.944 1.497 . . . . 0.0 110.638 179.987 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.9 t70 . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 121.022 0.439 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.2 109.65 0.25 Allowed Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -107.17 57.61 0.63 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.538 -0.977 . . . . 0.0 110.8 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -116.15 155.25 28.58 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.207 -0.933 . . . . 0.0 110.025 179.548 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.542 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -81.48 -128.84 0.99 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.457 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -146.77 -140.13 3.39 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.56 -33.5 15.87 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.288 -1.125 . . . . 0.0 110.769 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -146.75 68.31 1.17 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.405 -0.81 . . . . 0.0 109.788 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.542 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 18.1 m0 -94.92 161.83 13.99 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.453 -0.78 . . . . 0.0 109.844 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 1.2 mttp -89.68 136.54 32.97 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.108 -0.995 . . . . 0.0 111.062 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.1 p -151.06 156.52 41.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.702 -0.624 . . . . 0.0 110.172 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.92 -118.45 0.84 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.45 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.86 34.04 0.92 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.414 -1.05 . . . . 0.0 110.001 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.51 39.72 3.37 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.486 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 3.8 mtpt -77.81 -58.74 0.86 Allowed Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.368 -1.078 . . . . 0.0 110.814 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.486 ' HD3' ' CB ' ' A' ' 15' ' ' LYS . 46.5 Cg_endo -74.56 136.9 22.03 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 O-C-N 123.652 1.343 . . . . 0.0 110.369 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.94 115.8 4.48 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.934 1.492 . . . . 0.0 110.701 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.467 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 96.1 m -84.91 -179.42 7.07 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.395 -0.816 . . . . 0.0 110.168 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.515 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 2.1 m -88.28 165.81 14.75 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.357 -0.839 . . . . 0.0 110.238 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp -58.18 124.77 20.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.388 -0.82 . . . . 0.0 110.223 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.8 -25.79 27.03 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.488 ' CD1' ' HB2' ' A' ' 19' ' ' CYS . 80.0 m-85 -92.13 133.44 35.77 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.552 -0.969 . . . . 0.0 110.066 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.92 145.27 47.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.543 -0.723 . . . . 0.0 109.89 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 9.1 t -88.82 160.34 17.29 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.581 -0.699 . . . . 0.0 110.089 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.413 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 2.5 m -142.6 122.9 13.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.587 -0.696 . . . . 0.0 111.208 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.45 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -73.77 -41.35 62.56 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.824 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.1 m -61.98 -40.28 95.07 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.692 -0.63 . . . . 0.0 109.599 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.497 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 34.9 m0 -80.28 -38.43 30.82 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.61 14.84 56.29 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.497 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 2.5 p90 -151.94 176.72 11.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.987 -1.302 . . . . 0.0 111.021 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 37.3 t -124.28 125.89 45.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.516 -0.74 . . . . 0.0 110.118 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.53 -178.25 5.99 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.671 -0.643 . . . . 0.0 109.785 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.428 HG23 ' CE2' ' A' ' 22' ' ' TYR . 98.6 t -59.96 156.8 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.138 -0.976 . . . . 0.0 110.155 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -62.17 -85.88 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.516 -0.74 . . . . 0.0 110.675 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -170.56 136.23 1.16 Allowed Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.192 -0.943 . . . . 0.0 110.281 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo . . . . . 0 C--N 1.314 -1.249 0 O-C-N 123.784 1.412 . . . . 0.0 110.726 179.936 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 15.9 t70 . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.22 0.533 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.72 69.76 0.86 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -85.75 97.75 10.33 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.553 -0.969 . . . . 0.0 109.824 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.31 158.89 43.33 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.355 -0.84 . . . . 0.0 110.47 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.95 -122.45 3.79 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.552 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -151.31 -150.08 5.23 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 30.0 t80 -81.32 -42.68 20.21 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.316 -1.108 . . . . 0.0 110.824 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 8.8 t90 -136.98 74.85 1.5 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.397 -0.814 . . . . 0.0 109.944 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.552 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 13.5 m0 -102.44 173.92 6.14 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.619 -0.676 . . . . 0.0 109.744 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.05 139.17 30.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.019 -1.051 . . . . 0.0 110.242 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.402 ' SG ' ' HD2' ' A' ' 16' ' ' PRO . 43.2 t -151.08 160.75 43.7 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.474 -0.766 . . . . 0.0 110.209 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.43 -116.43 3.73 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.617 ' HA ' ' HB3' ' A' ' 26' ' ' LYS . 7.6 mmt180 -90.5 29.19 1.33 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.312 -1.11 . . . . 0.0 110.122 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.77 34.69 4.28 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.512 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -76.73 -59.99 0.9 Allowed Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.308 -1.113 . . . . 0.0 110.105 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.512 ' HD3' ' CB ' ' A' ' 15' ' ' LYS . 47.5 Cg_endo -75.13 128.67 11.57 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.654 1.344 . . . . 0.0 110.081 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.52 111.61 3.01 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.852 1.449 . . . . 0.0 110.588 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 79.3 m -83.72 161.64 20.96 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.606 -0.684 . . . . 0.0 110.018 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.484 ' HB2' ' CD2' ' A' ' 22' ' ' TYR . 0.1 OUTLIER -62.25 150.15 39.9 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.522 -0.736 . . . . 0.0 110.653 -179.74 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.39 123.11 12.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.602 -0.686 . . . . 0.0 110.269 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.11 -26.66 11.07 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.769 ' CE1' HG22 ' A' ' 33' ' ' VAL . 11.4 m-30 -89.21 160.52 16.91 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.378 -1.072 . . . . 0.0 109.809 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.19 144.68 50.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.457 -0.777 . . . . 0.0 110.308 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.4 ' SG ' ' N ' ' A' ' 25' ' ' SER . 25.7 t -89.57 162.62 15.57 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.624 -0.673 . . . . 0.0 110.271 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.4 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 15.6 m -138.9 94.68 2.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.409 -0.807 . . . . 0.0 110.81 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.617 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -61.58 -32.02 72.1 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.221 -0.925 . . . . 0.0 110.323 179.278 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.5 m -72.1 -38.58 69.3 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.583 -0.698 . . . . 0.0 110.186 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.56 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 46.2 m0 -82.96 -48.19 10.94 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.631 -0.668 . . . . 0.0 109.638 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.36 15.53 9.62 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.206 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.56 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.0 p90 -150.95 178.7 8.91 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.758 -1.437 . . . . 0.0 110.995 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 9.2 t -127.62 130.43 48.97 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.657 -0.652 . . . . 0.0 109.758 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -149.89 179.75 7.79 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.497 -0.752 . . . . 0.0 110.781 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.769 HG22 ' CE1' ' A' ' 22' ' ' TYR . 39.0 t -71.26 127.71 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.452 -0.78 . . . . 0.0 110.021 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -89.09 -17.21 29.73 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.519 -0.738 . . . . 0.0 111.05 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 34' ' ' GLU . . . 57.42 81.78 0.25 Allowed Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.462 -0.774 . . . . 0.0 110.798 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo . . . . . 0 C--N 1.312 -1.378 0 O-C-N 123.797 1.419 . . . . 0.0 110.636 -179.987 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 121.211 0.529 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -175.03 99.06 0.13 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.494 ' HG2' ' HG3' ' A' ' 17' ' ' PRO . 1.5 mt-10 -138.35 73.02 1.42 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.48 -1.012 . . . . 0.0 110.243 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.25 156.26 40.49 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.497 0.665 . . . . 0.0 110.572 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.465 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -113.24 -106.53 2.77 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.553 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -152.7 -161.22 10.12 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 36.5 p90 -82.56 -19.81 37.79 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.347 -1.09 . . . . 0.0 111.219 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 22.8 t90 -154.44 72.59 0.87 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.28 -0.888 . . . . 0.0 109.637 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.553 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 17.6 m0 -104.41 169.2 8.61 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.471 -0.768 . . . . 0.0 110.151 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -91.32 136.67 32.94 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.193 -0.942 . . . . 0.0 110.607 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.4 p -150.77 156.71 41.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.489 -0.757 . . . . 0.0 110.426 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.32 -117.72 1.63 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.588 ' HA ' ' HB3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.4 50.82 1.9 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.419 -1.048 . . . . 0.0 109.906 179.425 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.61 38.19 21.35 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.493 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -77.46 -60.03 0.78 Allowed Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.383 -1.069 . . . . 0.0 110.707 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.493 ' HD3' ' CB ' ' A' ' 15' ' ' LYS . 47.3 Cg_endo -75.07 131.95 14.79 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 123.615 1.324 . . . . 0.0 110.273 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.494 ' HG3' ' HG2' ' A' ' 3' ' ' GLU . 47.4 Cg_endo -74.21 119.69 5.93 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.833 1.438 . . . . 0.0 110.653 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -89.47 171.18 9.9 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.597 -0.689 . . . . 0.0 110.095 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.23 149.36 49.61 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.371 -0.831 . . . . 0.0 110.243 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.99 109.13 0.38 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.687 -0.633 . . . . 0.0 110.401 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.84 -39.24 1.82 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.804 ' CD1' HG22 ' A' ' 33' ' ' VAL . 4.6 m-85 -90.99 141.83 28.42 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.42 -1.047 . . . . 0.0 110.001 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -118.54 150.87 38.9 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.547 -0.721 . . . . 0.0 110.234 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 10.8 t -89.61 160.61 16.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.42 -0.8 . . . . 0.0 110.224 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.407 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 56.7 m -135.03 105.22 6.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.572 -0.705 . . . . 0.0 110.966 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.588 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -66.12 -31.61 72.56 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.458 -0.776 . . . . 0.0 110.064 179.211 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.543 ' N ' ' HG2' ' A' ' 26' ' ' LYS . 54.6 m -67.05 -39.9 87.03 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.696 -0.627 . . . . 0.0 110.168 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.629 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 43.4 m0 -86.76 -48.6 8.1 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.601 -0.687 . . . . 0.0 109.842 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.44 14.89 8.58 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.629 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.1 p90 -151.5 177.37 10.38 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.925 -1.338 . . . . 0.0 111.057 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 8.2 t -126.0 130.57 51.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.456 -0.777 . . . . 0.0 110.204 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -147.71 -172.22 3.99 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.597 -0.689 . . . . 0.0 110.184 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.804 HG22 ' CD1' ' A' ' 22' ' ' TYR . 10.6 t -73.64 122.73 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.35 -0.843 . . . . 0.0 110.022 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.13 167.45 15.73 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.505 -0.747 . . . . 0.0 110.719 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.52 130.21 23.62 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.496 -0.753 . . . . 0.0 110.185 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo . . . . . 0 C--N 1.315 -1.232 0 O-C-N 123.888 1.468 . . . . 0.0 110.729 179.836 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 . . . . . 0 N--CA 1.497 1.882 0 CA-C-O 121.193 0.521 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -101.4 103.41 2.54 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.516 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 13.1 mt-10 -72.62 130.6 40.96 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.471 -1.017 . . . . 0.0 110.419 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -134.84 160.79 37.09 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.51 -0.743 . . . . 0.0 109.906 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.473 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -101.25 -124.28 5.35 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.539 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -150.29 -154.77 6.57 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -77.8 -36.14 50.63 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.212 -1.169 . . . . 0.0 110.962 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 38.7 t90 -142.8 77.58 1.58 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.408 -0.808 . . . . 0.0 109.856 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.539 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 15.3 m0 -105.66 156.68 18.04 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.545 -0.722 . . . . 0.0 109.169 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.46 132.13 35.17 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.868 -1.145 . . . . 0.0 111.119 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.8 p -150.83 167.8 26.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.715 -0.615 . . . . 0.0 110.214 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.46 -121.18 0.54 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.591 ' HG3' ' HD3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.5 25.56 2.24 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.455 -1.026 . . . . 0.0 110.329 179.211 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.73 34.05 3.65 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.58 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 1.5 tptt -69.85 -54.47 10.15 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.276 -1.132 . . . . 0.0 109.975 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 50.1 Cg_endo -77.22 132.63 12.71 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 O-C-N 123.763 1.401 . . . . 0.0 109.716 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.516 ' HG2' ' HB3' ' A' ' 3' ' ' GLU . 44.3 Cg_endo -70.47 119.07 6.06 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.781 1.411 . . . . 0.0 110.75 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.402 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 94.9 m -84.14 -178.78 7.06 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.582 -0.698 . . . . 0.0 110.035 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.515 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -75.24 164.58 26.31 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.332 -0.855 . . . . 0.0 110.132 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.58 119.96 9.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.467 -0.771 . . . . 0.0 110.267 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.24 0.88 54.17 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 36.9 m-85 -112.55 133.38 54.63 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.117 -1.225 . . . . 0.0 109.677 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -119.58 144.71 46.94 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.394 -0.816 . . . . 0.0 110.496 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.559 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 0.8 OUTLIER -89.11 160.82 16.84 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.513 -0.742 . . . . 0.0 110.017 179.664 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 m -136.69 125.42 23.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.434 -0.792 . . . . 0.0 110.636 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.591 ' HD3' ' HG3' ' A' ' 13' ' ' ARG . 9.9 ttpt -76.55 -40.55 49.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.517 -0.739 . . . . 0.0 109.244 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.8 m -65.2 -38.68 91.22 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.738 -0.601 . . . . 0.0 109.623 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.462 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 42.8 m0 -81.49 -45.29 16.19 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.644 -0.66 . . . . 0.0 109.456 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.72 16.28 31.72 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.462 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.5 p90 -151.21 -179.11 7.06 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.903 -1.351 . . . . 0.0 111.359 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.559 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 8.4 t -121.7 128.39 51.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.676 -0.64 . . . . 0.0 110.447 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.41 165.54 30.81 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.753 -0.592 . . . . 0.0 110.143 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 67.2 t -64.68 146.27 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.249 -0.907 . . . . 0.0 110.175 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.38 83.9 3.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.403 -0.811 . . . . 0.0 110.003 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.805 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -65.95 -57.22 14.14 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.436 -0.79 . . . . 0.0 110.529 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.805 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 46.8 Cg_endo . . . . . 0 N--CA 1.488 1.153 0 O-C-N 123.511 1.269 . . . . 0.0 110.559 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.229 0.538 . . . . 0.0 110.426 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -175.46 67.22 0.1 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.28 174.59 7.61 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.617 -0.931 . . . . 0.0 110.367 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -136.12 156.58 48.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.552 -0.718 . . . . 0.0 110.433 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -111.9 -99.2 2.45 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.552 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -149.14 -154.95 6.52 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.578 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 12.2 m-85 -90.9 -30.26 17.01 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.418 -1.049 . . . . 0.0 110.484 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -142.65 68.87 1.31 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.511 -0.743 . . . . 0.0 109.44 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.552 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 17.3 m0 -99.25 154.14 18.4 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.366 -0.834 . . . . 0.0 109.786 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -88.48 134.93 33.71 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.042 -1.036 . . . . 0.0 111.133 -179.307 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.498 ' CB ' ' HG2' ' A' ' 16' ' ' PRO . 31.3 p -150.72 177.05 10.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.589 -0.694 . . . . 0.0 110.528 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.79 -120.28 0.45 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.447 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -87.71 -38.47 15.8 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.454 -1.027 . . . . 0.0 109.56 179.02 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -174.05 37.88 0.12 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.6 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 1.7 mtpm? -72.45 -69.7 0.32 Allowed Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 121.44 -1.035 . . . . 0.0 110.813 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.6 ' CD ' ' CB ' ' A' ' 15' ' ' LYS . 48.4 Cg_endo -74.02 125.36 9.79 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.391 1.206 . . . . 0.0 109.9 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -74.3 103.89 1.76 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.894 1.47 . . . . 0.0 111.495 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 t -64.95 164.87 11.83 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.554 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -53.02 149.62 6.43 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.96 -1.087 . . . . 0.0 110.621 -179.489 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -50.21 120.64 4.67 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.626 -0.671 . . . . 0.0 110.011 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.83 -25.48 10.85 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.768 ' CE2' HG23 ' A' ' 33' ' ' VAL . 31.0 m-85 -99.71 132.88 44.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.514 -0.992 . . . . 0.0 109.229 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -114.64 154.92 27.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.269 -0.894 . . . . 0.0 110.243 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 31' ' ' CYS . 0.9 OUTLIER -89.18 151.19 22.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.444 -0.785 . . . . 0.0 109.58 179.703 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.512 ' CB ' ' HB2' ' A' ' 28' ' ' TRP . 3.1 m -125.44 130.68 52.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.448 -0.783 . . . . 0.0 110.739 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.447 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 0.5 OUTLIER -75.25 -42.46 55.11 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.523 -0.736 . . . . 0.0 109.351 179.136 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.1 m -68.19 -38.13 81.66 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.87 -0.519 . . . . 0.0 109.819 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.512 ' HB2' ' CB ' ' A' ' 25' ' ' SER . 38.0 m0 -79.35 -46.3 17.92 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.596 -0.69 . . . . 0.0 109.453 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.45 17.92 34.88 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.528 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 2.9 p90 -151.35 178.26 9.45 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.025 -1.279 . . . . 0.0 111.091 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.668 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 2.4 p -119.32 123.6 44.59 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.918 0.866 . . . . 0.0 110.202 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.475 ' HA ' ' HD2' ' A' ' 22' ' ' TYR . . . -150.72 -179.69 7.47 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.768 HG23 ' CE2' ' A' ' 22' ' ' TYR . 92.5 t -69.96 117.13 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.091 -1.006 . . . . 0.0 109.751 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.79 152.04 45.26 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.51 -0.744 . . . . 0.0 110.852 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 50.08 63.68 9.68 Favored Pre-proline 0 N--CA 1.501 2.08 0 O-C-N 121.724 -0.61 . . . . 0.0 110.751 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo . . . . . 0 C--N 1.314 -1.271 0 O-C-N 123.813 1.428 . . . . 0.0 110.79 -179.976 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 121.162 0.506 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 112.28 -41.64 2.17 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.97 55.22 3.06 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.43 -1.041 . . . . 0.0 110.516 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.532 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -121.88 155.86 34.53 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.151 -0.968 . . . . 0.0 110.121 179.849 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.495 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -80.36 -120.66 0.42 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.486 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -152.91 -142.68 3.52 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.505 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 48.8 t80 -90.27 -38.72 13.22 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.462 -1.023 . . . . 0.0 110.71 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -139.11 74.24 1.46 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.278 -0.889 . . . . 0.0 109.672 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.495 ' CZ3' ' HA2' ' A' ' 5' ' ' GLY . 13.9 m0 -102.09 155.25 18.31 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.457 -0.777 . . . . 0.0 109.487 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -89.71 132.89 34.95 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.91 -1.119 . . . . 0.0 111.56 -179.013 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.499 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 27.8 p -151.57 174.72 13.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.788 -0.57 . . . . 0.0 110.382 178.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.4 -114.97 3.08 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.615 ' HD3' ' HD3' ' A' ' 26' ' ' LYS . 30.5 tpt180 -90.59 38.08 0.93 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.521 -0.988 . . . . 0.0 109.701 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.25 35.13 7.16 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.528 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -66.7 -59.86 7.33 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 121.514 -0.992 . . . . 0.0 110.044 179.68 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 48.0 Cg_endo -74.69 139.01 24.62 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 O-C-N 123.774 1.408 . . . . 0.0 110.037 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.4 115.66 4.37 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.927 1.488 . . . . 0.0 110.947 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.432 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 95.1 m -84.97 176.26 8.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.49 -0.757 . . . . 0.0 110.02 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.57 ' HB2' ' CD1' ' A' ' 22' ' ' TYR . 3.7 m -86.55 165.43 16.22 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.213 -0.93 . . . . 0.0 109.957 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -56.33 126.75 27.66 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.411 -0.805 . . . . 0.0 111.059 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.32 -24.07 33.72 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.57 ' CD1' ' HB2' ' A' ' 19' ' ' CYS . 78.7 m-85 -95.83 129.01 43.19 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.279 -1.13 . . . . 0.0 110.238 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -118.42 150.79 38.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.64 -0.663 . . . . 0.0 109.866 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.513 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 0.9 OUTLIER -89.35 158.68 17.69 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.361 -0.837 . . . . 0.0 110.553 -179.725 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.37 113.95 12.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.467 -0.771 . . . . 0.0 110.737 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.615 ' HD3' ' HD3' ' A' ' 13' ' ' ARG . 12.0 tttt -70.55 -36.56 73.73 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.456 -0.778 . . . . 0.0 109.763 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.5 m -61.54 -42.02 98.2 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.549 -0.72 . . . . 0.0 109.904 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.59 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 47.7 m0 -85.75 -56.85 3.29 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.738 -0.601 . . . . 0.0 109.516 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.12 20.77 4.33 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.185 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.59 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.8 p90 -151.11 -174.66 4.88 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 119.064 1.432 . . . . 0.0 111.519 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.513 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 6.5 t -128.13 127.49 43.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.689 -0.632 . . . . 0.0 110.29 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -150.49 174.19 13.22 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.239 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.4 t -56.92 152.07 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.361 -0.837 . . . . 0.0 110.122 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.05 94.83 6.02 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.373 -0.83 . . . . 0.0 110.236 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.57 149.04 19.48 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.517 -0.74 . . . . 0.0 110.593 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo . . . . . 0 C--N 1.313 -1.335 0 O-C-N 123.966 1.508 . . . . 0.0 110.784 179.647 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.032 0.444 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.29 129.97 13.08 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.72 53.65 2.64 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.399 -1.059 . . . . 0.0 110.464 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.94 157.66 41.68 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.291 -0.88 . . . . 0.0 110.037 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.487 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -105.01 -109.3 3.4 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.545 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -153.56 -159.37 9.09 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 71.2 t80 -80.74 -33.21 35.3 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.554 -0.968 . . . . 0.0 110.616 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 30.3 t90 -141.98 78.41 1.63 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.297 -0.877 . . . . 0.0 109.931 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.545 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 14.0 m0 -108.2 156.26 19.54 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.548 -0.72 . . . . 0.0 109.374 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -89.63 134.32 34.2 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.794 -1.191 . . . . 0.0 111.067 -179.271 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.554 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 21.4 p -151.06 166.78 29.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.673 -0.642 . . . . 0.0 110.305 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.07 -111.88 1.08 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.478 ' HG3' ' HB3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.73 29.08 1.38 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.47 -1.018 . . . . 0.0 109.87 179.1 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.09 35.36 4.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.519 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -63.97 -61.09 7.42 Favored Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.313 -1.11 . . . . 0.0 110.363 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' A' ' 11' ' ' CYS . 47.9 Cg_endo -74.71 129.23 12.41 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.643 1.338 . . . . 0.0 109.72 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.47 114.91 4.08 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.692 1.364 . . . . 0.0 110.175 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.423 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 73.4 m -82.02 171.72 14.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.519 -0.738 . . . . 0.0 110.145 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.89 148.46 49.38 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.304 -0.873 . . . . 0.0 109.862 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.49 133.4 24.94 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.556 -0.715 . . . . 0.0 110.981 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.0 -27.77 18.94 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.913 ' CE1' HG22 ' A' ' 33' ' ' VAL . 12.5 m-30 -90.72 154.23 19.7 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.425 -1.044 . . . . 0.0 110.124 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.949 ' HB3' ' HB2' ' A' ' 34' ' ' GLU . . . -136.3 151.69 49.89 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.542 -0.724 . . . . 0.0 109.912 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.497 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 0.8 OUTLIER -89.81 162.92 15.26 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.299 -0.876 . . . . 0.0 110.045 179.798 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.562 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 0.6 OUTLIER -131.6 101.19 5.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.502 -0.749 . . . . 0.0 110.457 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.478 ' HB3' ' HG3' ' A' ' 13' ' ' ARG . 11.2 pttm -60.36 -33.55 72.6 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.606 -0.684 . . . . 0.0 110.186 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.7 m -70.51 -39.86 73.85 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.618 -0.676 . . . . 0.0 110.235 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.562 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 46.6 m0 -82.64 -52.31 6.92 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.588 -0.695 . . . . 0.0 109.804 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.42 18.55 6.58 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 5.0 p90 -151.13 -170.6 3.7 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.753 -1.44 . . . . 0.0 111.464 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.497 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 8.9 t -132.87 130.98 40.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.604 -0.685 . . . . 0.0 110.414 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -149.4 -175.93 5.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.666 -0.646 . . . . 0.0 109.921 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.913 HG22 ' CE1' ' A' ' 22' ' ' TYR . 12.5 t -72.84 91.73 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.949 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 30.9 mt-10 -107.79 -30.99 8.22 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.46 -0.775 . . . . 0.0 110.868 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.99 155.26 55.43 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.277 -0.89 . . . . 0.0 110.44 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 C--N 1.313 -1.328 0 O-C-N 123.904 1.476 . . . . 0.0 110.619 -179.953 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 121.197 0.522 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.69 -74.45 0.2 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -107.22 95.18 5.52 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.404 -1.056 . . . . 0.0 110.33 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.561 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -139.51 154.51 47.7 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.567 -0.708 . . . . 0.0 109.961 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.447 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -86.44 -126.34 1.96 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.551 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -145.77 -148.67 4.84 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.426 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 44.7 t80 -86.55 -27.3 24.03 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.343 -1.092 . . . . 0.0 110.855 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -151.06 68.69 0.94 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.432 -0.793 . . . . 0.0 109.833 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.551 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 16.9 m0 -96.64 160.31 14.45 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.454 -0.779 . . . . 0.0 109.629 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -90.14 130.84 36.24 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.999 -1.063 . . . . 0.0 111.391 -179.076 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.406 ' HB2' ' CD ' ' A' ' 16' ' ' PRO . 29.7 p -151.73 179.39 8.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.762 -0.586 . . . . 0.0 110.522 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.61 -121.42 4.61 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.72 53.39 2.4 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.554 -0.968 . . . . 0.0 109.899 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.437 ' HA2' ' HB2' ' A' ' 24' ' ' CYS . . . 77.93 37.81 28.48 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.547 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 0.3 OUTLIER -71.09 -58.37 4.11 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.493 -1.004 . . . . 0.0 110.199 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.547 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 48.4 Cg_endo -76.42 143.42 24.71 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 O-C-N 123.736 1.388 . . . . 0.0 109.958 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.422 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 48.8 Cg_endo -73.9 99.06 1.12 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.757 1.398 . . . . 0.0 110.762 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.418 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 0.1 OUTLIER -69.67 177.04 3.18 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.266 -0.896 . . . . 0.0 109.376 179.229 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.561 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 2.7 m -81.16 161.61 23.98 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.137 -0.977 . . . . 0.0 109.654 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -55.95 120.46 7.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.391 -0.818 . . . . 0.0 110.457 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.0 -14.72 44.63 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.523 ' CD1' ' HB2' ' A' ' 19' ' ' CYS . 66.8 m-85 -102.59 131.63 49.22 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.051 -1.264 . . . . 0.0 110.122 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -117.45 147.36 42.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.57 -0.706 . . . . 0.0 110.24 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 1.1 m -89.36 159.26 17.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.415 -0.803 . . . . 0.0 110.065 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 2.0 m -130.22 117.77 20.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.576 -0.703 . . . . 0.0 110.483 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -69.82 -37.63 76.31 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.551 -0.718 . . . . 0.0 109.751 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.3 m -71.83 -39.73 69.58 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.625 -0.672 . . . . 0.0 110.255 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.571 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 43.9 m0 -78.9 -48.69 14.14 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.555 -0.716 . . . . 0.0 109.803 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.54 18.08 15.47 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.571 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.5 p90 -150.85 -179.23 7.1 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.856 -1.379 . . . . 0.0 111.157 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.629 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 22.8 t -123.91 129.94 51.79 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.662 -0.649 . . . . 0.0 110.232 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.12 169.65 19.53 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.787 -0.571 . . . . 0.0 110.135 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.461 ' CG2' ' CE2' ' A' ' 22' ' ' TYR . 59.4 t -60.1 157.01 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.445 -0.784 . . . . 0.0 110.443 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -94.97 34.06 1.42 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.44 -0.788 . . . . 0.0 110.795 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.718 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -71.56 -51.15 9.73 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.278 -0.889 . . . . 0.0 110.478 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.718 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 47.9 Cg_endo . . . . . 0 N--CA 1.486 1.058 0 O-C-N 123.405 1.213 . . . . 0.0 110.791 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 N--CA 1.498 1.949 0 CA-C-O 121.201 0.524 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -134.07 70.21 0.52 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 17' ' ' PRO . 0.5 OUTLIER -120.99 168.7 11.23 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.579 -0.954 . . . . 0.0 110.296 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.545 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -123.76 155.75 37.34 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.353 -0.842 . . . . 0.0 109.926 179.598 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.437 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -94.76 -120.89 3.44 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.524 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -144.97 -149.6 5.06 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -88.44 -17.28 30.75 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.305 -1.115 . . . . 0.0 110.685 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 -160.06 68.06 0.38 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.322 -0.861 . . . . 0.0 110.07 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.524 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 20.2 m0 -96.81 173.69 7.18 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.401 -0.812 . . . . 0.0 110.087 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -94.81 133.31 38.65 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.185 -0.947 . . . . 0.0 110.945 -179.486 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 24.8 p -150.75 159.38 44.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.606 -0.684 . . . . 0.0 110.47 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -93.61 -118.0 2.76 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.551 ' HB2' ' HD2' ' A' ' 26' ' ' LYS . 0.3 OUTLIER -90.78 43.01 1.13 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.528 -0.984 . . . . 0.0 109.723 179.388 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.95 39.92 5.36 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.569 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 6.4 mttt -76.89 -64.0 0.49 Allowed Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.431 -1.041 . . . . 0.0 110.023 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.569 ' CD ' ' CB ' ' A' ' 15' ' ' LYS . 48.5 Cg_endo -74.39 133.64 17.85 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 O-C-N 123.579 1.305 . . . . 0.0 109.633 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.472 ' HB2' ' O ' ' A' ' 3' ' ' GLU . 50.6 Cg_endo -73.26 111.51 3.3 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.678 1.357 . . . . 0.0 110.319 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.4 m -77.39 179.2 6.59 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.402 -0.811 . . . . 0.0 110.101 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.545 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 2.7 m -87.4 150.81 23.56 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.382 -0.824 . . . . 0.0 110.078 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.16 118.78 3.46 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.607 -0.683 . . . . 0.0 110.532 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.29 -35.98 3.69 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.792 ' CD1' HG22 ' A' ' 33' ' ' VAL . 5.6 m-85 -93.66 152.16 19.17 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.35 -1.088 . . . . 0.0 110.069 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -126.27 146.74 49.88 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.648 -0.658 . . . . 0.0 110.178 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 13.4 t -89.75 159.84 16.85 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.457 -0.777 . . . . 0.0 110.331 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.6 m -140.75 116.69 10.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.653 -0.655 . . . . 0.0 110.559 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.551 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -73.72 -39.25 64.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.419 -0.801 . . . . 0.0 109.19 179.051 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.1 m -62.85 -40.59 97.93 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.555 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 40.5 m0 -79.98 -38.83 31.39 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.26 13.97 50.02 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.555 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.3 p90 -150.92 177.03 10.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.903 -1.351 . . . . 0.0 111.273 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 31.2 t -126.08 121.88 34.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.752 -0.592 . . . . 0.0 109.714 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.75 -178.26 5.34 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.541 -0.725 . . . . 0.0 110.046 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.792 HG22 ' CD1' ' A' ' 22' ' ' TYR . 21.5 t -63.72 156.82 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.272 -0.892 . . . . 0.0 110.188 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -54.98 102.04 0.06 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.638 -0.663 . . . . 0.0 110.235 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -161.31 148.24 11.7 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.416 -0.803 . . . . 0.0 110.501 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo . . . . . 0 C--N 1.314 -1.285 0 O-C-N 123.954 1.502 . . . . 0.0 110.58 179.728 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 121.347 0.594 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.9 -155.45 52.83 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -159.31 85.92 0.8 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.352 -1.087 . . . . 0.0 110.382 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -145.09 154.24 42.27 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.469 -0.77 . . . . 0.0 110.218 179.902 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.47 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -95.72 -129.02 5.77 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.53 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -147.22 -153.73 6.0 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 77.5 t80 -79.66 -29.63 40.95 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.346 -1.091 . . . . 0.0 110.899 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -149.21 74.92 1.27 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.18 -0.95 . . . . 0.0 109.883 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.53 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 16.3 m0 -105.05 178.32 4.59 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.666 -0.646 . . . . 0.0 109.377 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.98 133.52 35.22 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.93 -1.106 . . . . 0.0 110.778 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.581 ' SG ' ' HD2' ' A' ' 16' ' ' PRO . 40.7 t -151.69 162.36 41.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.653 -0.654 . . . . 0.0 110.372 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -102.57 -119.01 4.52 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 108.889 -1.685 . . . . 0.0 108.889 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.553 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -91.15 31.24 1.13 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.322 -1.105 . . . . 0.0 110.129 179.153 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.83 36.77 3.61 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.537 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -76.57 -63.92 0.53 Allowed Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.372 -1.075 . . . . 0.0 110.557 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.581 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 44.1 Cg_endo -71.18 135.28 26.77 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.729 1.384 . . . . 0.0 110.042 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.439 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 45.5 Cg_endo -71.88 100.97 1.13 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.81 1.426 . . . . 0.0 110.844 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.0 m -72.77 169.25 17.11 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.342 -0.848 . . . . 0.0 109.216 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.2 147.9 46.35 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.941 -1.1 . . . . 0.0 110.025 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.55 119.81 4.52 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.638 -0.663 . . . . 0.0 110.571 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.26 -22.61 17.63 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.867 ' CE1' HG22 ' A' ' 33' ' ' VAL . 12.4 m-30 -89.07 157.95 18.15 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.416 -1.05 . . . . 0.0 109.974 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -133.29 151.32 51.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.506 -0.746 . . . . 0.0 109.917 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.3 m -89.12 167.17 13.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.506 -0.746 . . . . 0.0 110.694 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.492 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 17.3 m -132.66 102.21 5.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.613 -0.679 . . . . 0.0 110.324 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.553 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 1.8 ttpt -65.09 -31.42 72.63 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.555 -0.716 . . . . 0.0 110.841 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.9 m -82.92 -36.13 25.5 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.435 -0.79 . . . . 0.0 110.873 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.588 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 45.0 m0 -79.95 -42.63 23.62 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.477 -0.765 . . . . 0.0 110.236 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.07 16.88 22.18 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.498 -0.858 . . . . 0.0 110.976 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.588 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 2.8 p90 -150.59 178.82 8.71 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.107 -1.231 . . . . 0.0 110.822 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 22.6 t -121.01 135.88 55.11 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.548 -0.72 . . . . 0.0 109.786 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -146.03 -179.59 6.82 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.436 -0.79 . . . . 0.0 110.242 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.867 HG22 ' CE1' ' A' ' 22' ' ' TYR . 11.9 t -75.01 151.64 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.388 -0.82 . . . . 0.0 109.802 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -68.86 -26.4 65.13 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.51 -0.744 . . . . 0.0 110.813 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.26 150.51 95.55 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.379 -0.826 . . . . 0.0 110.437 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 C--N 1.312 -1.384 0 O-C-N 123.892 1.47 . . . . 0.0 110.863 179.971 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.643 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.314 0.578 . . . . 0.0 109.879 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.421 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -92.13 -118.32 2.41 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.492 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -147.55 -143.1 3.78 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -90.68 -37.78 13.51 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.296 -1.12 . . . . 0.0 110.59 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.82 70.49 1.35 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.513 -0.742 . . . . 0.0 109.808 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.492 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 16.7 m0 -96.85 166.19 11.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.36 -0.838 . . . . 0.0 109.734 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -92.12 134.74 34.57 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.166 -0.958 . . . . 0.0 110.919 -179.55 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 31.2 p -151.07 159.03 44.76 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.579 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.82 -115.89 1.0 Allowed Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.554 ' HG3' ' HB3' ' A' ' 26' ' ' LYS . 1.0 OUTLIER -90.66 29.58 1.29 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.435 -1.038 . . . . 0.0 110.044 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.92 38.68 3.31 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.594 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -74.16 -57.34 2.31 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.406 -1.055 . . . . 0.0 110.572 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 46.9 Cg_endo -74.58 134.99 19.3 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 O-C-N 123.719 1.378 . . . . 0.0 109.975 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -71.84 105.77 1.87 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.92 1.484 . . . . 0.0 110.693 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.0 m -74.79 176.57 6.92 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.397 -0.814 . . . . 0.0 109.761 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.643 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.1 m -81.2 161.9 23.81 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.28 -0.887 . . . . 0.0 110.301 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -56.24 125.66 22.77 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.562 -0.711 . . . . 0.0 110.543 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.6 -18.73 54.71 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.52 ' CD1' ' HB2' ' A' ' 19' ' ' CYS . 52.8 m-85 -94.58 142.47 27.4 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.253 -1.145 . . . . 0.0 110.153 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -124.82 140.81 52.59 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.426 -0.796 . . . . 0.0 110.349 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 14.1 t -89.44 159.56 17.22 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.51 -0.744 . . . . 0.0 110.158 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -138.14 123.27 19.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.62 -0.675 . . . . 0.0 111.031 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.554 ' HB3' ' HG3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -76.63 -35.12 58.24 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.658 -0.651 . . . . 0.0 110.003 179.157 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.4 m -69.99 -38.75 76.1 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.46 -0.775 . . . . 0.0 109.389 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.528 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 40.3 m0 -80.02 -40.85 26.94 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.48 16.37 43.3 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.528 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.0 p90 -151.0 177.84 9.77 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.999 -1.295 . . . . 0.0 111.021 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 25.2 t -127.27 128.37 45.88 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.698 -0.626 . . . . 0.0 110.235 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.48 172.83 14.34 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.605 -0.684 . . . . 0.0 110.096 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.444 HG23 ' CE2' ' A' ' 22' ' ' TYR . 99.1 t . . . . . 0 N--CA 1.501 2.108 0 O-C-N 121.389 -0.82 . . . . 0.0 110.018 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.442 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.081 0.467 . . . . 0.0 109.958 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.565 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -78.84 -142.87 2.31 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.5 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -142.7 -151.48 5.5 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -76.92 -29.33 55.63 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.34 -1.094 . . . . 0.0 111.059 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -153.83 69.97 0.81 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.315 -0.866 . . . . 0.0 110.233 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.565 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 20.8 m0 -98.62 176.07 5.77 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.494 -0.754 . . . . 0.0 109.704 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.77 138.93 31.06 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.143 -0.973 . . . . 0.0 110.393 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.4 ' SG ' ' HD2' ' A' ' 16' ' ' PRO . 33.6 t -150.99 161.01 43.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.541 -0.724 . . . . 0.0 110.442 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -103.49 -121.43 4.93 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.556 ' HA ' ' HB3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.71 37.37 0.92 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.364 -1.08 . . . . 0.0 110.347 179.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.17 34.55 7.09 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.585 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 1.4 tptp -77.58 -58.97 0.87 Allowed Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.319 -1.107 . . . . 0.0 110.19 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 47.2 Cg_endo -75.07 133.4 16.43 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.694 1.365 . . . . 0.0 110.018 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.63 104.93 1.68 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 O-C-N 123.899 1.473 . . . . 0.0 110.589 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.2 m -72.38 166.36 22.7 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.414 -0.804 . . . . 0.0 109.728 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.442 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -67.77 155.97 38.09 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.255 -0.903 . . . . 0.0 110.407 -179.689 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.02 128.67 28.18 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.667 -0.646 . . . . 0.0 111.138 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.65 -20.42 50.73 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.856 ' CE1' HG22 ' A' ' 33' ' ' VAL . 12.3 m-30 -89.7 150.89 22.13 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.168 -1.195 . . . . 0.0 110.31 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.39 142.42 51.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.671 -0.643 . . . . 0.0 109.852 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 18.3 t -89.3 159.69 17.26 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.447 -0.783 . . . . 0.0 110.622 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.0 m -138.64 106.92 5.78 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.635 -0.666 . . . . 0.0 110.424 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.556 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -72.99 -33.4 65.79 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.371 -0.83 . . . . 0.0 110.285 179.363 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.6 m -68.87 -36.74 78.46 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.471 -0.768 . . . . 0.0 109.83 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.583 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 47.0 m0 -84.04 -40.16 18.71 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.747 -0.595 . . . . 0.0 109.565 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.96 14.91 25.46 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.583 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 2.6 p90 -151.46 177.77 9.96 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.843 -1.387 . . . . 0.0 111.458 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 15.8 t -126.89 126.53 43.44 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.9 177.91 7.63 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.555 -0.715 . . . . 0.0 110.498 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.856 HG22 ' CE1' ' A' ' 22' ' ' TYR . 17.6 t . . . . . 0 N--CA 1.496 1.87 0 O-C-N 121.452 -0.78 . . . . 0.0 110.208 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 121.281 0.563 . . . . 0.0 109.92 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.544 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -77.22 -149.61 3.49 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.437 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -139.49 -139.56 3.8 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -90.25 -19.22 24.39 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.447 -1.031 . . . . 0.0 111.242 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -161.85 65.01 0.25 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.27 -0.894 . . . . 0.0 109.679 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.544 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 20.7 m0 -97.15 162.19 13.47 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.472 -0.767 . . . . 0.0 109.697 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -90.79 134.41 34.46 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.994 -1.066 . . . . 0.0 110.873 -179.555 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.1 p -150.79 169.85 20.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.516 -0.74 . . . . 0.0 110.471 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.6 -131.02 2.53 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.626 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.45 55.02 2.89 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.478 -1.013 . . . . 0.0 110.026 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 78.68 35.4 32.22 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.5 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 2.3 mttt -76.36 -60.32 0.94 Allowed Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.327 -1.102 . . . . 0.0 110.356 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.5 ' CD ' ' CB ' ' A' ' 15' ' ' LYS . 47.3 Cg_endo -73.2 141.36 32.27 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.651 1.343 . . . . 0.0 110.168 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.465 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 42.9 Cg_endo -71.78 103.23 1.43 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.856 1.45 . . . . 0.0 110.867 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.493 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 24.7 m -71.27 162.16 29.88 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.366 -0.834 . . . . 0.0 109.659 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 148.99 48.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.125 -0.985 . . . . 0.0 109.681 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.54 126.0 18.16 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.618 -0.676 . . . . 0.0 111.101 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.34 -29.21 9.82 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.789 ' CE1' HG22 ' A' ' 33' ' ' VAL . 5.5 m-85 -95.26 152.87 18.0 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.299 -1.118 . . . . 0.0 110.497 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -128.78 146.97 50.76 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.648 -0.658 . . . . 0.0 110.143 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.55 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 0.8 OUTLIER -91.82 160.87 15.1 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.435 -0.79 . . . . 0.0 110.566 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.553 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 0.5 OUTLIER -135.88 122.33 20.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.647 -0.658 . . . . 0.0 110.392 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.626 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -73.68 -42.02 61.88 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.456 -0.777 . . . . 0.0 109.38 179.189 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.8 m -63.27 -40.0 96.17 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.686 -0.634 . . . . 0.0 109.782 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.553 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 42.4 m0 -80.18 -46.07 17.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.773 -0.579 . . . . 0.0 109.5 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.7 18.45 23.01 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.51 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.8 p90 -151.38 -176.54 5.62 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.924 -1.339 . . . . 0.0 111.394 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.55 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 6.6 t -126.46 125.56 42.33 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.58 174.33 10.67 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.442 -0.786 . . . . 0.0 110.668 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.789 HG22 ' CE1' ' A' ' 22' ' ' TYR . 19.0 t . . . . . 0 N--CA 1.497 1.887 0 O-C-N 121.485 -0.759 . . . . 0.0 110.07 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 121.268 0.556 . . . . 0.0 109.976 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.486 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -81.07 -149.45 6.57 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.432 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -131.44 -140.9 4.67 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.542 ' HA ' ' CE1' ' A' ' 22' ' ' TYR . 20.6 p90 -90.51 -22.03 21.54 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.402 -1.058 . . . . 0.0 110.901 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 32.4 t90 -156.59 69.44 0.61 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.247 -0.908 . . . . 0.0 109.701 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.486 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 17.8 m0 -99.69 174.37 6.26 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.441 -0.787 . . . . 0.0 109.662 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.9 mtmm -90.15 138.52 31.45 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.955 -1.091 . . . . 0.0 110.261 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.424 ' SG ' ' HD2' ' A' ' 16' ' ' PRO . 13.9 t -150.67 162.44 40.69 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.256 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -102.27 -117.65 4.31 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.572 ' HA ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -91.25 28.99 1.51 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.42 -1.047 . . . . 0.0 110.305 179.362 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.15 32.54 5.52 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.592 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 4.8 tptt -72.22 -58.7 3.03 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.373 -1.075 . . . . 0.0 110.2 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.592 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 49.1 Cg_endo -75.85 131.89 13.78 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.701 1.369 . . . . 0.0 109.974 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.448 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 42.8 Cg_endo -71.82 100.95 1.12 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.767 1.404 . . . . 0.0 110.167 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.8 m -67.92 161.32 26.71 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.33 -0.856 . . . . 0.0 109.994 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.407 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -64.7 156.47 30.22 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.462 -0.774 . . . . 0.0 110.087 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.53 128.38 35.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.445 -0.784 . . . . 0.0 110.616 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.28 -28.0 16.19 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.542 ' CE1' ' HA ' ' A' ' 7' ' ' PHE . 88.9 m-85 -94.36 142.98 26.79 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.503 -0.998 . . . . 0.0 110.112 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.41 148.81 43.29 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.549 -0.719 . . . . 0.0 110.056 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.5 t -88.73 160.96 17.07 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.495 -0.753 . . . . 0.0 110.266 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.7 m -140.05 102.24 4.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.651 -0.656 . . . . 0.0 110.701 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.572 ' HB2' ' HA ' ' A' ' 13' ' ' ARG . 2.1 tptp -69.12 -36.31 77.35 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.311 -0.868 . . . . 0.0 109.76 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.4 m -62.26 -37.79 86.8 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.619 -0.676 . . . . 0.0 110.185 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.576 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 45.7 m0 -88.44 -50.23 6.44 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.622 -0.674 . . . . 0.0 109.952 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.54 16.08 6.66 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.209 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.576 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.4 p90 -150.51 -177.85 6.2 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.831 -1.394 . . . . 0.0 111.281 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 22.5 t -129.92 126.23 37.39 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.671 -0.643 . . . . 0.0 110.233 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.19 173.22 14.17 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.672 -0.642 . . . . 0.0 110.191 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.421 HG23 ' CE1' ' A' ' 22' ' ' TYR . 98.5 t . . . . . 0 N--CA 1.501 2.106 0 O-C-N 121.272 -0.892 . . . . 0.0 109.904 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.576 0.703 . . . . 0.0 110.239 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.47 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -92.56 -126.09 3.9 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.509 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -147.66 -142.41 3.67 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -90.57 -32.66 16.2 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.443 -1.033 . . . . 0.0 110.528 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -145.02 70.52 1.27 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.497 -0.752 . . . . 0.0 109.93 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.509 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 15.6 m0 -100.52 175.51 5.65 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.425 -0.797 . . . . 0.0 109.983 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt -89.8 138.76 31.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.133 -0.979 . . . . 0.0 110.55 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.462 ' SG ' ' HD2' ' A' ' 16' ' ' PRO . 29.1 t -151.61 161.85 41.98 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.546 -0.721 . . . . 0.0 110.38 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.56 -117.1 3.92 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.437 ' HD2' ' HB2' ' A' ' 26' ' ' LYS . 13.6 tpt180 -90.7 21.69 3.92 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.393 -1.063 . . . . 0.0 109.898 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.51 34.18 3.41 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.556 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -77.28 -54.7 1.45 Allowed Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.361 -1.082 . . . . 0.0 110.824 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 47.5 Cg_endo -74.28 132.38 16.37 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.678 1.357 . . . . 0.0 110.115 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -71.45 104.57 1.59 Allowed 'Trans proline' 0 C--N 1.314 -1.271 0 O-C-N 123.771 1.406 . . . . 0.0 110.667 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.2 m -75.26 167.2 22.37 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.404 -0.81 . . . . 0.0 109.386 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.459 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -64.37 165.1 10.2 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.25 -0.906 . . . . 0.0 110.303 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.0 126.17 27.19 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.322 -0.861 . . . . 0.0 110.195 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.44 4.97 54.7 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 87.9 m-85 -118.28 150.71 39.01 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.082 -1.246 . . . . 0.0 109.507 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -127.84 147.21 50.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.325 -0.86 . . . . 0.0 110.589 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.4 t -88.97 162.08 16.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.585 -0.697 . . . . 0.0 110.539 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.478 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 7.7 t -139.26 113.6 8.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.652 -0.655 . . . . 0.0 110.63 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.437 ' HB2' ' HD2' ' A' ' 13' ' ' ARG . 14.2 tptm -74.01 -39.83 63.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.496 -0.753 . . . . 0.0 110.213 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.3 m -65.5 -36.93 85.31 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.487 -0.758 . . . . 0.0 110.306 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.518 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 49.0 m0 -83.86 -46.9 11.64 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.613 -0.679 . . . . 0.0 110.027 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.02 19.98 10.26 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.174 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.518 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.7 p90 -150.79 -175.28 5.06 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.864 -1.374 . . . . 0.0 110.991 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 18.5 t -133.39 125.22 28.64 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.507 -0.746 . . . . 0.0 110.214 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.29 168.16 24.87 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.779 -0.575 . . . . 0.0 109.727 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 81.5 t . . . . . 0 N--CA 1.502 2.125 0 O-C-N 121.315 -0.866 . . . . 0.0 109.753 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 121.3 0.572 . . . . 0.0 110.646 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.449 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -106.44 -112.16 3.66 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.533 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -152.77 -148.98 5.01 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.436 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 3.1 t80 -89.62 -35.87 15.61 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.3 -1.118 . . . . 0.0 110.585 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -137.28 78.37 1.69 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.326 -0.859 . . . . 0.0 108.954 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.533 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 11.7 m0 -109.33 166.97 10.46 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.401 -0.812 . . . . 0.0 110.069 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.08 137.64 32.24 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.016 -1.053 . . . . 0.0 110.814 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.8 p -150.87 166.72 29.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.581 -0.7 . . . . 0.0 110.419 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.12 -118.6 3.69 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.553 ' HA ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.93 38.36 0.95 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.508 -0.995 . . . . 0.0 110.097 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.95 37.08 5.81 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.568 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 2.0 tttt -80.11 -56.55 0.72 Allowed Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.366 -1.079 . . . . 0.0 110.771 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 48.7 Cg_endo -75.94 126.39 9.33 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.647 1.341 . . . . 0.0 110.266 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.03 114.61 4.09 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.901 1.474 . . . . 0.0 110.55 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.407 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 81.1 m -83.4 -179.16 7.29 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.581 -0.699 . . . . 0.0 110.128 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.464 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.4 OUTLIER -72.42 158.64 35.38 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.261 -0.899 . . . . 0.0 110.243 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -54.99 122.47 10.98 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.454 -0.779 . . . . 0.0 110.07 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.2 -26.3 22.36 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.48 ' CE2' ' CG2' ' A' ' 33' ' ' VAL . 88.3 m-85 -89.72 135.97 33.31 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.408 -1.054 . . . . 0.0 109.492 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -123.2 148.56 45.67 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.272 -0.892 . . . . 0.0 110.34 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 7.1 t -89.04 159.49 17.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.517 -0.74 . . . . 0.0 110.251 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.403 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 2.4 m -137.41 113.41 9.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.679 -0.638 . . . . 0.0 110.465 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.553 ' HB2' ' HA ' ' A' ' 13' ' ' ARG . 3.3 ttpt -70.79 -39.76 72.96 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.531 -0.731 . . . . 0.0 109.57 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.0 m -62.05 -39.09 91.17 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.658 -0.651 . . . . 0.0 109.666 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.491 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 42.5 m0 -82.22 -41.6 20.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.727 -0.608 . . . . 0.0 109.626 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.5 14.92 33.68 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.491 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.7 p90 -151.62 -179.95 7.86 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.013 -1.287 . . . . 0.0 110.941 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 49.2 t -126.43 127.2 45.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.62 -0.675 . . . . 0.0 110.209 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -148.04 174.74 11.62 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.511 -0.743 . . . . 0.0 109.915 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.48 ' CG2' ' CE2' ' A' ' 22' ' ' TYR . 87.2 t . . . . . 0 N--CA 1.499 2.008 0 O-C-N 121.238 -0.914 . . . . 0.0 110.424 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.524 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 121.455 0.645 . . . . 0.0 110.245 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.543 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -83.93 -134.9 2.71 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.457 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -146.47 -147.11 4.5 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -77.07 -30.14 55.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.326 -1.102 . . . . 0.0 111.26 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -153.65 72.8 0.93 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.242 -0.911 . . . . 0.0 110.186 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.543 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 18.1 m0 -102.49 174.86 5.71 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.46 -0.775 . . . . 0.0 109.444 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.16 145.47 25.41 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.028 -1.045 . . . . 0.0 110.199 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.559 ' SG ' ' HG2' ' A' ' 16' ' ' PRO . 44.4 t -151.04 160.38 43.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.55 -0.719 . . . . 0.0 110.714 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.02 -123.84 4.64 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.637 ' HA ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -88.71 -37.96 15.11 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.377 -1.073 . . . . 0.0 109.789 179.391 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.02 36.2 0.13 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.641 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 5.0 mttp -89.72 -69.15 0.1 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.371 -1.076 . . . . 0.0 110.534 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.641 ' HD3' ' CB ' ' A' ' 15' ' ' LYS . 49.6 Cg_endo -77.25 113.07 3.51 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 O-C-N 123.525 1.276 . . . . 0.0 109.913 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.452 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 49.5 Cg_endo -77.24 116.47 4.16 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.834 1.439 . . . . 0.0 110.7 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.434 ' SG ' ' HB2' ' A' ' 22' ' ' TYR . 0.5 OUTLIER -68.4 157.39 35.88 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.117 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.524 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -60.7 153.1 24.93 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.083 -1.011 . . . . 0.0 110.461 -179.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -45.07 127.85 6.91 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.795 -0.566 . . . . 0.0 111.076 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.66 -29.04 10.35 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.693 ' CD1' HG22 ' A' ' 33' ' ' VAL . 4.1 m-85 -104.1 129.84 51.8 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.41 -1.053 . . . . 0.0 110.245 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -101.31 148.54 25.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.47 -0.769 . . . . 0.0 109.538 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 2.8 t -89.15 159.41 17.51 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.17 -0.956 . . . . 0.0 110.27 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.534 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 0.3 OUTLIER -143.96 121.2 11.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.585 -0.697 . . . . 0.0 111.289 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.637 ' HB2' ' HA ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -75.92 -41.43 51.85 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.536 -0.727 . . . . 0.0 109.402 178.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.6 m -58.92 -37.29 76.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.74 -0.6 . . . . 0.0 109.702 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.534 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 42.5 m0 -86.15 -37.29 18.9 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.38 16.1 47.99 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.493 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 2.6 p90 -152.01 178.15 9.74 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.001 -1.294 . . . . 0.0 110.779 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.426 ' O ' ' SG ' ' A' ' 31' ' ' CYS . 9.8 p -130.66 127.27 38.56 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.433 -0.792 . . . . 0.0 110.117 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.8 -178.22 6.33 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.682 -0.636 . . . . 0.0 110.124 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.693 HG22 ' CD1' ' A' ' 22' ' ' TYR . 24.8 t . . . . . 0 N--CA 1.503 2.184 0 O-C-N 121.222 -0.924 . . . . 0.0 110.302 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 121.28 0.562 . . . . 0.0 110.494 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.434 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -105.78 -112.27 3.68 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.549 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -151.06 -153.62 6.23 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -85.13 -33.42 22.36 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.221 -1.164 . . . . 0.0 110.706 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 16.8 t90 -142.76 75.01 1.47 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.332 -0.855 . . . . 0.0 109.593 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.549 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 14.5 m0 -104.51 166.16 10.58 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.651 -0.656 . . . . 0.0 109.447 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -90.61 136.83 32.81 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.999 -1.063 . . . . 0.0 110.568 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.1 p -150.84 171.81 16.63 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.723 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.33 -123.23 3.17 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.461 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -91.11 24.86 2.67 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.416 -1.05 . . . . 0.0 110.441 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.415 ' HA2' ' HB3' ' A' ' 24' ' ' CYS . . . 108.76 37.3 2.06 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.434 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 0.5 OUTLIER -82.43 -56.86 0.5 Allowed Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.4 -1.059 . . . . 0.0 111.062 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' A' ' 15' ' ' LYS . 46.9 Cg_endo -73.93 130.89 14.95 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 O-C-N 123.568 1.299 . . . . 0.0 110.517 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -73.14 113.06 3.68 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.785 1.413 . . . . 0.0 110.951 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.41 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 84.8 m -85.27 -178.99 6.89 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.638 -0.664 . . . . 0.0 110.221 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.93 151.78 38.86 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.235 -0.916 . . . . 0.0 110.211 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.33 115.6 2.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.703 -0.623 . . . . 0.0 110.638 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.83 -33.77 3.8 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.549 ' HD1' HG22 ' A' ' 33' ' ' VAL . 5.3 m-85 -94.7 149.99 20.67 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.507 -0.996 . . . . 0.0 110.304 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -126.19 150.05 48.59 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.569 -0.707 . . . . 0.0 109.789 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 15.9 t -89.06 158.22 18.05 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.226 -0.921 . . . . 0.0 110.395 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.1 m -141.51 131.59 24.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.651 -0.655 . . . . 0.0 110.77 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.461 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 11.6 tptp -84.73 -44.48 13.32 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.669 -0.644 . . . . 0.0 109.34 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.2 m -59.12 -38.94 80.82 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.482 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 44.3 m0 -81.88 -41.57 20.77 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.61 16.81 41.13 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.482 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 2.9 p90 -151.18 178.33 9.33 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.94 -1.329 . . . . 0.0 111.302 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 17.5 t -123.26 119.02 28.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.764 -0.585 . . . . 0.0 110.148 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.16 178.49 8.93 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.828 -0.545 . . . . 0.0 110.012 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.549 HG22 ' HD1' ' A' ' 22' ' ' TYR . 63.9 t . . . . . 0 N--CA 1.5 2.071 0 O-C-N 121.31 -0.869 . . . . 0.0 110.27 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.451 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 121.206 0.527 . . . . 0.0 110.229 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.542 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -98.02 -133.89 8.12 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.555 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -144.7 -150.76 5.29 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -85.35 -24.38 27.63 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.37 -1.077 . . . . 0.0 111.438 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.419 ' CD1' ' N ' ' A' ' 8' ' ' TRP . 17.5 p-90 -149.45 61.03 1.02 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.062 -1.024 . . . . 0.0 110.046 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.555 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 17.2 m0 -94.23 154.7 17.41 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.24 -0.912 . . . . 0.0 109.43 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -88.89 132.76 34.54 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.885 -1.135 . . . . 0.0 111.379 -178.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.436 ' HB2' ' CG ' ' A' ' 16' ' ' PRO . 31.4 p -150.87 173.66 13.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.819 -0.551 . . . . 0.0 110.28 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.38 -132.16 3.11 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.51 54.16 2.65 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.474 -1.015 . . . . 0.0 109.819 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.8 41.12 7.82 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.538 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -81.76 -61.01 0.38 Allowed Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.444 -1.033 . . . . 0.0 110.585 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.538 ' HD3' ' CB ' ' A' ' 15' ' ' LYS . 51.2 Cg_endo -76.38 140.44 21.81 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.668 1.352 . . . . 0.0 110.267 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.45 113.8 3.82 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.799 1.42 . . . . 0.0 110.779 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.418 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 0.1 OUTLIER -83.56 176.6 8.91 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.43 -0.794 . . . . 0.0 109.818 179.395 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.451 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -71.32 151.96 43.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.274 -0.892 . . . . 0.0 109.31 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.08 124.05 11.98 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.194 -0.941 . . . . 0.0 110.331 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.7 -24.84 27.41 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.461 ' CE2' ' CG2' ' A' ' 33' ' ' VAL . 85.3 m-85 -91.11 136.76 32.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.199 -1.177 . . . . 0.0 110.057 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -121.34 150.0 42.11 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.586 -0.697 . . . . 0.0 110.145 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 1.0 OUTLIER -89.46 162.39 15.76 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.322 -0.861 . . . . 0.0 110.228 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.582 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 0.4 OUTLIER -137.12 120.33 16.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.451 -0.78 . . . . 0.0 110.648 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -36.36 63.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.433 -0.792 . . . . 0.0 109.542 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.8 m -64.49 -43.29 94.61 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.672 -0.643 . . . . 0.0 109.735 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.582 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 42.2 m0 -81.83 -46.92 13.49 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.796 -0.565 . . . . 0.0 109.645 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.71 18.14 15.0 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.629 -0.989 . . . . 0.0 110.629 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.516 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.7 p90 -150.85 -175.65 5.21 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.011 -1.287 . . . . 0.0 111.194 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.602 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 46.1 t -122.58 130.88 53.49 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.536 -0.728 . . . . 0.0 110.576 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.53 174.42 10.78 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.962 -0.462 . . . . 0.0 109.98 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.461 ' CG2' ' CE2' ' A' ' 22' ' ' TYR . 97.5 t . . . . . 0 N--CA 1.5 2.059 0 O-C-N 121.224 -0.922 . . . . 0.0 110.044 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.535 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 121.208 0.528 . . . . 0.0 109.949 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.506 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -86.64 -122.63 1.48 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.485 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -151.54 -145.34 4.11 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.424 ' HE1' ' HH ' ' A' ' 22' ' ' TYR . 0.2 OUTLIER -90.41 -27.28 19.4 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.221 -1.164 . . . . 0.0 110.817 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 33.0 t90 -149.13 73.84 1.22 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.411 -0.806 . . . . 0.0 109.623 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.506 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 15.4 m0 -104.56 159.05 16.07 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.456 -0.778 . . . . 0.0 109.428 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 1.9 mptt -90.7 132.99 35.48 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.852 -1.155 . . . . 0.0 111.311 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 23.7 p -150.82 170.35 19.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.61 -0.681 . . . . 0.0 110.604 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -117.58 1.87 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.574 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.73 41.48 1.06 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.533 -0.98 . . . . 0.0 110.176 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.17 33.4 17.7 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.595 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 0.2 OUTLIER -69.57 -55.27 9.56 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.247 -1.149 . . . . 0.0 110.489 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 47.9 Cg_endo -74.38 135.87 20.98 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 O-C-N 123.586 1.308 . . . . 0.0 109.729 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.42 107.39 2.27 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.704 1.371 . . . . 0.0 110.986 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.46 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 0.1 OUTLIER -74.88 174.99 8.49 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.346 -0.846 . . . . 0.0 109.327 179.072 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.535 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 2.2 m -80.22 147.11 31.38 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.931 -1.106 . . . . 0.0 108.799 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -44.78 127.51 6.32 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.466 -0.771 . . . . 0.0 111.278 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.6 -25.81 21.75 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.827 ' CD1' HG22 ' A' ' 33' ' ' VAL . 7.9 m-30 -99.33 136.64 38.98 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.079 -1.248 . . . . 0.0 110.19 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -118.29 149.79 40.56 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.413 -0.804 . . . . 0.0 109.778 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.702 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 0.8 OUTLIER -89.28 160.07 17.08 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.353 -0.842 . . . . 0.0 110.694 -179.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.4 m -132.56 110.84 10.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.582 -0.699 . . . . 0.0 110.517 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.574 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 39.7 tptt -68.86 -36.8 78.55 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.478 -0.764 . . . . 0.0 110.061 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.9 m -66.27 -37.69 86.05 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.637 -0.665 . . . . 0.0 109.921 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.524 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 42.7 m0 -86.07 -48.17 8.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.717 -0.614 . . . . 0.0 109.949 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.24 16.35 12.44 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.186 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.524 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.0 p90 -150.87 179.46 8.21 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.717 -1.461 . . . . 0.0 111.426 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.702 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 49.1 t -121.39 128.99 52.77 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.633 -0.667 . . . . 0.0 110.028 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -146.9 174.86 11.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.711 -0.618 . . . . 0.0 110.087 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.827 HG22 ' CD1' ' A' ' 22' ' ' TYR . 12.5 t . . . . . 0 N--CA 1.498 1.954 0 O-C-N 121.371 -0.831 . . . . 0.0 109.875 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 121.312 0.577 . . . . 0.0 110.025 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.542 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -81.48 -128.84 0.99 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.457 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -146.77 -140.13 3.39 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.56 -33.5 15.87 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.288 -1.125 . . . . 0.0 110.769 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -146.75 68.31 1.17 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.405 -0.81 . . . . 0.0 109.788 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.542 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 18.1 m0 -94.92 161.83 13.99 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.453 -0.78 . . . . 0.0 109.844 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 1.2 mttp -89.68 136.54 32.97 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.108 -0.995 . . . . 0.0 111.062 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.1 p -151.06 156.52 41.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.702 -0.624 . . . . 0.0 110.172 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.92 -118.45 0.84 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.45 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.86 34.04 0.92 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.414 -1.05 . . . . 0.0 110.001 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.51 39.72 3.37 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.486 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 3.8 mtpt -77.81 -58.74 0.86 Allowed Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.368 -1.078 . . . . 0.0 110.814 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.486 ' HD3' ' CB ' ' A' ' 15' ' ' LYS . 46.5 Cg_endo -74.56 136.9 22.03 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 O-C-N 123.652 1.343 . . . . 0.0 110.369 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.94 115.8 4.48 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.934 1.492 . . . . 0.0 110.701 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.467 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 96.1 m -84.91 -179.42 7.07 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.395 -0.816 . . . . 0.0 110.168 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.515 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 2.1 m -88.28 165.81 14.75 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.357 -0.839 . . . . 0.0 110.238 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp -58.18 124.77 20.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.388 -0.82 . . . . 0.0 110.223 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.8 -25.79 27.03 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.488 ' CD1' ' HB2' ' A' ' 19' ' ' CYS . 80.0 m-85 -92.13 133.44 35.77 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.552 -0.969 . . . . 0.0 110.066 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.92 145.27 47.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.543 -0.723 . . . . 0.0 109.89 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 9.1 t -88.82 160.34 17.29 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.581 -0.699 . . . . 0.0 110.089 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.413 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 2.5 m -142.6 122.9 13.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.587 -0.696 . . . . 0.0 111.208 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.45 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -73.77 -41.35 62.56 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.1 m -61.98 -40.28 95.07 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.692 -0.63 . . . . 0.0 109.599 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.497 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 34.9 m0 -80.28 -38.43 30.82 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.61 14.84 56.29 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.497 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 2.5 p90 -151.94 176.72 11.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.987 -1.302 . . . . 0.0 111.021 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 37.3 t -124.28 125.89 45.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.516 -0.74 . . . . 0.0 110.118 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.53 -178.25 5.99 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.671 -0.643 . . . . 0.0 109.785 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.428 HG23 ' CE2' ' A' ' 22' ' ' TYR . 98.6 t . . . . . 0 N--CA 1.501 2.087 0 O-C-N 121.138 -0.976 . . . . 0.0 110.155 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 121.303 0.573 . . . . 0.0 110.47 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.95 -122.45 3.79 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.552 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -151.31 -150.08 5.23 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 30.0 t80 -81.32 -42.68 20.21 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.316 -1.108 . . . . 0.0 110.824 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 8.8 t90 -136.98 74.85 1.5 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.397 -0.814 . . . . 0.0 109.944 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.552 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 13.5 m0 -102.44 173.92 6.14 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.619 -0.676 . . . . 0.0 109.744 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.05 139.17 30.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.019 -1.051 . . . . 0.0 110.242 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.402 ' SG ' ' HD2' ' A' ' 16' ' ' PRO . 43.2 t -151.08 160.75 43.7 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.474 -0.766 . . . . 0.0 110.209 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.43 -116.43 3.73 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.617 ' HA ' ' HB3' ' A' ' 26' ' ' LYS . 7.6 mmt180 -90.5 29.19 1.33 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.312 -1.11 . . . . 0.0 110.122 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.77 34.69 4.28 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.512 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -76.73 -59.99 0.9 Allowed Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.308 -1.113 . . . . 0.0 110.105 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.512 ' HD3' ' CB ' ' A' ' 15' ' ' LYS . 47.5 Cg_endo -75.13 128.67 11.57 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.654 1.344 . . . . 0.0 110.081 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.52 111.61 3.01 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.852 1.449 . . . . 0.0 110.588 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 79.3 m -83.72 161.64 20.96 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.606 -0.684 . . . . 0.0 110.018 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.484 ' HB2' ' CD2' ' A' ' 22' ' ' TYR . 0.1 OUTLIER -62.25 150.15 39.9 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.522 -0.736 . . . . 0.0 110.653 -179.74 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.39 123.11 12.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.602 -0.686 . . . . 0.0 110.269 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.11 -26.66 11.07 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.769 ' CE1' HG22 ' A' ' 33' ' ' VAL . 11.4 m-30 -89.21 160.52 16.91 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.378 -1.072 . . . . 0.0 109.809 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.19 144.68 50.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.457 -0.777 . . . . 0.0 110.308 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.4 ' SG ' ' N ' ' A' ' 25' ' ' SER . 25.7 t -89.57 162.62 15.57 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.624 -0.673 . . . . 0.0 110.271 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.4 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 15.6 m -138.9 94.68 2.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.409 -0.807 . . . . 0.0 110.81 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.617 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -61.58 -32.02 72.1 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.221 -0.925 . . . . 0.0 110.323 179.278 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.5 m -72.1 -38.58 69.3 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.583 -0.698 . . . . 0.0 110.186 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.56 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 46.2 m0 -82.96 -48.19 10.94 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.631 -0.668 . . . . 0.0 109.638 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.36 15.53 9.62 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.206 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.56 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.0 p90 -150.95 178.7 8.91 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.758 -1.437 . . . . 0.0 110.995 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 9.2 t -127.62 130.43 48.97 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.657 -0.652 . . . . 0.0 109.758 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -149.89 179.75 7.79 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.497 -0.752 . . . . 0.0 110.781 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.769 HG22 ' CE1' ' A' ' 22' ' ' TYR . 39.0 t . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.452 -0.78 . . . . 0.0 110.021 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 121.497 0.665 . . . . 0.0 110.572 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.465 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -113.24 -106.53 2.77 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.553 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -152.7 -161.22 10.12 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 36.5 p90 -82.56 -19.81 37.79 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.347 -1.09 . . . . 0.0 111.219 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 22.8 t90 -154.44 72.59 0.87 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.28 -0.888 . . . . 0.0 109.637 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.553 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 17.6 m0 -104.41 169.2 8.61 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.471 -0.768 . . . . 0.0 110.151 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -91.32 136.67 32.94 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.193 -0.942 . . . . 0.0 110.607 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.4 p -150.77 156.71 41.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.489 -0.757 . . . . 0.0 110.426 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.32 -117.72 1.63 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.588 ' HA ' ' HB3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.4 50.82 1.9 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.419 -1.048 . . . . 0.0 109.906 179.425 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.61 38.19 21.35 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.493 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -77.46 -60.03 0.78 Allowed Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.383 -1.069 . . . . 0.0 110.707 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.493 ' HD3' ' CB ' ' A' ' 15' ' ' LYS . 47.3 Cg_endo -75.07 131.95 14.79 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 123.615 1.324 . . . . 0.0 110.273 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.21 119.69 5.93 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.833 1.438 . . . . 0.0 110.653 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -89.47 171.18 9.9 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.597 -0.689 . . . . 0.0 110.095 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.23 149.36 49.61 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.371 -0.831 . . . . 0.0 110.243 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.99 109.13 0.38 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.687 -0.633 . . . . 0.0 110.401 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.84 -39.24 1.82 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.804 ' CD1' HG22 ' A' ' 33' ' ' VAL . 4.6 m-85 -90.99 141.83 28.42 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.42 -1.047 . . . . 0.0 110.001 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -118.54 150.87 38.9 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.547 -0.721 . . . . 0.0 110.234 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 10.8 t -89.61 160.61 16.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.42 -0.8 . . . . 0.0 110.224 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.407 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 56.7 m -135.03 105.22 6.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.572 -0.705 . . . . 0.0 110.966 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.588 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -66.12 -31.61 72.56 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.458 -0.776 . . . . 0.0 110.064 179.211 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.543 ' N ' ' HG2' ' A' ' 26' ' ' LYS . 54.6 m -67.05 -39.9 87.03 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.696 -0.627 . . . . 0.0 110.168 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.629 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 43.4 m0 -86.76 -48.6 8.1 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.601 -0.687 . . . . 0.0 109.842 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.44 14.89 8.58 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.629 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.1 p90 -151.5 177.37 10.38 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.925 -1.338 . . . . 0.0 111.057 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 8.2 t -126.0 130.57 51.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.456 -0.777 . . . . 0.0 110.204 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -147.71 -172.22 3.99 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.597 -0.689 . . . . 0.0 110.184 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.804 HG22 ' CD1' ' A' ' 22' ' ' TYR . 10.6 t . . . . . 0 N--CA 1.5 2.027 0 O-C-N 121.35 -0.843 . . . . 0.0 110.022 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.909 0 CA-C-O 121.163 0.506 . . . . 0.0 109.906 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.473 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -101.25 -124.28 5.35 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.539 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -150.29 -154.77 6.57 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -77.8 -36.14 50.63 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.212 -1.169 . . . . 0.0 110.962 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 38.7 t90 -142.8 77.58 1.58 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.408 -0.808 . . . . 0.0 109.856 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.539 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 15.3 m0 -105.66 156.68 18.04 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.545 -0.722 . . . . 0.0 109.169 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.46 132.13 35.17 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.868 -1.145 . . . . 0.0 111.119 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.8 p -150.83 167.8 26.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.715 -0.615 . . . . 0.0 110.214 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.46 -121.18 0.54 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.591 ' HG3' ' HD3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.5 25.56 2.24 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.455 -1.026 . . . . 0.0 110.329 179.211 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.73 34.05 3.65 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.58 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 1.5 tptt -69.85 -54.47 10.15 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.276 -1.132 . . . . 0.0 109.975 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 50.1 Cg_endo -77.22 132.63 12.71 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 O-C-N 123.763 1.401 . . . . 0.0 109.716 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.47 119.07 6.06 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.781 1.411 . . . . 0.0 110.75 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.402 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 94.9 m -84.14 -178.78 7.06 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.582 -0.698 . . . . 0.0 110.035 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.515 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -75.24 164.58 26.31 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.332 -0.855 . . . . 0.0 110.132 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.58 119.96 9.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.467 -0.771 . . . . 0.0 110.267 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.24 0.88 54.17 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 36.9 m-85 -112.55 133.38 54.63 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.117 -1.225 . . . . 0.0 109.677 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -119.58 144.71 46.94 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.394 -0.816 . . . . 0.0 110.496 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.559 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 0.8 OUTLIER -89.11 160.82 16.84 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.513 -0.742 . . . . 0.0 110.017 179.664 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 m -136.69 125.42 23.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.434 -0.792 . . . . 0.0 110.636 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.591 ' HD3' ' HG3' ' A' ' 13' ' ' ARG . 9.9 ttpt -76.55 -40.55 49.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.517 -0.739 . . . . 0.0 109.244 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.8 m -65.2 -38.68 91.22 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.738 -0.601 . . . . 0.0 109.623 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.462 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 42.8 m0 -81.49 -45.29 16.19 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.644 -0.66 . . . . 0.0 109.456 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.72 16.28 31.72 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.462 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.5 p90 -151.21 -179.11 7.06 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.903 -1.351 . . . . 0.0 111.359 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.559 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 8.4 t -121.7 128.39 51.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.676 -0.64 . . . . 0.0 110.447 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.41 165.54 30.81 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.753 -0.592 . . . . 0.0 110.143 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 67.2 t . . . . . 0 N--CA 1.497 1.918 0 O-C-N 121.249 -0.907 . . . . 0.0 110.175 -179.94 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.485 0.66 . . . . 0.0 110.433 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -111.9 -99.2 2.45 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.552 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -149.14 -154.95 6.52 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.578 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 12.2 m-85 -90.9 -30.26 17.01 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.418 -1.049 . . . . 0.0 110.484 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -142.65 68.87 1.31 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.511 -0.743 . . . . 0.0 109.44 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.552 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 17.3 m0 -99.25 154.14 18.4 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.366 -0.834 . . . . 0.0 109.786 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -88.48 134.93 33.71 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.042 -1.036 . . . . 0.0 111.133 -179.307 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.498 ' CB ' ' HG2' ' A' ' 16' ' ' PRO . 31.3 p -150.72 177.05 10.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.589 -0.694 . . . . 0.0 110.528 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.79 -120.28 0.45 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.447 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -87.71 -38.47 15.8 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.454 -1.027 . . . . 0.0 109.56 179.02 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -174.05 37.88 0.12 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.6 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 1.7 mtpm? -72.45 -69.7 0.32 Allowed Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 121.44 -1.035 . . . . 0.0 110.813 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.6 ' CD ' ' CB ' ' A' ' 15' ' ' LYS . 48.4 Cg_endo -74.02 125.36 9.79 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.391 1.206 . . . . 0.0 109.9 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -74.3 103.89 1.76 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.894 1.47 . . . . 0.0 111.495 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 t -64.95 164.87 11.83 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.554 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -53.02 149.62 6.43 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.96 -1.087 . . . . 0.0 110.621 -179.489 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -50.21 120.64 4.67 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.626 -0.671 . . . . 0.0 110.011 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.83 -25.48 10.85 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.768 ' CE2' HG23 ' A' ' 33' ' ' VAL . 31.0 m-85 -99.71 132.88 44.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.514 -0.992 . . . . 0.0 109.229 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -114.64 154.92 27.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.269 -0.894 . . . . 0.0 110.243 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 31' ' ' CYS . 0.9 OUTLIER -89.18 151.19 22.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.444 -0.785 . . . . 0.0 109.58 179.703 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.512 ' CB ' ' HB2' ' A' ' 28' ' ' TRP . 3.1 m -125.44 130.68 52.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.448 -0.783 . . . . 0.0 110.739 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.447 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 0.5 OUTLIER -75.25 -42.46 55.11 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.523 -0.736 . . . . 0.0 109.351 179.136 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.1 m -68.19 -38.13 81.66 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.87 -0.519 . . . . 0.0 109.819 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.512 ' HB2' ' CB ' ' A' ' 25' ' ' SER . 38.0 m0 -79.35 -46.3 17.92 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.596 -0.69 . . . . 0.0 109.453 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.45 17.92 34.88 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.528 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 2.9 p90 -151.35 178.26 9.45 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.025 -1.279 . . . . 0.0 111.091 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.668 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 2.4 p -119.32 123.6 44.59 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.918 0.866 . . . . 0.0 110.202 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.475 ' HA ' ' HD2' ' A' ' 22' ' ' TYR . . . -150.72 -179.69 7.47 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.768 HG23 ' CE2' ' A' ' 22' ' ' TYR . 92.5 t . . . . . 0 N--CA 1.498 1.975 0 O-C-N 121.091 -1.006 . . . . 0.0 109.751 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.532 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 121.065 0.459 . . . . 0.0 110.121 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.495 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -80.36 -120.66 0.42 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.486 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -152.91 -142.68 3.52 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.505 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 48.8 t80 -90.27 -38.72 13.22 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.462 -1.023 . . . . 0.0 110.71 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -139.11 74.24 1.46 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.278 -0.889 . . . . 0.0 109.672 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.495 ' CZ3' ' HA2' ' A' ' 5' ' ' GLY . 13.9 m0 -102.09 155.25 18.31 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.457 -0.777 . . . . 0.0 109.487 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -89.71 132.89 34.95 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.91 -1.119 . . . . 0.0 111.56 -179.013 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.499 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 27.8 p -151.57 174.72 13.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.788 -0.57 . . . . 0.0 110.382 178.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.4 -114.97 3.08 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.615 ' HD3' ' HD3' ' A' ' 26' ' ' LYS . 30.5 tpt180 -90.59 38.08 0.93 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.521 -0.988 . . . . 0.0 109.701 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.25 35.13 7.16 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.528 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -66.7 -59.86 7.33 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 121.514 -0.992 . . . . 0.0 110.044 179.68 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 48.0 Cg_endo -74.69 139.01 24.62 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 O-C-N 123.774 1.408 . . . . 0.0 110.037 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.4 115.66 4.37 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.927 1.488 . . . . 0.0 110.947 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.432 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 95.1 m -84.97 176.26 8.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.49 -0.757 . . . . 0.0 110.02 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.57 ' HB2' ' CD1' ' A' ' 22' ' ' TYR . 3.7 m -86.55 165.43 16.22 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.213 -0.93 . . . . 0.0 109.957 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -56.33 126.75 27.66 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.411 -0.805 . . . . 0.0 111.059 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.32 -24.07 33.72 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.57 ' CD1' ' HB2' ' A' ' 19' ' ' CYS . 78.7 m-85 -95.83 129.01 43.19 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.279 -1.13 . . . . 0.0 110.238 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -118.42 150.79 38.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.64 -0.663 . . . . 0.0 109.866 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.513 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 0.9 OUTLIER -89.35 158.68 17.69 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.361 -0.837 . . . . 0.0 110.553 -179.725 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.37 113.95 12.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.467 -0.771 . . . . 0.0 110.737 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.615 ' HD3' ' HD3' ' A' ' 13' ' ' ARG . 12.0 tttt -70.55 -36.56 73.73 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.456 -0.778 . . . . 0.0 109.763 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.5 m -61.54 -42.02 98.2 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.549 -0.72 . . . . 0.0 109.904 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.59 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 47.7 m0 -85.75 -56.85 3.29 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.738 -0.601 . . . . 0.0 109.516 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.12 20.77 4.33 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.185 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.59 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.8 p90 -151.11 -174.66 4.88 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 119.064 1.432 . . . . 0.0 111.519 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.513 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 6.5 t -128.13 127.49 43.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.689 -0.632 . . . . 0.0 110.29 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -150.49 174.19 13.22 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.239 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 N--CA 1.498 1.957 0 O-C-N 121.361 -0.837 . . . . 0.0 110.122 179.901 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 121.326 0.584 . . . . 0.0 110.037 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.487 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -105.01 -109.3 3.4 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.545 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -153.56 -159.37 9.09 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 71.2 t80 -80.74 -33.21 35.3 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.554 -0.968 . . . . 0.0 110.616 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 30.3 t90 -141.98 78.41 1.63 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.297 -0.877 . . . . 0.0 109.931 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.545 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 14.0 m0 -108.2 156.26 19.54 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.548 -0.72 . . . . 0.0 109.374 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -89.63 134.32 34.2 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.794 -1.191 . . . . 0.0 111.067 -179.271 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.554 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 21.4 p -151.06 166.78 29.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.673 -0.642 . . . . 0.0 110.305 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.07 -111.88 1.08 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.478 ' HG3' ' HB3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.73 29.08 1.38 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.47 -1.018 . . . . 0.0 109.87 179.1 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.09 35.36 4.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.519 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -63.97 -61.09 7.42 Favored Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.313 -1.11 . . . . 0.0 110.363 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' A' ' 11' ' ' CYS . 47.9 Cg_endo -74.71 129.23 12.41 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.643 1.338 . . . . 0.0 109.72 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.47 114.91 4.08 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.692 1.364 . . . . 0.0 110.175 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.423 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 73.4 m -82.02 171.72 14.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.519 -0.738 . . . . 0.0 110.145 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.89 148.46 49.38 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.304 -0.873 . . . . 0.0 109.862 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.49 133.4 24.94 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.556 -0.715 . . . . 0.0 110.981 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.0 -27.77 18.94 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.913 ' CE1' HG22 ' A' ' 33' ' ' VAL . 12.5 m-30 -90.72 154.23 19.7 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.425 -1.044 . . . . 0.0 110.124 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -136.3 151.69 49.89 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.542 -0.724 . . . . 0.0 109.912 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.497 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 0.8 OUTLIER -89.81 162.92 15.26 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.299 -0.876 . . . . 0.0 110.045 179.798 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.562 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 0.6 OUTLIER -131.6 101.19 5.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.502 -0.749 . . . . 0.0 110.457 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.478 ' HB3' ' HG3' ' A' ' 13' ' ' ARG . 11.2 pttm -60.36 -33.55 72.6 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.606 -0.684 . . . . 0.0 110.186 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.7 m -70.51 -39.86 73.85 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.618 -0.676 . . . . 0.0 110.235 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.562 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 46.6 m0 -82.64 -52.31 6.92 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.588 -0.695 . . . . 0.0 109.804 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.42 18.55 6.58 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 5.0 p90 -151.13 -170.6 3.7 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.753 -1.44 . . . . 0.0 111.464 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.497 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 8.9 t -132.87 130.98 40.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.604 -0.685 . . . . 0.0 110.414 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -149.4 -175.93 5.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.666 -0.646 . . . . 0.0 109.921 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.913 HG22 ' CE1' ' A' ' 22' ' ' TYR . 12.5 t . . . . . 0 N--CA 1.5 2.057 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.561 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 121.139 0.495 . . . . 0.0 109.961 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.447 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -86.44 -126.34 1.96 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.551 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -145.77 -148.67 4.84 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.426 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 44.7 t80 -86.55 -27.3 24.03 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.343 -1.092 . . . . 0.0 110.855 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -151.06 68.69 0.94 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.432 -0.793 . . . . 0.0 109.833 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.551 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 16.9 m0 -96.64 160.31 14.45 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.454 -0.779 . . . . 0.0 109.629 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -90.14 130.84 36.24 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.999 -1.063 . . . . 0.0 111.391 -179.076 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.406 ' HB2' ' CD ' ' A' ' 16' ' ' PRO . 29.7 p -151.73 179.39 8.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.762 -0.586 . . . . 0.0 110.522 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.61 -121.42 4.61 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.72 53.39 2.4 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.554 -0.968 . . . . 0.0 109.899 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.437 ' HA2' ' HB2' ' A' ' 24' ' ' CYS . . . 77.93 37.81 28.48 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.547 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 0.3 OUTLIER -71.09 -58.37 4.11 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.493 -1.004 . . . . 0.0 110.199 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.547 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 48.4 Cg_endo -76.42 143.42 24.71 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 O-C-N 123.736 1.388 . . . . 0.0 109.958 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.422 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 48.8 Cg_endo -73.9 99.06 1.12 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.757 1.398 . . . . 0.0 110.762 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.418 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 0.1 OUTLIER -69.67 177.04 3.18 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.266 -0.896 . . . . 0.0 109.376 179.229 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.561 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 2.7 m -81.16 161.61 23.98 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.137 -0.977 . . . . 0.0 109.654 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -55.95 120.46 7.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.391 -0.818 . . . . 0.0 110.457 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.0 -14.72 44.63 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.523 ' CD1' ' HB2' ' A' ' 19' ' ' CYS . 66.8 m-85 -102.59 131.63 49.22 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.051 -1.264 . . . . 0.0 110.122 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -117.45 147.36 42.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.57 -0.706 . . . . 0.0 110.24 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 1.1 m -89.36 159.26 17.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.415 -0.803 . . . . 0.0 110.065 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 2.0 m -130.22 117.77 20.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.576 -0.703 . . . . 0.0 110.483 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -69.82 -37.63 76.31 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.551 -0.718 . . . . 0.0 109.751 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.3 m -71.83 -39.73 69.58 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.625 -0.672 . . . . 0.0 110.255 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.571 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 43.9 m0 -78.9 -48.69 14.14 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.555 -0.716 . . . . 0.0 109.803 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.54 18.08 15.47 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.571 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.5 p90 -150.85 -179.23 7.1 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.856 -1.379 . . . . 0.0 111.157 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.629 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 22.8 t -123.91 129.94 51.79 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.662 -0.649 . . . . 0.0 110.232 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.12 169.65 19.53 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.787 -0.571 . . . . 0.0 110.135 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.461 ' CG2' ' CE2' ' A' ' 22' ' ' TYR . 59.4 t . . . . . 0 N--CA 1.501 2.081 0 O-C-N 121.445 -0.784 . . . . 0.0 110.443 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.545 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.91 0 CA-C-O 121.201 0.524 . . . . 0.0 109.926 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.437 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -94.76 -120.89 3.44 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.524 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -144.97 -149.6 5.06 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -88.44 -17.28 30.75 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.305 -1.115 . . . . 0.0 110.685 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 -160.06 68.06 0.38 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.322 -0.861 . . . . 0.0 110.07 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.524 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 20.2 m0 -96.81 173.69 7.18 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.401 -0.812 . . . . 0.0 110.087 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -94.81 133.31 38.65 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.185 -0.947 . . . . 0.0 110.945 -179.486 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 24.8 p -150.75 159.38 44.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.606 -0.684 . . . . 0.0 110.47 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -93.61 -118.0 2.76 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.551 ' HB2' ' HD2' ' A' ' 26' ' ' LYS . 0.3 OUTLIER -90.78 43.01 1.13 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.528 -0.984 . . . . 0.0 109.723 179.388 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.95 39.92 5.36 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.569 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 6.4 mttt -76.89 -64.0 0.49 Allowed Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.431 -1.041 . . . . 0.0 110.023 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.569 ' CD ' ' CB ' ' A' ' 15' ' ' LYS . 48.5 Cg_endo -74.39 133.64 17.85 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 O-C-N 123.579 1.305 . . . . 0.0 109.633 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.26 111.51 3.3 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.678 1.357 . . . . 0.0 110.319 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.4 m -77.39 179.2 6.59 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.402 -0.811 . . . . 0.0 110.101 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.545 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 2.7 m -87.4 150.81 23.56 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.382 -0.824 . . . . 0.0 110.078 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.16 118.78 3.46 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.607 -0.683 . . . . 0.0 110.532 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.29 -35.98 3.69 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.792 ' CD1' HG22 ' A' ' 33' ' ' VAL . 5.6 m-85 -93.66 152.16 19.17 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.35 -1.088 . . . . 0.0 110.069 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -126.27 146.74 49.88 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.648 -0.658 . . . . 0.0 110.178 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 13.4 t -89.75 159.84 16.85 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.457 -0.777 . . . . 0.0 110.331 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.6 m -140.75 116.69 10.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.653 -0.655 . . . . 0.0 110.559 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.551 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -73.72 -39.25 64.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.419 -0.801 . . . . 0.0 109.19 179.051 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.1 m -62.85 -40.59 97.93 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.555 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 40.5 m0 -79.98 -38.83 31.39 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.26 13.97 50.02 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.555 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.3 p90 -150.92 177.03 10.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.903 -1.351 . . . . 0.0 111.273 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 31.2 t -126.08 121.88 34.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.752 -0.592 . . . . 0.0 109.714 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.75 -178.26 5.34 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.541 -0.725 . . . . 0.0 110.046 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.792 HG22 ' CD1' ' A' ' 22' ' ' TYR . 21.5 t . . . . . 0 N--CA 1.499 2.014 0 O-C-N 121.272 -0.892 . . . . 0.0 110.188 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 121.36 0.6 . . . . 0.0 110.218 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.47 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -95.72 -129.02 5.77 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.53 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -147.22 -153.73 6.0 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 77.5 t80 -79.66 -29.63 40.95 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.346 -1.091 . . . . 0.0 110.899 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -149.21 74.92 1.27 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.18 -0.95 . . . . 0.0 109.883 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.53 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 16.3 m0 -105.05 178.32 4.59 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.666 -0.646 . . . . 0.0 109.377 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.98 133.52 35.22 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.93 -1.106 . . . . 0.0 110.778 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.581 ' SG ' ' HD2' ' A' ' 16' ' ' PRO . 40.7 t -151.69 162.36 41.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.653 -0.654 . . . . 0.0 110.372 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -102.57 -119.01 4.52 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 108.889 -1.685 . . . . 0.0 108.889 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.553 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -91.15 31.24 1.13 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.322 -1.105 . . . . 0.0 110.129 179.153 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.83 36.77 3.61 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.537 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -76.57 -63.92 0.53 Allowed Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.372 -1.075 . . . . 0.0 110.557 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.581 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 44.1 Cg_endo -71.18 135.28 26.77 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.729 1.384 . . . . 0.0 110.042 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.439 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 45.5 Cg_endo -71.88 100.97 1.13 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.81 1.426 . . . . 0.0 110.844 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.0 m -72.77 169.25 17.11 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.342 -0.848 . . . . 0.0 109.216 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.2 147.9 46.35 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.941 -1.1 . . . . 0.0 110.025 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.55 119.81 4.52 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.638 -0.663 . . . . 0.0 110.571 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.26 -22.61 17.63 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.867 ' CE1' HG22 ' A' ' 33' ' ' VAL . 12.4 m-30 -89.07 157.95 18.15 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.416 -1.05 . . . . 0.0 109.974 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -133.29 151.32 51.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.506 -0.746 . . . . 0.0 109.917 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.3 m -89.12 167.17 13.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.506 -0.746 . . . . 0.0 110.694 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.492 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 17.3 m -132.66 102.21 5.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.613 -0.679 . . . . 0.0 110.324 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.553 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 1.8 ttpt -65.09 -31.42 72.63 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.555 -0.716 . . . . 0.0 110.841 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.9 m -82.92 -36.13 25.5 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.435 -0.79 . . . . 0.0 110.873 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.588 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 45.0 m0 -79.95 -42.63 23.62 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.477 -0.765 . . . . 0.0 110.236 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.07 16.88 22.18 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.498 -0.858 . . . . 0.0 110.976 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.588 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 2.8 p90 -150.59 178.82 8.71 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.107 -1.231 . . . . 0.0 110.822 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 22.6 t -121.01 135.88 55.11 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.548 -0.72 . . . . 0.0 109.786 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -146.03 -179.59 6.82 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.436 -0.79 . . . . 0.0 110.242 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.867 HG22 ' CE1' ' A' ' 22' ' ' TYR . 11.9 t . . . . . 0 N--CA 1.498 1.956 0 O-C-N 121.388 -0.82 . . . . 0.0 109.802 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 121.431 0.634 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -66.89 139.96 37.39 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.39 153.73 41.29 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.613 -0.934 . . . . 0.0 110.367 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.643 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -134.17 153.22 51.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.485 -0.759 . . . . 0.0 109.879 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.421 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -92.13 -118.32 2.41 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.492 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -147.55 -143.1 3.78 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -90.68 -37.78 13.51 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.296 -1.12 . . . . 0.0 110.59 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.82 70.49 1.35 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.513 -0.742 . . . . 0.0 109.808 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.492 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 16.7 m0 -96.85 166.19 11.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.36 -0.838 . . . . 0.0 109.734 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -92.12 134.74 34.57 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.166 -0.958 . . . . 0.0 110.919 -179.55 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 31.2 p -151.07 159.03 44.76 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.579 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.82 -115.89 1.0 Allowed Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.554 ' HG3' ' HB3' ' A' ' 26' ' ' LYS . 1.0 OUTLIER -90.66 29.58 1.29 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.435 -1.038 . . . . 0.0 110.044 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.92 38.68 3.31 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.594 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -74.16 -57.34 2.31 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.406 -1.055 . . . . 0.0 110.572 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 46.9 Cg_endo -74.58 134.99 19.3 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 O-C-N 123.719 1.378 . . . . 0.0 109.975 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -71.84 105.77 1.87 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.92 1.484 . . . . 0.0 110.693 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.0 m -74.79 176.57 6.92 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.397 -0.814 . . . . 0.0 109.761 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.643 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 3.1 m -81.2 161.9 23.81 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.28 -0.887 . . . . 0.0 110.301 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -56.24 125.66 22.77 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.562 -0.711 . . . . 0.0 110.543 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.6 -18.73 54.71 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.52 ' CD1' ' HB2' ' A' ' 19' ' ' CYS . 52.8 m-85 -94.58 142.47 27.4 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.253 -1.145 . . . . 0.0 110.153 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.426 ' HB3' ' HG2' ' A' ' 34' ' ' GLU . . . -124.82 140.81 52.59 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.426 -0.796 . . . . 0.0 110.349 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 14.1 t -89.44 159.56 17.22 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.51 -0.744 . . . . 0.0 110.158 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -138.14 123.27 19.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.62 -0.675 . . . . 0.0 111.031 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.554 ' HB3' ' HG3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -76.63 -35.12 58.24 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.658 -0.651 . . . . 0.0 110.003 179.157 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.4 m -69.99 -38.75 76.1 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.46 -0.775 . . . . 0.0 109.389 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.528 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 40.3 m0 -80.02 -40.85 26.94 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.48 16.37 43.3 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.528 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.0 p90 -151.0 177.84 9.77 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.999 -1.295 . . . . 0.0 111.021 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 25.2 t -127.27 128.37 45.88 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.698 -0.626 . . . . 0.0 110.235 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.48 172.83 14.34 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.605 -0.684 . . . . 0.0 110.096 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.444 HG23 ' CE2' ' A' ' 22' ' ' TYR . 99.1 t -58.89 138.53 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.389 -0.82 . . . . 0.0 110.018 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.426 ' HG2' ' HB3' ' A' ' 23' ' ' ALA . 0.9 OUTLIER -84.59 72.45 10.67 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.591 -0.693 . . . . 0.0 110.252 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.8 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -70.59 -54.55 8.29 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.491 -0.756 . . . . 0.0 110.377 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.8 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 46.3 Cg_endo . . . . . 0 C--N 1.318 -1.034 0 O-C-N 123.551 1.29 . . . . 0.0 110.69 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.1 t70 . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 121.227 0.537 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 113.61 -137.98 14.57 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -145.2 50.92 1.22 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.475 -1.015 . . . . 0.0 110.222 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.442 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -148.65 154.9 40.32 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.39 -0.819 . . . . 0.0 109.958 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.565 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -78.84 -142.87 2.31 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.5 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -142.7 -151.48 5.5 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -76.92 -29.33 55.63 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.34 -1.094 . . . . 0.0 111.059 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -153.83 69.97 0.81 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.315 -0.866 . . . . 0.0 110.233 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.565 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 20.8 m0 -98.62 176.07 5.77 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.494 -0.754 . . . . 0.0 109.704 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.77 138.93 31.06 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.143 -0.973 . . . . 0.0 110.393 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.4 ' SG ' ' HD2' ' A' ' 16' ' ' PRO . 33.6 t -150.99 161.01 43.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.541 -0.724 . . . . 0.0 110.442 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -103.49 -121.43 4.93 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.556 ' HA ' ' HB3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.71 37.37 0.92 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.364 -1.08 . . . . 0.0 110.347 179.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.17 34.55 7.09 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.585 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 1.4 tptp -77.58 -58.97 0.87 Allowed Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.319 -1.107 . . . . 0.0 110.19 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 47.2 Cg_endo -75.07 133.4 16.43 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.694 1.365 . . . . 0.0 110.018 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.63 104.93 1.68 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 O-C-N 123.899 1.473 . . . . 0.0 110.589 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.2 m -72.38 166.36 22.7 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.414 -0.804 . . . . 0.0 109.728 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.442 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -67.77 155.97 38.09 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.255 -0.903 . . . . 0.0 110.407 -179.689 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.02 128.67 28.18 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.667 -0.646 . . . . 0.0 111.138 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.65 -20.42 50.73 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.856 ' CE1' HG22 ' A' ' 33' ' ' VAL . 12.3 m-30 -89.7 150.89 22.13 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.168 -1.195 . . . . 0.0 110.31 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.39 142.42 51.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.671 -0.643 . . . . 0.0 109.852 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 18.3 t -89.3 159.69 17.26 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.447 -0.783 . . . . 0.0 110.622 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.0 m -138.64 106.92 5.78 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.635 -0.666 . . . . 0.0 110.424 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.556 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -72.99 -33.4 65.79 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.371 -0.83 . . . . 0.0 110.285 179.363 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.6 m -68.87 -36.74 78.46 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.471 -0.768 . . . . 0.0 109.83 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.583 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 47.0 m0 -84.04 -40.16 18.71 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.747 -0.595 . . . . 0.0 109.565 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.96 14.91 25.46 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.583 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 2.6 p90 -151.46 177.77 9.96 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.843 -1.387 . . . . 0.0 111.458 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 15.8 t -126.89 126.53 43.44 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.9 177.91 7.63 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.555 -0.715 . . . . 0.0 110.498 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.856 HG22 ' CE1' ' A' ' 22' ' ' TYR . 17.6 t -69.34 137.31 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.452 -0.78 . . . . 0.0 110.208 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.23 52.23 1.57 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.367 -0.833 . . . . 0.0 110.236 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.52 116.15 63.03 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.261 -0.899 . . . . 0.0 109.947 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 C--N 1.313 -1.322 0 O-C-N 123.888 1.467 . . . . 0.0 110.794 -179.774 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.3 t70 . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 121.4 0.619 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.76 125.72 3.2 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.31 -166.14 1.36 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.538 -0.978 . . . . 0.0 110.285 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -88.49 150.95 22.85 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.431 -0.793 . . . . 0.0 109.92 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.544 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -77.22 -149.61 3.49 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.437 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -139.49 -139.56 3.8 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -90.25 -19.22 24.39 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.447 -1.031 . . . . 0.0 111.242 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -161.85 65.01 0.25 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.27 -0.894 . . . . 0.0 109.679 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.544 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 20.7 m0 -97.15 162.19 13.47 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.472 -0.767 . . . . 0.0 109.697 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -90.79 134.41 34.46 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.994 -1.066 . . . . 0.0 110.873 -179.555 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.1 p -150.79 169.85 20.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.516 -0.74 . . . . 0.0 110.471 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.6 -131.02 2.53 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.626 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.45 55.02 2.89 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.478 -1.013 . . . . 0.0 110.026 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 78.68 35.4 32.22 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.5 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 2.3 mttt -76.36 -60.32 0.94 Allowed Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.327 -1.102 . . . . 0.0 110.356 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.5 ' CD ' ' CB ' ' A' ' 15' ' ' LYS . 47.3 Cg_endo -73.2 141.36 32.27 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.651 1.343 . . . . 0.0 110.168 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.465 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 42.9 Cg_endo -71.78 103.23 1.43 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.856 1.45 . . . . 0.0 110.867 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.493 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 24.7 m -71.27 162.16 29.88 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.366 -0.834 . . . . 0.0 109.659 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 148.99 48.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.125 -0.985 . . . . 0.0 109.681 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.54 126.0 18.16 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.618 -0.676 . . . . 0.0 111.101 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.34 -29.21 9.82 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.789 ' CE1' HG22 ' A' ' 33' ' ' VAL . 5.5 m-85 -95.26 152.87 18.0 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.299 -1.118 . . . . 0.0 110.497 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -128.78 146.97 50.76 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.648 -0.658 . . . . 0.0 110.143 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.55 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 0.8 OUTLIER -91.82 160.87 15.1 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.435 -0.79 . . . . 0.0 110.566 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.553 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 0.5 OUTLIER -135.88 122.33 20.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.647 -0.658 . . . . 0.0 110.392 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.626 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -73.68 -42.02 61.88 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.456 -0.777 . . . . 0.0 109.38 179.189 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.8 m -63.27 -40.0 96.17 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.686 -0.634 . . . . 0.0 109.782 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.553 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 42.4 m0 -80.18 -46.07 17.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.773 -0.579 . . . . 0.0 109.5 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.7 18.45 23.01 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.51 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.8 p90 -151.38 -176.54 5.62 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.924 -1.339 . . . . 0.0 111.394 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.55 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 6.6 t -126.46 125.56 42.33 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.58 174.33 10.67 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.442 -0.786 . . . . 0.0 110.668 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.789 HG22 ' CE1' ' A' ' 22' ' ' TYR . 19.0 t -75.45 146.42 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.485 -0.759 . . . . 0.0 110.07 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -74.68 151.43 39.26 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.488 -0.758 . . . . 0.0 110.185 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.08 115.8 29.25 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.527 -0.733 . . . . 0.0 110.396 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo . . . . . 0 C--N 1.314 -1.272 0 O-C-N 124.002 1.527 . . . . 0.0 110.813 -179.884 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 19.4 t70 . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.165 0.507 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -119.5 -117.42 2.66 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -115.91 -168.42 1.42 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.528 -0.984 . . . . 0.0 110.312 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -89.01 153.73 20.78 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.449 -0.782 . . . . 0.0 109.976 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.486 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -81.07 -149.45 6.57 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.432 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -131.44 -140.9 4.67 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.542 ' HA ' ' CE1' ' A' ' 22' ' ' TYR . 20.6 p90 -90.51 -22.03 21.54 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.402 -1.058 . . . . 0.0 110.901 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 32.4 t90 -156.59 69.44 0.61 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.247 -0.908 . . . . 0.0 109.701 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.486 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 17.8 m0 -99.69 174.37 6.26 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.441 -0.787 . . . . 0.0 109.662 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.9 mtmm -90.15 138.52 31.45 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.955 -1.091 . . . . 0.0 110.261 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.424 ' SG ' ' HD2' ' A' ' 16' ' ' PRO . 13.9 t -150.67 162.44 40.69 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.256 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -102.27 -117.65 4.31 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.572 ' HA ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -91.25 28.99 1.51 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.42 -1.047 . . . . 0.0 110.305 179.362 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.15 32.54 5.52 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.592 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 4.8 tptt -72.22 -58.7 3.03 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.373 -1.075 . . . . 0.0 110.2 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.592 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 49.1 Cg_endo -75.85 131.89 13.78 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.701 1.369 . . . . 0.0 109.974 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.448 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 42.8 Cg_endo -71.82 100.95 1.12 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.767 1.404 . . . . 0.0 110.167 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.8 m -67.92 161.32 26.71 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.33 -0.856 . . . . 0.0 109.994 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.407 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -64.7 156.47 30.22 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.462 -0.774 . . . . 0.0 110.087 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.53 128.38 35.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.445 -0.784 . . . . 0.0 110.616 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.28 -28.0 16.19 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.542 ' CE1' ' HA ' ' A' ' 7' ' ' PHE . 88.9 m-85 -94.36 142.98 26.79 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.503 -0.998 . . . . 0.0 110.112 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.41 148.81 43.29 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.549 -0.719 . . . . 0.0 110.056 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.5 t -88.73 160.96 17.07 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.495 -0.753 . . . . 0.0 110.266 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.7 m -140.05 102.24 4.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.651 -0.656 . . . . 0.0 110.701 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.572 ' HB2' ' HA ' ' A' ' 13' ' ' ARG . 2.1 tptp -69.12 -36.31 77.35 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.311 -0.868 . . . . 0.0 109.76 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.4 m -62.26 -37.79 86.8 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.619 -0.676 . . . . 0.0 110.185 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.576 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 45.7 m0 -88.44 -50.23 6.44 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.622 -0.674 . . . . 0.0 109.952 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.54 16.08 6.66 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.209 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.576 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.4 p90 -150.51 -177.85 6.2 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.831 -1.394 . . . . 0.0 111.281 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 22.5 t -129.92 126.23 37.39 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.671 -0.643 . . . . 0.0 110.233 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.19 173.22 14.17 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.672 -0.642 . . . . 0.0 110.191 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.421 HG23 ' CE1' ' A' ' 22' ' ' TYR . 98.5 t -56.58 134.37 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.272 -0.892 . . . . 0.0 109.904 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.54 -62.9 1.42 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.493 -0.755 . . . . 0.0 110.764 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.88 149.97 42.09 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.513 -0.742 . . . . 0.0 110.612 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo . . . . . 0 C--N 1.314 -1.288 0 O-C-N 123.96 1.505 . . . . 0.0 110.685 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 14.4 t70 . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 121.213 0.53 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.53 56.45 0.06 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.59 ' HG2' ' HG2' ' A' ' 17' ' ' PRO . 6.6 pt-20 -144.56 -169.75 3.22 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.612 -0.934 . . . . 0.0 110.44 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -129.71 153.9 47.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.405 -0.809 . . . . 0.0 110.239 179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.47 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -92.56 -126.09 3.9 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.509 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -147.66 -142.41 3.67 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -90.57 -32.66 16.2 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.443 -1.033 . . . . 0.0 110.528 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -145.02 70.52 1.27 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.497 -0.752 . . . . 0.0 109.93 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.509 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 15.6 m0 -100.52 175.51 5.65 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.425 -0.797 . . . . 0.0 109.983 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt -89.8 138.76 31.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.133 -0.979 . . . . 0.0 110.55 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.462 ' SG ' ' HD2' ' A' ' 16' ' ' PRO . 29.1 t -151.61 161.85 41.98 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.546 -0.721 . . . . 0.0 110.38 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.56 -117.1 3.92 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.437 ' HD2' ' HB2' ' A' ' 26' ' ' LYS . 13.6 tpt180 -90.7 21.69 3.92 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.393 -1.063 . . . . 0.0 109.898 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.51 34.18 3.41 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.556 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -77.28 -54.7 1.45 Allowed Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.361 -1.082 . . . . 0.0 110.824 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 47.5 Cg_endo -74.28 132.38 16.37 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.678 1.357 . . . . 0.0 110.115 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.59 ' HG2' ' HG2' ' A' ' 3' ' ' GLU . 50.4 Cg_endo -71.45 104.57 1.59 Allowed 'Trans proline' 0 C--N 1.314 -1.271 0 O-C-N 123.771 1.406 . . . . 0.0 110.667 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.2 m -75.26 167.2 22.37 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.404 -0.81 . . . . 0.0 109.386 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.459 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -64.37 165.1 10.2 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.25 -0.906 . . . . 0.0 110.303 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.0 126.17 27.19 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.322 -0.861 . . . . 0.0 110.195 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.44 4.97 54.7 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 87.9 m-85 -118.28 150.71 39.01 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.082 -1.246 . . . . 0.0 109.507 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -127.84 147.21 50.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.325 -0.86 . . . . 0.0 110.589 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.4 t -88.97 162.08 16.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.585 -0.697 . . . . 0.0 110.539 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.478 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 7.7 t -139.26 113.6 8.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.652 -0.655 . . . . 0.0 110.63 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.437 ' HB2' ' HD2' ' A' ' 13' ' ' ARG . 14.2 tptm -74.01 -39.83 63.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.496 -0.753 . . . . 0.0 110.213 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.3 m -65.5 -36.93 85.31 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.487 -0.758 . . . . 0.0 110.306 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.518 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 49.0 m0 -83.86 -46.9 11.64 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.613 -0.679 . . . . 0.0 110.027 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.02 19.98 10.26 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.174 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.518 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.7 p90 -150.79 -175.28 5.06 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.864 -1.374 . . . . 0.0 110.991 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 18.5 t -133.39 125.22 28.64 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.507 -0.746 . . . . 0.0 110.214 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.29 168.16 24.87 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.779 -0.575 . . . . 0.0 109.727 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 81.5 t -55.57 143.52 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 O-C-N 121.315 -0.866 . . . . 0.0 109.753 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.22 101.44 0.23 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.425 -0.797 . . . . 0.0 110.718 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.755 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -76.49 -56.02 1.54 Allowed Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.673 -0.642 . . . . 0.0 110.732 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.755 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 46.1 Cg_endo . . . . . 0 N--CA 1.486 1.056 0 O-C-N 123.405 1.213 . . . . 0.0 110.88 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 N--CA 1.497 1.901 0 CA-C-O 121.17 0.509 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -143.64 43.81 0.98 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 55.02 87.77 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.741 -0.858 . . . . 0.0 110.691 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -140.18 160.43 39.97 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.553 -0.717 . . . . 0.0 110.646 -179.629 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.449 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -106.44 -112.16 3.66 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.533 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -152.77 -148.98 5.01 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.436 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 3.1 t80 -89.62 -35.87 15.61 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.3 -1.118 . . . . 0.0 110.585 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -137.28 78.37 1.69 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.326 -0.859 . . . . 0.0 108.954 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.533 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 11.7 m0 -109.33 166.97 10.46 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.401 -0.812 . . . . 0.0 110.069 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.08 137.64 32.24 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.016 -1.053 . . . . 0.0 110.814 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.8 p -150.87 166.72 29.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.581 -0.7 . . . . 0.0 110.419 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.12 -118.6 3.69 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.553 ' HA ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.93 38.36 0.95 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.508 -0.995 . . . . 0.0 110.097 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.95 37.08 5.81 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.568 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 2.0 tttt -80.11 -56.55 0.72 Allowed Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.366 -1.079 . . . . 0.0 110.771 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 48.7 Cg_endo -75.94 126.39 9.33 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.647 1.341 . . . . 0.0 110.266 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.03 114.61 4.09 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.901 1.474 . . . . 0.0 110.55 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.407 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 81.1 m -83.4 -179.16 7.29 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.581 -0.699 . . . . 0.0 110.128 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.464 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.4 OUTLIER -72.42 158.64 35.38 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.261 -0.899 . . . . 0.0 110.243 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -54.99 122.47 10.98 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.454 -0.779 . . . . 0.0 110.07 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.2 -26.3 22.36 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.48 ' CE2' ' CG2' ' A' ' 33' ' ' VAL . 88.3 m-85 -89.72 135.97 33.31 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.408 -1.054 . . . . 0.0 109.492 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -123.2 148.56 45.67 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.272 -0.892 . . . . 0.0 110.34 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 7.1 t -89.04 159.49 17.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.517 -0.74 . . . . 0.0 110.251 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.403 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 2.4 m -137.41 113.41 9.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.679 -0.638 . . . . 0.0 110.465 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.553 ' HB2' ' HA ' ' A' ' 13' ' ' ARG . 3.3 ttpt -70.79 -39.76 72.96 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.531 -0.731 . . . . 0.0 109.57 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.0 m -62.05 -39.09 91.17 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.658 -0.651 . . . . 0.0 109.666 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.491 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 42.5 m0 -82.22 -41.6 20.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.727 -0.608 . . . . 0.0 109.626 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.5 14.92 33.68 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.491 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.7 p90 -151.62 -179.95 7.86 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.013 -1.287 . . . . 0.0 110.941 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 49.2 t -126.43 127.2 45.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.62 -0.675 . . . . 0.0 110.209 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -148.04 174.74 11.62 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.511 -0.743 . . . . 0.0 109.915 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.48 ' CG2' ' CE2' ' A' ' 22' ' ' TYR . 87.2 t -61.32 145.04 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.238 -0.914 . . . . 0.0 110.424 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -99.64 63.5 1.24 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.519 -0.738 . . . . 0.0 109.77 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.09 113.17 65.81 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.314 -0.866 . . . . 0.0 110.343 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo . . . . . 0 C--N 1.312 -1.345 0 O-C-N 123.846 1.445 . . . . 0.0 110.762 179.746 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.173 0.511 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 110.69 137.6 7.55 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 17' ' ' PRO . 2.0 tt0 -91.36 -166.99 1.69 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.544 -0.974 . . . . 0.0 110.327 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.524 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -88.31 151.35 22.68 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.313 -0.867 . . . . 0.0 110.245 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.543 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -83.93 -134.9 2.71 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.457 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -146.47 -147.11 4.5 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -77.07 -30.14 55.39 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.326 -1.102 . . . . 0.0 111.26 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -153.65 72.8 0.93 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.242 -0.911 . . . . 0.0 110.186 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.543 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 18.1 m0 -102.49 174.86 5.71 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.46 -0.775 . . . . 0.0 109.444 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.16 145.47 25.41 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.028 -1.045 . . . . 0.0 110.199 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.559 ' SG ' ' HG2' ' A' ' 16' ' ' PRO . 44.4 t -151.04 160.38 43.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.55 -0.719 . . . . 0.0 110.714 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.02 -123.84 4.64 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.637 ' HA ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -88.71 -37.96 15.11 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.377 -1.073 . . . . 0.0 109.789 179.391 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.02 36.2 0.13 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.641 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 5.0 mttp -89.72 -69.15 0.1 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.371 -1.076 . . . . 0.0 110.534 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.641 ' HD3' ' CB ' ' A' ' 15' ' ' LYS . 49.6 Cg_endo -77.25 113.07 3.51 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 O-C-N 123.525 1.276 . . . . 0.0 109.913 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.452 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 49.5 Cg_endo -77.24 116.47 4.16 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.834 1.439 . . . . 0.0 110.7 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.434 ' SG ' ' HB2' ' A' ' 22' ' ' TYR . 0.5 OUTLIER -68.4 157.39 35.88 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.117 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.524 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -60.7 153.1 24.93 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.083 -1.011 . . . . 0.0 110.461 -179.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -45.07 127.85 6.91 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.795 -0.566 . . . . 0.0 111.076 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.66 -29.04 10.35 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.693 ' CD1' HG22 ' A' ' 33' ' ' VAL . 4.1 m-85 -104.1 129.84 51.8 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.41 -1.053 . . . . 0.0 110.245 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.52 ' HB3' ' HG3' ' A' ' 34' ' ' GLU . . . -101.31 148.54 25.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.47 -0.769 . . . . 0.0 109.538 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 2.8 t -89.15 159.41 17.51 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.17 -0.956 . . . . 0.0 110.27 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.534 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 0.3 OUTLIER -143.96 121.2 11.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.585 -0.697 . . . . 0.0 111.289 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.637 ' HB2' ' HA ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -75.92 -41.43 51.85 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.536 -0.727 . . . . 0.0 109.402 178.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.6 m -58.92 -37.29 76.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.74 -0.6 . . . . 0.0 109.702 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.534 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 42.5 m0 -86.15 -37.29 18.9 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.38 16.1 47.99 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.493 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 2.6 p90 -152.01 178.15 9.74 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.001 -1.294 . . . . 0.0 110.779 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.426 ' O ' ' SG ' ' A' ' 31' ' ' CYS . 9.8 p -130.66 127.27 38.56 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.433 -0.792 . . . . 0.0 110.117 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.8 -178.22 6.33 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.682 -0.636 . . . . 0.0 110.124 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.693 HG22 ' CD1' ' A' ' 22' ' ' TYR . 24.8 t -60.07 137.3 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.222 -0.924 . . . . 0.0 110.302 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.52 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -112.66 111.83 22.91 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.516 -0.74 . . . . 0.0 110.365 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.72 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -69.05 -53.76 13.39 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.619 -0.676 . . . . 0.0 110.867 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.72 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 45.0 Cg_endo . . . . . 0 N--CA 1.487 1.135 0 O-C-N 123.507 1.267 . . . . 0.0 110.902 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.7 t70 . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 121.096 0.474 . . . . 0.0 110.367 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -64.83 -57.79 11.46 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.24 103.88 12.63 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.582 -0.952 . . . . 0.0 109.688 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -144.88 160.15 41.76 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.414 -0.804 . . . . 0.0 110.494 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.434 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -105.78 -112.27 3.68 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.549 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -151.06 -153.62 6.23 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -85.13 -33.42 22.36 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.221 -1.164 . . . . 0.0 110.706 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 16.8 t90 -142.76 75.01 1.47 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.332 -0.855 . . . . 0.0 109.593 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.549 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 14.5 m0 -104.51 166.16 10.58 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.651 -0.656 . . . . 0.0 109.447 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -90.61 136.83 32.81 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.999 -1.063 . . . . 0.0 110.568 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.1 p -150.84 171.81 16.63 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.723 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.33 -123.23 3.17 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.461 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -91.11 24.86 2.67 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.416 -1.05 . . . . 0.0 110.441 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.415 ' HA2' ' HB3' ' A' ' 24' ' ' CYS . . . 108.76 37.3 2.06 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.434 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 0.5 OUTLIER -82.43 -56.86 0.5 Allowed Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.4 -1.059 . . . . 0.0 111.062 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' A' ' 15' ' ' LYS . 46.9 Cg_endo -73.93 130.89 14.95 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 O-C-N 123.568 1.299 . . . . 0.0 110.517 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -73.14 113.06 3.68 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.785 1.413 . . . . 0.0 110.951 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.41 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 84.8 m -85.27 -178.99 6.89 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.638 -0.664 . . . . 0.0 110.221 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.93 151.78 38.86 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.235 -0.916 . . . . 0.0 110.211 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.33 115.6 2.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.703 -0.623 . . . . 0.0 110.638 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.83 -33.77 3.8 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.549 ' HD1' HG22 ' A' ' 33' ' ' VAL . 5.3 m-85 -94.7 149.99 20.67 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.507 -0.996 . . . . 0.0 110.304 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -126.19 150.05 48.59 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.569 -0.707 . . . . 0.0 109.789 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 15.9 t -89.06 158.22 18.05 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.226 -0.921 . . . . 0.0 110.395 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.1 m -141.51 131.59 24.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.651 -0.655 . . . . 0.0 110.77 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.461 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 11.6 tptp -84.73 -44.48 13.32 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.669 -0.644 . . . . 0.0 109.34 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.2 m -59.12 -38.94 80.82 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.482 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 44.3 m0 -81.88 -41.57 20.77 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.61 16.81 41.13 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.482 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 2.9 p90 -151.18 178.33 9.33 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.94 -1.329 . . . . 0.0 111.302 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 17.5 t -123.26 119.02 28.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.764 -0.585 . . . . 0.0 110.148 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.16 178.49 8.93 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.828 -0.545 . . . . 0.0 110.012 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.549 HG22 ' HD1' ' A' ' 22' ' ' TYR . 63.9 t -59.51 117.88 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.31 -0.869 . . . . 0.0 110.27 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.62 116.13 5.37 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.592 -0.692 . . . . 0.0 110.667 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 54.06 86.56 0.16 Allowed Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 121.716 -0.615 . . . . 0.0 110.882 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo . . . . . 0 C--N 1.314 -1.286 0 O-C-N 123.739 1.389 . . . . 0.0 110.702 -179.831 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 121.138 0.494 . . . . 0.0 110.119 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 150.06 151.81 5.62 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.424 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 2.0 tt0 -76.92 101.11 5.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.483 -1.01 . . . . 0.0 110.068 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.451 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -137.93 159.77 41.1 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.588 -0.695 . . . . 0.0 110.229 -179.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.542 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -98.02 -133.89 8.12 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.555 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -144.7 -150.76 5.29 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -85.35 -24.38 27.63 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.37 -1.077 . . . . 0.0 111.438 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.419 ' CD1' ' N ' ' A' ' 8' ' ' TRP . 17.5 p-90 -149.45 61.03 1.02 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.062 -1.024 . . . . 0.0 110.046 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.555 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 17.2 m0 -94.23 154.7 17.41 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.24 -0.912 . . . . 0.0 109.43 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -88.89 132.76 34.54 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.885 -1.135 . . . . 0.0 111.379 -178.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.436 ' HB2' ' CG ' ' A' ' 16' ' ' PRO . 31.4 p -150.87 173.66 13.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.819 -0.551 . . . . 0.0 110.28 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.38 -132.16 3.11 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.51 54.16 2.65 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.474 -1.015 . . . . 0.0 109.819 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.8 41.12 7.82 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.538 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -81.76 -61.01 0.38 Allowed Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.444 -1.033 . . . . 0.0 110.585 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.538 ' HD3' ' CB ' ' A' ' 15' ' ' LYS . 51.2 Cg_endo -76.38 140.44 21.81 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.668 1.352 . . . . 0.0 110.267 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.424 ' HG2' ' HB3' ' A' ' 3' ' ' GLU . 46.8 Cg_endo -72.45 113.8 3.82 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.799 1.42 . . . . 0.0 110.779 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.418 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 0.1 OUTLIER -83.56 176.6 8.91 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.43 -0.794 . . . . 0.0 109.818 179.395 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.451 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -71.32 151.96 43.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.274 -0.892 . . . . 0.0 109.31 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.08 124.05 11.98 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.194 -0.941 . . . . 0.0 110.331 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.7 -24.84 27.41 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.461 ' CE2' ' CG2' ' A' ' 33' ' ' VAL . 85.3 m-85 -91.11 136.76 32.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.199 -1.177 . . . . 0.0 110.057 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -121.34 150.0 42.11 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.586 -0.697 . . . . 0.0 110.145 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 1.0 OUTLIER -89.46 162.39 15.76 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.322 -0.861 . . . . 0.0 110.228 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.582 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 0.4 OUTLIER -137.12 120.33 16.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.451 -0.78 . . . . 0.0 110.648 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -36.36 63.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.433 -0.792 . . . . 0.0 109.542 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.8 m -64.49 -43.29 94.61 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.672 -0.643 . . . . 0.0 109.735 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.582 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 42.2 m0 -81.83 -46.92 13.49 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.796 -0.565 . . . . 0.0 109.645 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.71 18.14 15.0 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.629 -0.989 . . . . 0.0 110.629 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.516 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.7 p90 -150.85 -175.65 5.21 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.011 -1.287 . . . . 0.0 111.194 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.602 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 46.1 t -122.58 130.88 53.49 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.536 -0.728 . . . . 0.0 110.576 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.53 174.42 10.78 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.962 -0.462 . . . . 0.0 109.98 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.461 ' CG2' ' CE2' ' A' ' 22' ' ' TYR . 97.5 t -67.99 142.64 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.224 -0.922 . . . . 0.0 110.044 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -72.14 112.68 8.44 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.518 -0.739 . . . . 0.0 110.193 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.01 127.59 18.27 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.495 -0.753 . . . . 0.0 110.195 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo . . . . . 0 C--N 1.313 -1.29 0 O-C-N 123.803 1.423 . . . . 0.0 110.658 -179.978 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 121.119 0.485 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.01 91.89 0.11 Allowed Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -113.24 90.11 3.26 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.439 -1.036 . . . . 0.0 110.735 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.535 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -140.33 151.97 45.46 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.416 -0.802 . . . . 0.0 109.949 179.366 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.506 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -86.64 -122.63 1.48 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.485 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -151.54 -145.34 4.11 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.424 ' HE1' ' HH ' ' A' ' 22' ' ' TYR . 0.2 OUTLIER -90.41 -27.28 19.4 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.221 -1.164 . . . . 0.0 110.817 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 33.0 t90 -149.13 73.84 1.22 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.411 -0.806 . . . . 0.0 109.623 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.506 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 15.4 m0 -104.56 159.05 16.07 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.456 -0.778 . . . . 0.0 109.428 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 1.9 mptt -90.7 132.99 35.48 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.852 -1.155 . . . . 0.0 111.311 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 23.7 p -150.82 170.35 19.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.61 -0.681 . . . . 0.0 110.604 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -117.58 1.87 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.574 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.73 41.48 1.06 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.533 -0.98 . . . . 0.0 110.176 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.17 33.4 17.7 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.595 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 0.2 OUTLIER -69.57 -55.27 9.56 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.247 -1.149 . . . . 0.0 110.489 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 47.9 Cg_endo -74.38 135.87 20.98 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 O-C-N 123.586 1.308 . . . . 0.0 109.729 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.42 107.39 2.27 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.704 1.371 . . . . 0.0 110.986 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.46 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 0.1 OUTLIER -74.88 174.99 8.49 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.346 -0.846 . . . . 0.0 109.327 179.072 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.535 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 2.2 m -80.22 147.11 31.38 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.931 -1.106 . . . . 0.0 108.799 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -44.78 127.51 6.32 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.466 -0.771 . . . . 0.0 111.278 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.6 -25.81 21.75 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.827 ' CD1' HG22 ' A' ' 33' ' ' VAL . 7.9 m-30 -99.33 136.64 38.98 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.079 -1.248 . . . . 0.0 110.19 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.528 ' HB3' ' HG3' ' A' ' 34' ' ' GLU . . . -118.29 149.79 40.56 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.413 -0.804 . . . . 0.0 109.778 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.702 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 0.8 OUTLIER -89.28 160.07 17.08 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.353 -0.842 . . . . 0.0 110.694 -179.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.4 m -132.56 110.84 10.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.582 -0.699 . . . . 0.0 110.517 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.574 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 39.7 tptt -68.86 -36.8 78.55 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.478 -0.764 . . . . 0.0 110.061 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.9 m -66.27 -37.69 86.05 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.637 -0.665 . . . . 0.0 109.921 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.524 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 42.7 m0 -86.07 -48.17 8.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.717 -0.614 . . . . 0.0 109.949 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.24 16.35 12.44 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.186 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.524 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.0 p90 -150.87 179.46 8.21 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.717 -1.461 . . . . 0.0 111.426 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.702 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 49.1 t -121.39 128.99 52.77 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.633 -0.667 . . . . 0.0 110.028 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -146.9 174.86 11.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.711 -0.618 . . . . 0.0 110.087 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.827 HG22 ' CD1' ' A' ' 22' ' ' TYR . 12.5 t -70.26 105.94 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.371 -0.831 . . . . 0.0 109.875 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.528 ' HG3' ' HB3' ' A' ' 23' ' ' ALA . 5.9 mm-40 -80.09 89.68 5.4 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.418 -0.801 . . . . 0.0 109.906 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -153.0 151.98 27.25 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.544 -0.722 . . . . 0.0 110.348 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 C--N 1.313 -1.334 0 O-C-N 123.944 1.497 . . . . 0.0 110.638 179.987 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.9 t70 . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 121.022 0.439 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.2 109.65 0.25 Allowed Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -107.17 57.61 0.63 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.538 -0.977 . . . . 0.0 110.8 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -116.15 155.25 28.58 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.207 -0.933 . . . . 0.0 110.025 179.548 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.542 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -81.48 -128.84 0.99 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.457 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -146.77 -140.13 3.39 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.56 -33.5 15.87 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.288 -1.125 . . . . 0.0 110.769 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -146.75 68.31 1.17 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.405 -0.81 . . . . 0.0 109.788 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.542 ' CE3' ' HA2' ' A' ' 5' ' ' GLY . 18.1 m0 -94.92 161.83 13.99 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.453 -0.78 . . . . 0.0 109.844 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 1.2 mttp -89.68 136.54 32.97 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.108 -0.995 . . . . 0.0 111.062 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.1 p -151.06 156.52 41.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.702 -0.624 . . . . 0.0 110.172 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.92 -118.45 0.84 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.45 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.86 34.04 0.92 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.414 -1.05 . . . . 0.0 110.001 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.51 39.72 3.37 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.486 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 3.8 mtpt -77.81 -58.74 0.86 Allowed Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.368 -1.078 . . . . 0.0 110.814 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.486 ' HD3' ' CB ' ' A' ' 15' ' ' LYS . 46.5 Cg_endo -74.56 136.9 22.03 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 O-C-N 123.652 1.343 . . . . 0.0 110.369 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.94 115.8 4.48 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.934 1.492 . . . . 0.0 110.701 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.467 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 96.1 m -84.91 -179.42 7.07 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.395 -0.816 . . . . 0.0 110.168 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.515 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 2.1 m -88.28 165.81 14.75 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.357 -0.839 . . . . 0.0 110.238 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp -58.18 124.77 20.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.388 -0.82 . . . . 0.0 110.223 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.8 -25.79 27.03 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.488 ' CD1' ' HB2' ' A' ' 19' ' ' CYS . 80.0 m-85 -92.13 133.44 35.77 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.552 -0.969 . . . . 0.0 110.066 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.92 145.27 47.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.543 -0.723 . . . . 0.0 109.89 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 9.1 t -88.82 160.34 17.29 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.581 -0.699 . . . . 0.0 110.089 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.413 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 2.5 m -142.6 122.9 13.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.587 -0.696 . . . . 0.0 111.208 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.45 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -73.77 -41.35 62.56 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.1 m -61.98 -40.28 95.07 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.692 -0.63 . . . . 0.0 109.599 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.497 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 34.9 m0 -80.28 -38.43 30.82 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.61 14.84 56.29 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.497 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 2.5 p90 -151.94 176.72 11.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.987 -1.302 . . . . 0.0 111.021 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 37.3 t -124.28 125.89 45.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.516 -0.74 . . . . 0.0 110.118 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.53 -178.25 5.99 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.671 -0.643 . . . . 0.0 109.785 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.428 HG23 ' CE2' ' A' ' 22' ' ' TYR . 98.6 t -59.96 156.8 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.138 -0.976 . . . . 0.0 110.155 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -62.17 -85.88 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.516 -0.74 . . . . 0.0 110.675 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -170.56 136.23 1.16 Allowed Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.192 -0.943 . . . . 0.0 110.281 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo . . . . . 0 C--N 1.314 -1.249 0 O-C-N 123.784 1.412 . . . . 0.0 110.726 179.936 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 15.9 t70 . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.22 0.533 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.72 69.76 0.86 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -85.75 97.75 10.33 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.553 -0.969 . . . . 0.0 109.824 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.31 158.89 43.33 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.355 -0.84 . . . . 0.0 110.47 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.95 -122.45 3.79 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.552 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -151.31 -150.08 5.23 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 30.0 t80 -81.32 -42.68 20.21 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.316 -1.108 . . . . 0.0 110.824 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 8.8 t90 -136.98 74.85 1.5 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.397 -0.814 . . . . 0.0 109.944 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.552 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 13.5 m0 -102.44 173.92 6.14 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.619 -0.676 . . . . 0.0 109.744 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.05 139.17 30.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.019 -1.051 . . . . 0.0 110.242 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.402 ' SG ' ' HD2' ' A' ' 16' ' ' PRO . 43.2 t -151.08 160.75 43.7 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.474 -0.766 . . . . 0.0 110.209 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.43 -116.43 3.73 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.617 ' HA ' ' HB3' ' A' ' 26' ' ' LYS . 7.6 mmt180 -90.5 29.19 1.33 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.312 -1.11 . . . . 0.0 110.122 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.77 34.69 4.28 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.512 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -76.73 -59.99 0.9 Allowed Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.308 -1.113 . . . . 0.0 110.105 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.512 ' HD3' ' CB ' ' A' ' 15' ' ' LYS . 47.5 Cg_endo -75.13 128.67 11.57 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.654 1.344 . . . . 0.0 110.081 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.52 111.61 3.01 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.852 1.449 . . . . 0.0 110.588 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 79.3 m -83.72 161.64 20.96 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.606 -0.684 . . . . 0.0 110.018 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.484 ' HB2' ' CD2' ' A' ' 22' ' ' TYR . 0.1 OUTLIER -62.25 150.15 39.9 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.522 -0.736 . . . . 0.0 110.653 -179.74 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.39 123.11 12.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.602 -0.686 . . . . 0.0 110.269 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.11 -26.66 11.07 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.769 ' CE1' HG22 ' A' ' 33' ' ' VAL . 11.4 m-30 -89.21 160.52 16.91 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.378 -1.072 . . . . 0.0 109.809 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.19 144.68 50.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.457 -0.777 . . . . 0.0 110.308 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.4 ' SG ' ' N ' ' A' ' 25' ' ' SER . 25.7 t -89.57 162.62 15.57 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.624 -0.673 . . . . 0.0 110.271 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.4 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 15.6 m -138.9 94.68 2.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.409 -0.807 . . . . 0.0 110.81 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.617 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -61.58 -32.02 72.1 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.221 -0.925 . . . . 0.0 110.323 179.278 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.5 m -72.1 -38.58 69.3 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.583 -0.698 . . . . 0.0 110.186 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.56 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 46.2 m0 -82.96 -48.19 10.94 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.631 -0.668 . . . . 0.0 109.638 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.36 15.53 9.62 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.206 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.56 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.0 p90 -150.95 178.7 8.91 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.758 -1.437 . . . . 0.0 110.995 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 9.2 t -127.62 130.43 48.97 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.657 -0.652 . . . . 0.0 109.758 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -149.89 179.75 7.79 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.497 -0.752 . . . . 0.0 110.781 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.769 HG22 ' CE1' ' A' ' 22' ' ' TYR . 39.0 t -71.26 127.71 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.452 -0.78 . . . . 0.0 110.021 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -89.09 -17.21 29.73 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.519 -0.738 . . . . 0.0 111.05 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 34' ' ' GLU . . . 57.42 81.78 0.25 Allowed Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.462 -0.774 . . . . 0.0 110.798 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo . . . . . 0 C--N 1.312 -1.378 0 O-C-N 123.797 1.419 . . . . 0.0 110.636 -179.987 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 121.211 0.529 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -175.03 99.06 0.13 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.494 ' HG2' ' HG3' ' A' ' 17' ' ' PRO . 1.5 mt-10 -138.35 73.02 1.42 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.48 -1.012 . . . . 0.0 110.243 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.25 156.26 40.49 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.497 0.665 . . . . 0.0 110.572 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.465 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -113.24 -106.53 2.77 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.553 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -152.7 -161.22 10.12 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 36.5 p90 -82.56 -19.81 37.79 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.347 -1.09 . . . . 0.0 111.219 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 22.8 t90 -154.44 72.59 0.87 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.28 -0.888 . . . . 0.0 109.637 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.553 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 17.6 m0 -104.41 169.2 8.61 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.471 -0.768 . . . . 0.0 110.151 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -91.32 136.67 32.94 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.193 -0.942 . . . . 0.0 110.607 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.4 p -150.77 156.71 41.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.489 -0.757 . . . . 0.0 110.426 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.32 -117.72 1.63 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.588 ' HA ' ' HB3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.4 50.82 1.9 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.419 -1.048 . . . . 0.0 109.906 179.425 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.61 38.19 21.35 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.493 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -77.46 -60.03 0.78 Allowed Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.383 -1.069 . . . . 0.0 110.707 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.493 ' HD3' ' CB ' ' A' ' 15' ' ' LYS . 47.3 Cg_endo -75.07 131.95 14.79 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 123.615 1.324 . . . . 0.0 110.273 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.494 ' HG3' ' HG2' ' A' ' 3' ' ' GLU . 47.4 Cg_endo -74.21 119.69 5.93 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.833 1.438 . . . . 0.0 110.653 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -89.47 171.18 9.9 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.597 -0.689 . . . . 0.0 110.095 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.23 149.36 49.61 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.371 -0.831 . . . . 0.0 110.243 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.99 109.13 0.38 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.687 -0.633 . . . . 0.0 110.401 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.84 -39.24 1.82 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.804 ' CD1' HG22 ' A' ' 33' ' ' VAL . 4.6 m-85 -90.99 141.83 28.42 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.42 -1.047 . . . . 0.0 110.001 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -118.54 150.87 38.9 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.547 -0.721 . . . . 0.0 110.234 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 10.8 t -89.61 160.61 16.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.42 -0.8 . . . . 0.0 110.224 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.407 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 56.7 m -135.03 105.22 6.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.572 -0.705 . . . . 0.0 110.966 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.588 ' HB3' ' HA ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -66.12 -31.61 72.56 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.458 -0.776 . . . . 0.0 110.064 179.211 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.543 ' N ' ' HG2' ' A' ' 26' ' ' LYS . 54.6 m -67.05 -39.9 87.03 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.696 -0.627 . . . . 0.0 110.168 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.629 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 43.4 m0 -86.76 -48.6 8.1 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.601 -0.687 . . . . 0.0 109.842 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.44 14.89 8.58 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.629 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.1 p90 -151.5 177.37 10.38 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.925 -1.338 . . . . 0.0 111.057 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 8.2 t -126.0 130.57 51.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.456 -0.777 . . . . 0.0 110.204 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -147.71 -172.22 3.99 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.597 -0.689 . . . . 0.0 110.184 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.804 HG22 ' CD1' ' A' ' 22' ' ' TYR . 10.6 t -73.64 122.73 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.35 -0.843 . . . . 0.0 110.022 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.13 167.45 15.73 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.505 -0.747 . . . . 0.0 110.719 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.52 130.21 23.62 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.496 -0.753 . . . . 0.0 110.185 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo . . . . . 0 C--N 1.315 -1.232 0 O-C-N 123.888 1.468 . . . . 0.0 110.729 179.836 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 . . . . . 0 N--CA 1.497 1.882 0 CA-C-O 121.193 0.521 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -101.4 103.41 2.54 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.516 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 13.1 mt-10 -72.62 130.6 40.96 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.471 -1.017 . . . . 0.0 110.419 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -134.84 160.79 37.09 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.51 -0.743 . . . . 0.0 109.906 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.473 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -101.25 -124.28 5.35 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.539 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -150.29 -154.77 6.57 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -77.8 -36.14 50.63 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.212 -1.169 . . . . 0.0 110.962 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 38.7 t90 -142.8 77.58 1.58 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.408 -0.808 . . . . 0.0 109.856 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.539 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 15.3 m0 -105.66 156.68 18.04 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.545 -0.722 . . . . 0.0 109.169 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.46 132.13 35.17 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.868 -1.145 . . . . 0.0 111.119 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.8 p -150.83 167.8 26.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.715 -0.615 . . . . 0.0 110.214 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.46 -121.18 0.54 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.591 ' HG3' ' HD3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.5 25.56 2.24 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.455 -1.026 . . . . 0.0 110.329 179.211 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.73 34.05 3.65 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.58 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 1.5 tptt -69.85 -54.47 10.15 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.276 -1.132 . . . . 0.0 109.975 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 50.1 Cg_endo -77.22 132.63 12.71 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 O-C-N 123.763 1.401 . . . . 0.0 109.716 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.516 ' HG2' ' HB3' ' A' ' 3' ' ' GLU . 44.3 Cg_endo -70.47 119.07 6.06 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.781 1.411 . . . . 0.0 110.75 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.402 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 94.9 m -84.14 -178.78 7.06 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.582 -0.698 . . . . 0.0 110.035 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.515 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -75.24 164.58 26.31 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.332 -0.855 . . . . 0.0 110.132 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.58 119.96 9.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.467 -0.771 . . . . 0.0 110.267 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.24 0.88 54.17 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 36.9 m-85 -112.55 133.38 54.63 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.117 -1.225 . . . . 0.0 109.677 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -119.58 144.71 46.94 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.394 -0.816 . . . . 0.0 110.496 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.559 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 0.8 OUTLIER -89.11 160.82 16.84 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.513 -0.742 . . . . 0.0 110.017 179.664 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 m -136.69 125.42 23.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.434 -0.792 . . . . 0.0 110.636 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.591 ' HD3' ' HG3' ' A' ' 13' ' ' ARG . 9.9 ttpt -76.55 -40.55 49.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.517 -0.739 . . . . 0.0 109.244 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.8 m -65.2 -38.68 91.22 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.738 -0.601 . . . . 0.0 109.623 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.462 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 42.8 m0 -81.49 -45.29 16.19 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.644 -0.66 . . . . 0.0 109.456 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.72 16.28 31.72 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.462 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.5 p90 -151.21 -179.11 7.06 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.903 -1.351 . . . . 0.0 111.359 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.559 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 8.4 t -121.7 128.39 51.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.676 -0.64 . . . . 0.0 110.447 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.41 165.54 30.81 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.753 -0.592 . . . . 0.0 110.143 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 67.2 t -64.68 146.27 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.249 -0.907 . . . . 0.0 110.175 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.38 83.9 3.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.403 -0.811 . . . . 0.0 110.003 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.805 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -65.95 -57.22 14.14 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.436 -0.79 . . . . 0.0 110.529 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.805 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 46.8 Cg_endo . . . . . 0 N--CA 1.488 1.153 0 O-C-N 123.511 1.269 . . . . 0.0 110.559 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.229 0.538 . . . . 0.0 110.426 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -175.46 67.22 0.1 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.28 174.59 7.61 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.617 -0.931 . . . . 0.0 110.367 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -136.12 156.58 48.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.552 -0.718 . . . . 0.0 110.433 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -111.9 -99.2 2.45 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.552 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -149.14 -154.95 6.52 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.578 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 12.2 m-85 -90.9 -30.26 17.01 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.418 -1.049 . . . . 0.0 110.484 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -142.65 68.87 1.31 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.511 -0.743 . . . . 0.0 109.44 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.552 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 17.3 m0 -99.25 154.14 18.4 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.366 -0.834 . . . . 0.0 109.786 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -88.48 134.93 33.71 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.042 -1.036 . . . . 0.0 111.133 -179.307 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.498 ' CB ' ' HG2' ' A' ' 16' ' ' PRO . 31.3 p -150.72 177.05 10.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.589 -0.694 . . . . 0.0 110.528 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.79 -120.28 0.45 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.447 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -87.71 -38.47 15.8 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.454 -1.027 . . . . 0.0 109.56 179.02 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -174.05 37.88 0.12 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.6 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 1.7 mtpm? -72.45 -69.7 0.32 Allowed Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 121.44 -1.035 . . . . 0.0 110.813 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.6 ' CD ' ' CB ' ' A' ' 15' ' ' LYS . 48.4 Cg_endo -74.02 125.36 9.79 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.391 1.206 . . . . 0.0 109.9 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -74.3 103.89 1.76 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.894 1.47 . . . . 0.0 111.495 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 t -64.95 164.87 11.83 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.554 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -53.02 149.62 6.43 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.96 -1.087 . . . . 0.0 110.621 -179.489 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -50.21 120.64 4.67 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.626 -0.671 . . . . 0.0 110.011 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.83 -25.48 10.85 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.768 ' CE2' HG23 ' A' ' 33' ' ' VAL . 31.0 m-85 -99.71 132.88 44.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.514 -0.992 . . . . 0.0 109.229 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -114.64 154.92 27.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.269 -0.894 . . . . 0.0 110.243 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 31' ' ' CYS . 0.9 OUTLIER -89.18 151.19 22.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.444 -0.785 . . . . 0.0 109.58 179.703 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.512 ' CB ' ' HB2' ' A' ' 28' ' ' TRP . 3.1 m -125.44 130.68 52.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.448 -0.783 . . . . 0.0 110.739 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.447 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 0.5 OUTLIER -75.25 -42.46 55.11 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.523 -0.736 . . . . 0.0 109.351 179.136 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.1 m -68.19 -38.13 81.66 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.87 -0.519 . . . . 0.0 109.819 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.512 ' HB2' ' CB ' ' A' ' 25' ' ' SER . 38.0 m0 -79.35 -46.3 17.92 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.596 -0.69 . . . . 0.0 109.453 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.45 17.92 34.88 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.528 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 2.9 p90 -151.35 178.26 9.45 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.025 -1.279 . . . . 0.0 111.091 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.668 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 2.4 p -119.32 123.6 44.59 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.918 0.866 . . . . 0.0 110.202 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.475 ' HA ' ' HD2' ' A' ' 22' ' ' TYR . . . -150.72 -179.69 7.47 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.768 HG23 ' CE2' ' A' ' 22' ' ' TYR . 92.5 t -69.96 117.13 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.091 -1.006 . . . . 0.0 109.751 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.79 152.04 45.26 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.51 -0.744 . . . . 0.0 110.852 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 50.08 63.68 9.68 Favored Pre-proline 0 N--CA 1.501 2.08 0 O-C-N 121.724 -0.61 . . . . 0.0 110.751 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo . . . . . 0 C--N 1.314 -1.271 0 O-C-N 123.813 1.428 . . . . 0.0 110.79 -179.976 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 121.162 0.506 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 112.28 -41.64 2.17 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.97 55.22 3.06 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.43 -1.041 . . . . 0.0 110.516 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.532 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -121.88 155.86 34.53 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.151 -0.968 . . . . 0.0 110.121 179.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.495 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -80.36 -120.66 0.42 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.486 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -152.91 -142.68 3.52 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.505 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 48.8 t80 -90.27 -38.72 13.22 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.462 -1.023 . . . . 0.0 110.71 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -139.11 74.24 1.46 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.278 -0.889 . . . . 0.0 109.672 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.495 ' CZ3' ' HA2' ' A' ' 5' ' ' GLY . 13.9 m0 -102.09 155.25 18.31 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.457 -0.777 . . . . 0.0 109.487 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -89.71 132.89 34.95 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.91 -1.119 . . . . 0.0 111.56 -179.013 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.499 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 27.8 p -151.57 174.72 13.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.788 -0.57 . . . . 0.0 110.382 178.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.4 -114.97 3.08 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.615 ' HD3' ' HD3' ' A' ' 26' ' ' LYS . 30.5 tpt180 -90.59 38.08 0.93 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.521 -0.988 . . . . 0.0 109.701 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.25 35.13 7.16 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.528 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -66.7 -59.86 7.33 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 121.514 -0.992 . . . . 0.0 110.044 179.68 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 48.0 Cg_endo -74.69 139.01 24.62 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 O-C-N 123.774 1.408 . . . . 0.0 110.037 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.4 115.66 4.37 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.927 1.488 . . . . 0.0 110.947 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.432 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 95.1 m -84.97 176.26 8.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.49 -0.757 . . . . 0.0 110.02 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.57 ' HB2' ' CD1' ' A' ' 22' ' ' TYR . 3.7 m -86.55 165.43 16.22 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.213 -0.93 . . . . 0.0 109.957 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -56.33 126.75 27.66 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.411 -0.805 . . . . 0.0 111.059 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.32 -24.07 33.72 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.57 ' CD1' ' HB2' ' A' ' 19' ' ' CYS . 78.7 m-85 -95.83 129.01 43.19 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.279 -1.13 . . . . 0.0 110.238 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -118.42 150.79 38.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.64 -0.663 . . . . 0.0 109.866 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.513 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 0.9 OUTLIER -89.35 158.68 17.69 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.361 -0.837 . . . . 0.0 110.553 -179.725 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.37 113.95 12.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.467 -0.771 . . . . 0.0 110.737 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.615 ' HD3' ' HD3' ' A' ' 13' ' ' ARG . 12.0 tttt -70.55 -36.56 73.73 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.456 -0.778 . . . . 0.0 109.763 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.5 m -61.54 -42.02 98.2 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.549 -0.72 . . . . 0.0 109.904 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.59 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 47.7 m0 -85.75 -56.85 3.29 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.738 -0.601 . . . . 0.0 109.516 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.12 20.77 4.33 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.185 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.59 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.8 p90 -151.11 -174.66 4.88 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 119.064 1.432 . . . . 0.0 111.519 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.513 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 6.5 t -128.13 127.49 43.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.689 -0.632 . . . . 0.0 110.29 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -150.49 174.19 13.22 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.239 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.4 t -56.92 152.07 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.361 -0.837 . . . . 0.0 110.122 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.05 94.83 6.02 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.373 -0.83 . . . . 0.0 110.236 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.57 149.04 19.48 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.517 -0.74 . . . . 0.0 110.593 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo . . . . . 0 C--N 1.313 -1.335 0 O-C-N 123.966 1.508 . . . . 0.0 110.784 179.647 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.032 0.444 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.29 129.97 13.08 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.72 53.65 2.64 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.399 -1.059 . . . . 0.0 110.464 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.94 157.66 41.68 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.291 -0.88 . . . . 0.0 110.037 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.487 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -105.01 -109.3 3.4 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.545 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -153.56 -159.37 9.09 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 71.2 t80 -80.74 -33.21 35.3 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.554 -0.968 . . . . 0.0 110.616 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 30.3 t90 -141.98 78.41 1.63 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.297 -0.877 . . . . 0.0 109.931 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.545 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 14.0 m0 -108.2 156.26 19.54 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.548 -0.72 . . . . 0.0 109.374 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -89.63 134.32 34.2 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.794 -1.191 . . . . 0.0 111.067 -179.271 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.554 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 21.4 p -151.06 166.78 29.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.673 -0.642 . . . . 0.0 110.305 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.07 -111.88 1.08 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.478 ' HG3' ' HB3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -90.73 29.08 1.38 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.47 -1.018 . . . . 0.0 109.87 179.1 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.09 35.36 4.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.519 ' CB ' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -63.97 -61.09 7.42 Favored Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.313 -1.11 . . . . 0.0 110.363 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' A' ' 11' ' ' CYS . 47.9 Cg_endo -74.71 129.23 12.41 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.643 1.338 . . . . 0.0 109.72 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.47 114.91 4.08 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.692 1.364 . . . . 0.0 110.175 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.423 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 73.4 m -82.02 171.72 14.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.519 -0.738 . . . . 0.0 110.145 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.89 148.46 49.38 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.304 -0.873 . . . . 0.0 109.862 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.49 133.4 24.94 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.556 -0.715 . . . . 0.0 110.981 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.0 -27.77 18.94 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.913 ' CE1' HG22 ' A' ' 33' ' ' VAL . 12.5 m-30 -90.72 154.23 19.7 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.425 -1.044 . . . . 0.0 110.124 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.949 ' HB3' ' HB2' ' A' ' 34' ' ' GLU . . . -136.3 151.69 49.89 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.542 -0.724 . . . . 0.0 109.912 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.497 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 0.8 OUTLIER -89.81 162.92 15.26 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.299 -0.876 . . . . 0.0 110.045 179.798 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.562 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 0.6 OUTLIER -131.6 101.19 5.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.502 -0.749 . . . . 0.0 110.457 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.478 ' HB3' ' HG3' ' A' ' 13' ' ' ARG . 11.2 pttm -60.36 -33.55 72.6 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.606 -0.684 . . . . 0.0 110.186 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.7 m -70.51 -39.86 73.85 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.618 -0.676 . . . . 0.0 110.235 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.562 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 46.6 m0 -82.64 -52.31 6.92 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.588 -0.695 . . . . 0.0 109.804 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.42 18.55 6.58 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 5.0 p90 -151.13 -170.6 3.7 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.753 -1.44 . . . . 0.0 111.464 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.497 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 8.9 t -132.87 130.98 40.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.604 -0.685 . . . . 0.0 110.414 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -149.4 -175.93 5.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.666 -0.646 . . . . 0.0 109.921 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.913 HG22 ' CE1' ' A' ' 22' ' ' TYR . 12.5 t -72.84 91.73 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.949 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . 30.9 mt-10 -107.79 -30.99 8.22 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.46 -0.775 . . . . 0.0 110.868 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.99 155.26 55.43 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.277 -0.89 . . . . 0.0 110.44 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 C--N 1.313 -1.328 0 O-C-N 123.904 1.476 . . . . 0.0 110.619 -179.953 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 121.197 0.522 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.69 -74.45 0.2 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -107.22 95.18 5.52 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.404 -1.056 . . . . 0.0 110.33 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.561 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -139.51 154.51 47.7 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.567 -0.708 . . . . 0.0 109.961 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.447 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -86.44 -126.34 1.96 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.551 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -145.77 -148.67 4.84 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.426 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 44.7 t80 -86.55 -27.3 24.03 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.343 -1.092 . . . . 0.0 110.855 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -151.06 68.69 0.94 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.432 -0.793 . . . . 0.0 109.833 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.551 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 16.9 m0 -96.64 160.31 14.45 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.454 -0.779 . . . . 0.0 109.629 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -90.14 130.84 36.24 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.999 -1.063 . . . . 0.0 111.391 -179.076 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.406 ' HB2' ' CD ' ' A' ' 16' ' ' PRO . 29.7 p -151.73 179.39 8.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.762 -0.586 . . . . 0.0 110.522 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.61 -121.42 4.61 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.72 53.39 2.4 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.554 -0.968 . . . . 0.0 109.899 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.437 ' HA2' ' HB2' ' A' ' 24' ' ' CYS . . . 77.93 37.81 28.48 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.547 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 0.3 OUTLIER -71.09 -58.37 4.11 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.493 -1.004 . . . . 0.0 110.199 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.547 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 48.4 Cg_endo -76.42 143.42 24.71 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 O-C-N 123.736 1.388 . . . . 0.0 109.958 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.422 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 48.8 Cg_endo -73.9 99.06 1.12 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.757 1.398 . . . . 0.0 110.762 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.418 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 0.1 OUTLIER -69.67 177.04 3.18 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.266 -0.896 . . . . 0.0 109.376 179.229 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.561 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 2.7 m -81.16 161.61 23.98 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.137 -0.977 . . . . 0.0 109.654 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -55.95 120.46 7.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.391 -0.818 . . . . 0.0 110.457 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.0 -14.72 44.63 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.523 ' CD1' ' HB2' ' A' ' 19' ' ' CYS . 66.8 m-85 -102.59 131.63 49.22 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.051 -1.264 . . . . 0.0 110.122 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -117.45 147.36 42.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.57 -0.706 . . . . 0.0 110.24 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 1.1 m -89.36 159.26 17.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.415 -0.803 . . . . 0.0 110.065 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 2.0 m -130.22 117.77 20.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.576 -0.703 . . . . 0.0 110.483 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -69.82 -37.63 76.31 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.551 -0.718 . . . . 0.0 109.751 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.3 m -71.83 -39.73 69.58 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.625 -0.672 . . . . 0.0 110.255 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.571 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 43.9 m0 -78.9 -48.69 14.14 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.555 -0.716 . . . . 0.0 109.803 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.54 18.08 15.47 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.571 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.5 p90 -150.85 -179.23 7.1 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.856 -1.379 . . . . 0.0 111.157 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.629 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 22.8 t -123.91 129.94 51.79 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.662 -0.649 . . . . 0.0 110.232 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.12 169.65 19.53 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.787 -0.571 . . . . 0.0 110.135 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.461 ' CG2' ' CE2' ' A' ' 22' ' ' TYR . 59.4 t -60.1 157.01 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.445 -0.784 . . . . 0.0 110.443 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -94.97 34.06 1.42 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.44 -0.788 . . . . 0.0 110.795 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.718 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -71.56 -51.15 9.73 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.278 -0.889 . . . . 0.0 110.478 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.718 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 47.9 Cg_endo . . . . . 0 N--CA 1.486 1.058 0 O-C-N 123.405 1.213 . . . . 0.0 110.791 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 N--CA 1.498 1.949 0 CA-C-O 121.201 0.524 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -134.07 70.21 0.52 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 17' ' ' PRO . 0.5 OUTLIER -120.99 168.7 11.23 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.579 -0.954 . . . . 0.0 110.296 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.545 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -123.76 155.75 37.34 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.353 -0.842 . . . . 0.0 109.926 179.598 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.437 ' HA2' ' CZ3' ' A' ' 9' ' ' TRP . . . -94.76 -120.89 3.44 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.524 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -144.97 -149.6 5.06 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -88.44 -17.28 30.75 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.305 -1.115 . . . . 0.0 110.685 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 -160.06 68.06 0.38 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.322 -0.861 . . . . 0.0 110.07 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.524 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 20.2 m0 -96.81 173.69 7.18 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.401 -0.812 . . . . 0.0 110.087 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -94.81 133.31 38.65 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.185 -0.947 . . . . 0.0 110.945 -179.486 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' ' 31' ' ' CYS . 24.8 p -150.75 159.38 44.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.606 -0.684 . . . . 0.0 110.47 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -93.61 -118.0 2.76 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.551 ' HB2' ' HD2' ' A' ' 26' ' ' LYS . 0.3 OUTLIER -90.78 43.01 1.13 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.528 -0.984 . . . . 0.0 109.723 179.388 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.95 39.92 5.36 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.569 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 6.4 mttt -76.89 -64.0 0.49 Allowed Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.431 -1.041 . . . . 0.0 110.023 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.569 ' CD ' ' CB ' ' A' ' 15' ' ' LYS . 48.5 Cg_endo -74.39 133.64 17.85 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 O-C-N 123.579 1.305 . . . . 0.0 109.633 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.472 ' HB2' ' O ' ' A' ' 3' ' ' GLU . 50.6 Cg_endo -73.26 111.51 3.3 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.678 1.357 . . . . 0.0 110.319 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.4 m -77.39 179.2 6.59 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.402 -0.811 . . . . 0.0 110.101 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.545 ' HA ' ' HB2' ' A' ' 4' ' ' CYS . 2.7 m -87.4 150.81 23.56 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.382 -0.824 . . . . 0.0 110.078 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.16 118.78 3.46 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.607 -0.683 . . . . 0.0 110.532 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.29 -35.98 3.69 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.792 ' CD1' HG22 ' A' ' 33' ' ' VAL . 5.6 m-85 -93.66 152.16 19.17 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.35 -1.088 . . . . 0.0 110.069 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -126.27 146.74 49.88 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.648 -0.658 . . . . 0.0 110.178 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 13.4 t -89.75 159.84 16.85 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.457 -0.777 . . . . 0.0 110.331 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.6 m -140.75 116.69 10.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.653 -0.655 . . . . 0.0 110.559 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.551 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -73.72 -39.25 64.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.419 -0.801 . . . . 0.0 109.19 179.051 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.1 m -62.85 -40.59 97.93 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.555 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 40.5 m0 -79.98 -38.83 31.39 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.26 13.97 50.02 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.555 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 3.3 p90 -150.92 177.03 10.53 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.903 -1.351 . . . . 0.0 111.273 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 31.2 t -126.08 121.88 34.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.752 -0.592 . . . . 0.0 109.714 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.75 -178.26 5.34 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.541 -0.725 . . . . 0.0 110.046 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.792 HG22 ' CD1' ' A' ' 22' ' ' TYR . 21.5 t -63.72 156.82 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.272 -0.892 . . . . 0.0 110.188 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -54.98 102.04 0.06 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.638 -0.663 . . . . 0.0 110.235 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -161.31 148.24 11.7 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.416 -0.803 . . . . 0.0 110.501 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo . . . . . 0 C--N 1.314 -1.285 0 O-C-N 123.954 1.502 . . . . 0.0 110.58 179.728 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 121.347 0.594 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.9 -155.45 52.83 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -159.31 85.92 0.8 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.352 -1.087 . . . . 0.0 110.382 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -145.09 154.24 42.27 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.469 -0.77 . . . . 0.0 110.218 179.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.47 ' HA2' ' CE3' ' A' ' 9' ' ' TRP . . . -95.72 -129.02 5.77 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.53 ' HA3' ' NE1' ' A' ' 9' ' ' TRP . . . -147.22 -153.73 6.0 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 32' ' ' ALA . 77.5 t80 -79.66 -29.63 40.95 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.346 -1.091 . . . . 0.0 110.899 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -149.21 74.92 1.27 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.18 -0.95 . . . . 0.0 109.883 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.53 ' NE1' ' HA3' ' A' ' 6' ' ' GLY . 16.3 m0 -105.05 178.32 4.59 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.666 -0.646 . . . . 0.0 109.377 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.98 133.52 35.22 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.93 -1.106 . . . . 0.0 110.778 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.581 ' SG ' ' HD2' ' A' ' 16' ' ' PRO . 40.7 t -151.69 162.36 41.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.653 -0.654 . . . . 0.0 110.372 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -102.57 -119.01 4.52 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 108.889 -1.685 . . . . 0.0 108.889 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.553 ' HG2' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -91.15 31.24 1.13 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.322 -1.105 . . . . 0.0 110.129 179.153 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.83 36.77 3.61 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.537 ' CB ' ' CD ' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -76.57 -63.92 0.53 Allowed Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.372 -1.075 . . . . 0.0 110.557 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.581 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 44.1 Cg_endo -71.18 135.28 26.77 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.729 1.384 . . . . 0.0 110.042 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.439 ' O ' ' HA ' ' A' ' 4' ' ' CYS . 45.5 Cg_endo -71.88 100.97 1.13 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.81 1.426 . . . . 0.0 110.844 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.0 m -72.77 169.25 17.11 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.342 -0.848 . . . . 0.0 109.216 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.2 147.9 46.35 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.941 -1.1 . . . . 0.0 110.025 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.55 119.81 4.52 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.638 -0.663 . . . . 0.0 110.571 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.26 -22.61 17.63 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.867 ' CE1' HG22 ' A' ' 33' ' ' VAL . 12.4 m-30 -89.07 157.95 18.15 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.416 -1.05 . . . . 0.0 109.974 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -133.29 151.32 51.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.506 -0.746 . . . . 0.0 109.917 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.3 m -89.12 167.17 13.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.506 -0.746 . . . . 0.0 110.694 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.492 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 17.3 m -132.66 102.21 5.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.613 -0.679 . . . . 0.0 110.324 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.553 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 1.8 ttpt -65.09 -31.42 72.63 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.555 -0.716 . . . . 0.0 110.841 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.9 m -82.92 -36.13 25.5 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.435 -0.79 . . . . 0.0 110.873 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.588 ' HB3' ' CZ3' ' A' ' 30' ' ' TRP . 45.0 m0 -79.95 -42.63 23.62 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.477 -0.765 . . . . 0.0 110.236 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.07 16.88 22.18 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.498 -0.858 . . . . 0.0 110.976 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.588 ' CZ3' ' HB3' ' A' ' 28' ' ' TRP . 2.8 p90 -150.59 178.82 8.71 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.107 -1.231 . . . . 0.0 110.822 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 22.6 t -121.01 135.88 55.11 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.548 -0.72 . . . . 0.0 109.786 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 7' ' ' PHE . . . -146.03 -179.59 6.82 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.436 -0.79 . . . . 0.0 110.242 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.867 HG22 ' CE1' ' A' ' 22' ' ' TYR . 11.9 t -75.01 151.64 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.388 -0.82 . . . . 0.0 109.802 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -68.86 -26.4 65.13 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.51 -0.744 . . . . 0.0 110.813 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.26 150.51 95.55 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.379 -0.826 . . . . 0.0 110.437 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 C--N 1.312 -1.384 0 O-C-N 123.892 1.47 . . . . 0.0 110.863 179.971 . . . . . . . . 0 0 . 1 stop_ save_